World Sleep 2023 Scientific Program

The Precision of the Sleep Lab, Everywhere

The Nox SAS solution is a new, flexible way to record EEG, ECG and EMG data during polysomnography sleep studies conducted with the Nox A1s PSG system.

High level of agreement for all sleep stages when compared to the conventional montage.*

Applied in the sleep lab or by the patient at home.

Enables fast hookup and high signal quality.

Visit our booth #86 to learn about where PSG sleep studies are going next.

WELCOME TO WORLD SLEEP 2023

Dear Colleagues,

Welcome to Rio de Janeiro, Brazil for the 17th World Sleep congress! The World Sleep community has again demonstrated a strong commitment to international collaboration: over 1,300 individuals from 68 countries are presenting at this congress. We sincerely thank every contributor for their dedication to research and their enthusiasm for sharing it with the world. Your work makes such an incredible scientific program possible.

The Brazilian Sleep Association and city of Rio de Janeiro could not be better hosts for our international congress. It will be a pleasure to meet old friends and colleagues in this world-class destination. We hope you can take some time to enjoy the beauty of our host city, and we thank the Brazilian Sleep Association for their hospitality and warm welcome to Brazil.

Browse the program, mark your must-see sessions, make plans to connect with colleagues, and make time to build new connections, too. A World Sleep congress is an opportunity like no other. We’ll see you in Rio!

Sincerely,

2023 Program Committee

World Sleep 2023 Program Committee

Charles Morin, PhD Chair Université Laval

Monica Levy Andersen, PhD Universidade Federal de São Paulo (UNIFESP)

Luciano Drager, MD, PhD University of São Paulo

Peter Eastwood, PhD Murdoch University

Raffaele Ferri, MD Oasi Research Institute IRCCS

Pedro Genta, MD University of São Paulo

Birgit Högl, MD Medical University of Innsbruck

Clete Kushida, MD, PhD Stanford University Medical Center

Allan O’Bryan World Sleep Society

Judith Owens, MD Harvard Medical School

Thomas Penzel, PhD Charité Universitätsmedizin Berlin

Shelly Weiss, MD University of Toronto

Yun Kwok Wing, MBChB The Chinese University of Hong Kong

Edilson Zancanella, MD, PhD University of Campinas

Phyllis C. Zee, MD, PhD Northwestern University

2023 PROGRAM OVERVIEW

Congress Dates

October 20 – 25, 2023

Venue & Location

Windsor Convention & Expo Center

R. Martinho de Mesquita, 129

Barra da Tijuca, Rio de Janeiro

International Scientific Content

World Sleep 2023 provides a unique opportunity to connect in person with sleep medicine professionals from around the world. Over 1300 presenters are coming to Rio de Janeiro to share the latest results from all specialties that investigate sleep and circadian topics. Browse the extensive World Sleep 2023 scientific program and mark your “must-see” sessions, or search the online schedule available at worldsleepcongress.com by topic and time to create your custom agenda.

3,000+

Scientific Program Topics

• Aging and Developmental Issues

• Basic Research

• Sleep and Cognition

• Chronobiology/Circadian Disorders

• Dental

• Dreaming

• Excessive Daytime Sleepiness/Hypersomnia

• Insomnia

• Movement Disorders

• Narcolepsy

• Neurological Disorders Affecting Sleep

• Parasomnia

• Pediatrics

• Pharmacology

• Psychiatric Disorders Affecting Sleep/Wake

• REM Behavior Disorders

• Restless Legs Syndrome (RLS)

• Sleep Breathing Disorders

• Sleep Health

• Technology/Technical

• Women

Networking & Social Events

• Opening Ceremony

• Coffee Breaks

• Affiliate Meetings

• Poster Sessions

• Exhibit Hall

• Gala Dinner

• Closing Ceremony

ADVANCING SLEEP HEALTH WORLDWIDE

About the Organizers

World Sleep Society has collaborated with the Brazilian Sleep Association to host World Sleep 2023.

Brazilian Sleep Association

Brazilian Sleep Association (ABS), founded in August 1985 under the name Brazilian Sleep Society, is the interdisciplinary institution for all Brazilians who study sleep and who practice sleep medicine and related care. ABS promotes numerous activities, including courses, meetings with civil society and public policymakers, and the facilitation of sleep research and care.

World Sleep Society

The mission of World Sleep Society is to advance sleep health worldwide. A professional membership organization for sleep physicians, researchers, and other sleep professionals, World Sleep Society manages a variety of programs for its members, the interdisciplinary field of sleep medicine, and the public. The biennial World Sleep congress is organized to build global connections among upcoming and experienced professionals in sleep medicine and research.

Contact Information

World Sleep Society

3270 19th Street NW, Suite 109

Rochester, MN 55901 USA

+001-507-316-0084

info@worldsleepsociety.org

worldsleepsociety.org

Have Questions?

Visit the registration desk to ask any of your congress questions. The registration desk is located on floor 1 near the elevators and is open until 6pm daily.

Registration Questions

Administrative Assistant info@worldsleepsociety.org

Scientific Program Questions Meeting Manager granum@worldsleepsociety.org

Press & Public Relations

Communications Coordinator ringstad@worldsleepsociety.org

Membership Questions

Administrative Assistant info@worldsleepsociety.org

Exhibitor & Sponsorship Questions

Allan O’Bryan, Executive Director obryan@worldsleepsociety.org

2023 COMMITTEES

Scientific Selection for the Congress

The Program Committee of each World Sleep congress is created following the World Sleep Society bylaws of committee formation, including six members of World Sleep Society and three members of the local host society. Topics are determined and proposal reviews organized by the Program Committee using established policies and procedures to mitigate bias and ensure scientific excellence. Read more at worldsleepsociety.org/scientificselection-for-world-sleep-congress

World Sleep 2023 Program Committee

Chair

Charles Morin, PhD (Canada)

Monica Levy Andersen, PhD (Brazil)

Luciano Drager, MD, PhD (Brazil)

Peter Eastwood, PhD (Austrailia)

Raffaele Ferri, MD (Italy)

Pedro Genta, MD (Brazil)

Birgit Högl, MD (Austria)

Clete Kushida, MD, PhD (United States)

Allan O’Bryan (United States)

Judith Owens, MD (United States)

Thomas Penzel, PhD (Germany)

Shelly Weiss, MD (Canada)

Yun Kwok Wing, MBChB (Hong Kong)

Edilson Zancanella, MD, PhD (Brazil)

Phyllis C. Zee, MD, PhD (United States)

Executive Committee of World Sleep Society

Phyllis C. Zee, President (United States)

Raffaele Ferri, President-Elect (Italy)

Ofer Jacobowitz, Secretary (United States)

Maree Barnes, Treasurer (Australia)

Birgit Högl, Past President (Austria)

Governing Council of World Sleep Society

Africa: Lamia Afifi (Egypt)

Asia or Australia: Hiroshi Kadotani (Japan)

Europe: Federica Provini (Italy)

North America: Saverio Stranges (Canada)

Central or South America: Andrea Bacelar (Brazil)

American Academy of Sleep Medicine (AASM)

Asian Society of Sleep Medicine (ASSM)

Canadian Sleep Society (CSS)

European Sleep Research Society (ESRS)

Sleep Research Society (SRS)

2023 INTERNATIONAL SCIENTIFIC COMMITTEE

The International Scientific Committee is essential to the development of a scientifically and internationally balanced program, ensuring that the mission of advancing sleep health worldwide is being accomplished. The primary responsibility of the International Scientific Committee is to review and score oral and poster abstract submissions.

Alejandro Iranzo (Spain)

Aleksandar Videnovic (United States)

Alessandro Silvani (Italy)

Alister Neill (New Zealand)

Allan Pack (United States)

Alon Avidan (United States)

Ambra Stefani (Austria)

Amy Jordan (Australia)

Amy Reynolds (Australia)

Ana Hanlon-Dearman (Canada)

Andrew Vakulin (Australia)

Anna Castelnovo (Italy)

Anna Heidbreder (Austria)

Antje Büttner-Teleagă (Germany)

Antonio Culebras (United States)

Arturo Garay (Argentina)

Atul Malhotra (United States)

Audrey Yoon (United States)

Bei Bei (Australia)

Bhajan Singh (Australia)

Bjørn Bjorvatn (Norway)

Bradley Edwards (Australia)

Brian Murray (Canada)

Carlos Schenck (United States)

Cathy Goldstein (United States)

Celyne Bastien (Canada)

Clare Anderson (Australia)

Claudia Moreno (Brazil)

Claudia Trenkwalder (Germany)

Claudio Liguori (Italy)

Claudio Sergio Podestá (Argentina)

Clement Cheng-Hui (Taiwan)

Colin Espie (United Kingdom)

Dalva Poyares (Brazil)

Daniel Gottlieb (United States)

Daniel Vena (United States)

Danny Eckert (Australia)

David Neubauer (United States)

Diego Garcia-Borreguero (Spain)

Elizaveta Solomonova (Canada)

Emmanual Mignot (United States)

Eus van Someren (Netherlands)

Evelyn Constantin (Canada)

Fan Jiang (China)

Fang Han (China)

Federica Provini (Italy)

Frances Chung (Canada)

Friederike Sixel-Döring (Germany)

Gabrielle Rigney (Australia)

Garima Shukla (Canada)

Geert Mayer (Germany)

Geraldo Lorenzi (Brazil)

Giulio Alessandri-Bonetti (Italy)

Glenn Legault (Canada)

Graham Reid (Canada)

Guanghai Wang (China)

Gustavo Moreira (Brazil)

Hakan Kaynak (Türkiye)

Helen Driver (Canada)

Helena Hachul (Brazil)

Hrudananda Mallick (India)

Indra Narang (Canada)

Isabelle Arnulf (France)

Javier Puertas (Spain)

Jean-Louis Pépin (France)

Jeanne Duffy (United States)

Joachim Maurer (Germany)

Johan Verbraecken (Belgium)

John Fleetham (Canada)

John Peever (Canada)

John Winkelman (United States)

Joseph De Koninck (Canada)

Jun Kohyama (Japan)

Kai Spiegelhalder (Germany)

Karel Šonka (Czech Republic)

Kimberly Cote (Canada)

Kimberly Honn (United States)

Lais Fernanda Berro (United States)

Lamia Afifi (Egypt)

Laura Lewis (United States)

Laura Palagini (Italy)

Lecendreux Michel (France)

Lenise Jihe Kim (United States)

Leon Rosenthal (United States)

Lino Nobili (Italy)

Lourdes DelRosso (United States)

Lucie Barateau (France)

Ludovico Messineo (United States)

Luigi Ferini Strambi (Italy)

Lynn Marie Trotti (United States)

2023 INTERNATIONAL SCIENTIFIC COMMITTEE

Malcolm von Schantz (United Kingdom)

Maree Barnes (Australia)

Maria-Lucia Muntean (Germany)

Marie Marklund (Sweden)

Markku Partinen (Finland)

Marta Kaminska (Canada)

Mary Carskadon (United States)

Matteo Cesari (Austria)

Megan Thomas (Canada)

Mehdi Tafti (Switzerland)

Michael Chee (Singapore)

Michael Grandner (United States)

Michael Irwin (United States)

Mihaela Teodorescu (United States)

Monica Puligheddu (Italy)

Naima Covassin (United States)

Nancy Collop (United States)

Natalia Machado (United States)

Nigel McArdle (Australia)

Ning-Hung Chen (Taiwan)

Ofer Jacobowitz (United States)

Oluwatosin Olorunmoteni (Nigeria)

Osman Ipsiroglu (Canada)

Pedro Genta (Brazil)

Philip de Chazal (Australia)

Pierre Philip (France)

Pierre-Hervé Luppi (France)

Poul Jørgen Jennum (Denmark)

Priyattam Shiromani (United States)

Rachel Manber (United States)

Rainer Popovic (Austria)

Renata L. Riha (United Kingdom)

Renaud Tamisier (France)

Reshma Amin (Canada)

Reut Gruber (Canada)

Robert Owens (United States)

Robert Skomro (Canada)

Robert Thomas (United States)

Robyn Stremler (Canada)

Rosa Hasan (Brazil)

Rosalia Silvestri (Italy)

Ruth Benca (United States)

Saadoun Bin-Hasan (Kuwait)

Sara Nowakowski (United States)

Scott Sands (United States)

Sharon Keenan (United States)

Silke Ryan (Ireland)

Silvia Gonçalves Conway (Brazil)

Soňa Nevšímalová (Czech Republic)

Sonia Ancoli-Israel (United States)

Stanley Yung Liu (United States)

Suresh Kotagal (United States)

Susan Redline (United States)

Sutapa Mukherjee (Australia)

Suzanne Bertisch (United States)

Teresa Paiva (Portugal)

Thanh Dang-Vu (Canada)

Thomas Roth (United States)

Todd Arnedt (United States)

Tom DeBoer (Netherlands)

Valerie Cochen De Cock (France)

Vijaya Krishnan Paramasivan (India)

Virend Somers (United States)

Vishesh Kapur (United States)

Walter McNicholas (Ireland)

Wendy Hall (Canada)

Wendy Troxel (United States)

Winfried Randerath (Germany)

Yong Won Cho (South Korea)

Yuichi Inoue (Japan)

Yu-Shu Huang (Taiwan)

Yves Dauvilliers (France)

Zhi-Li Huang (China)

Zucconi Marco (Italy)

GENERAL INFORMATION

Congress Dates

October 20 – 25, 2023

Venue & Location

Windsor Convention & Expo Center

R. Martinho de Mesquita, 129

Barra da Tijuca, Rio de Janeiro

Continuing Medical Education (CME)

World Sleep Society will apply to offer CME credits at World Sleep 2023. Attendees will be responsible for purchasing the $25 CME fee, recording their activities and submitting them to World Sleep Society for processing. The final number of CME credits available at World Sleep 2023 is to be determined.

Badge Identification

All congress participants and guests must wear a World Sleep 2023 congress badge. Badges allow entrance to the scientific sessions and access to the convention center. Your cooperation with this policy is appreciated. Recycle your badge holder after the congress by dropping it off at the registration desk. Replacement badges can be obtained at the registration desk for a fee.

Membership

World Sleep Society membership records can be reviewed and memberships purchased at the registration desk. Learn more about membership benefits at worldsleepsociety.org.

Registration Desk – Floor 1

Registration materials (bags, final programs, tickets, etc.) will be provided at the registration desk located at the entrance to Windsor Convention & Expo Center. Tickets are required for entry to the gala dinner and to pre-congress courses on Saturday and Sunday. Tickets can be purchased online or at the registration desk.

Registration Desk Hours

Friday: 4:00pm to 8:00pm

Saturday: 7:00am to 6:00pm

Sunday: 7:00am to 6:00pm

Monday: 7:00am to 6:00pm

Tuesday: 7:00am to 6:00pm

Wednesday: 7:00am to 6:00pm

Exhibit Hall Hours

Monday: 9:30am–4:00pm

Tuesday: 9:30am–4:00pm

Wednesday: 9:30am–2:00pm

Speaker Ready Room – Room C04 on Floor 2

A speaker ready room is available for presenters to upload their presentations, test software, and make changes to their presentations. Speakers are required to upload their presentations in the speaker ready room at least 12 hours prior to their session. A technician will be available to assist as needed.

Speaker Ready Room Hours

Saturday: 7:00am to 5:00pm

Sunday: 7:00am to 5:00pm

Monday: 7:00am to 5:00pm

Tuesday: 7:00am to 5:00pm

Wednesday: 7:00am to 5:00pm

GENERAL INFORMATION

Press Room

Members of the press are able to use the speaker ready room to work and access the internet.

Recording Device Policy

No recording devices, audio or visual, may be used during CME activities. Duplication, distribution, or excerpting of this program without the express written permission of World Sleep Society is strictly prohibited. All of the proceedings of this program, including the presentation of scientific papers, are intended for limited publication only, and all property rights in the material presented, including common-law copyright, are expressly reserved by the Faculty, World Sleep Society, and/or CME provider. No statement of presentation made is to be regarded as dedicated to the public domain. Any sound reproduction, transcript, or other use of the material presented at this CME activity without the permission of World Sleep Society and CME provider is prohibited to the full extent of common-law copyright in such material.

Cameras and recording devices are not allowed to be used in the scientific meeting rooms at any time. Violation of this rule could result in removal from the congress along with the confiscation of the film and/or recording device.

Electronic Devices

Please turn all electronic devices (phones, pagers, etc.) to silent mode during presentations. As a courtesy to the presenters and audience, phone calls should be taken outside of the scientific sessions.

Seating

Scientific sessions are filled on a first-come, first-served basis. World Sleep Society and the Program Committee reviewed the scientific sessions to anticipate demand and match the room size with expected seating. Occasionally, a presentation will have higher demand than expected. We encourage delegates to arrive early for the best possible seating.

World Sleep 2023 Program Types

GETTING TO THE VENUE

World Sleep 2023 has coordinated with a tour company based in Rio de Janeiro to facilitate ground transportation between the airport and hotels. The official tour company is JulyTur.

Venue & Location

Windsor Convention & Expo Center

R. Martinho de Mesquita, 129 Barra da Tijuca, Rio de Janeiro

Reserve Airport Transportation

Ensure a smooth process from landing to check-in with pre-arranged ground transportation at the airport. Reservations with JulyTur can be made through the link on the official World Sleep 2023 website.

Visit the following page to reserve your transportation:

worldsleepcongress.com/transportation

Please note that JulyTur is the only official provider for this service.

Transportation within Rio de Janeiro

We recommend the use of licensed taxi drivers when possible. Uber is also widely available in Rio de Janeiro, but we recommend the use of the “Uber Black” service to better ensure the driver has a strong record. Please take sensible precautions while arranging transportation independently, verifying your driver is correct and credible.

Going to the Gala Dinner?

Attendees of the Gala Dinner on Monday night will have the option to take bus transportation from the congress venue to the gala dinner venue. No additional cost or reservation is necessary; just be sure to have your gala dinner ticket on hand. Your ticket will be provided at registration.

The gala dinner will take place from 7:00pm to 12:00am on Monday, October 23 at Mansão Carioca, a villa in the Alto da Boa Vista neighborhood of Rio de Janeiro. The gala dinner will include fine food, wine, deserts, and light entertainment.

Photo courtesy of Mansão Carioca, Rio de Janeiro

TOURS IN RIO DE JANEIRO

Tours in Rio de Janeiro

JulyTur is offering many pre-arranged tours for our attendees to experience Rio de Janeiro. Make lifelong memories with visits to Christ the Redeemer statue, Sugarloaf Mountain, the imperial palace of Petrópolis, and more.

Nearby parks include the State Park of Pedra Branca and the National Park of Tijuca. The green forests and hills of Rio de Janeiro are natural wonders that give this destination its uniquely beautiful character. We hope you can take the opportunity to explore Rio’s natural and historical beauty!

Stop by the registration area on Floor 1 for more information on tours or visit the following page to learn more about the available tours through JulyTur: eventosrj.julytur.com.br

Connect With Us!

1. Go to Settings on your mobile device

2. Select the Wi-fi option

3. Click on the Wi-Fi network: WorldSleep

4. Enter password: sleep

The WORLD SLEEP 2023 app will allow you to view and search speaker names, sessions, rooms, and topics. It will also include details about social events such as the Opening Ceremony. Available in the App Store and on Google Play.

Use #WorldSleep2023 on your socials

NETWORKING & SOCIAL EVENTS

Connect with colleagues, learn about the latest developments and build your network worldwide with the opportunities found in Rio de Janeiro during October 20-25, 2023.

Brazilian Sleep Association (ABS)

Annual Meeting

Friday, Oct 20 | 10am – 6pm | Room A06

Friday, Oct 20 | 10am – 6pm | Room A07

The Brazilian Sleep Association is hosting a Latin American Day on Friday. Find the complete schedule within the program or in the online schedule.

Sponsored by Avadel

Opening Ceremony & Reception

Sunday, Oct 22 | 6:30pm – 9:00pm | Room 34

The opening ceremony will feature remarks from the president of World Sleep Society, Brazilian Sleep Association leadership, award presentations, and entertainment. A reception will follow.

Sponsored by Revery Labs

Poster Sessions

Group 1 | Sunday, Oct 22: 5pm – 6pm | Exhibit Hall

Group 2 | Sunday, Oct 22: 6pm – 7pm | Exhibit Hall

Group 3 | Sunday, Oct 22: 6pm – 7pm | Exhibit Hall

Browse poster abstracts and discuss upcoming research methods and findings with investigators in a more open, personal format.

Exhibit Hall

World Sleep 2023 will feature exhibitors from companies and organizations around the globe. Browse the exhibit hall to meet new people and see the latest developments of interest to professionals in sleep medicine and research.

Exhibit Hall Hours

Monday: 9:30am–4:00pm

Tuesday: 9:30am–4:00pm

Wednesday: 9:30am–2:00pm

Sponsored by Avadel

Gala Dinner

Monday, Oct 23 | 7pm – 11pm Purchase a ticket to join us at the Gala Dinner on Monday evening. Plan for a night of fine food, entertainment and conversation with friends.

World Sleep Society Membership Meeting

Tuesday, Oct 24 | 7am - 8am | Room 33

All attendees of World Sleep are welcome to attend this meeting.

Closing Ceremony & Reception

Wednesday, Oct 25 | 6:15pm–7:00pm | Room 34

All attendees and exhibitors are invited to join the Closing Ceremony. Catch up with your colleagues about what caught your interest during the congress and stay for a special presentation from the hosts of World Sleep 2023 in Rio de Janeiro, Brazil.

WORLD SLEEP 2023 FLOOR PLANS

WORLD SLEEP 2023 FLOOR PLANS

Find all program information in the free World Sleep 2023 app. Available in the App Store and on Google Play. Download links at worldsleepcongress.com/app

Registration Desk Hours

Friday: 4:00pm to 8:00pm

Saturday: 7:00am to 6:00pm

Sunday: 7:00am to 6:00pm

Monday: 7:00am to 6:00pm

Tuesday: 7:00am to 6:00pm

Wednesday: 7:00am to 6:00pm

Exhibit Hall Hours

Monday: 9:30am–4:00pm

Tuesday: 9:30am–4:00pm

Wednesday: 9:30am–2:00pm

Speaker Ready Room Hours

Friday: 7:00am to 5:00pm

Saturday: 7:00am to 5:00pm

Sunday: 7:00am to 5:00pm

Monday: 7:00am to 5:00pm

Tuesday: 7:00am to 5:00pm

Wednesday: 7:00am to 5:00pm

worldsleepsociety.org

facebook.com/wasmf

2023 KEYNOTE SPEAKERS

Monday, October 23 | 8:00–8:45am

Room 17

Raffaele Ferri, MD (Italy)

K01: Measuring and analyzing movements in sleep

This keynote lecture will focus on the continuously developing field of the quantitative measurement and analysis of movements during sleep. The last decades have been characterized by a significant effort towards the establishment of quantitative rules for the detection and scoring of different types of muscle activities during sleep including, but not exclusively, limb movements and periodic leg movements during sleep, REM sleep atonia, and the recently defined “large muscle group movements” characterizing Restless Sleep Disorder.

These quantitative approaches based on measurable parameters allow an easier and more reliable automatic detection of movements during sleep, making this process faster and cost-effective, and offer the possibility to better classify and identify different subtypes of motor events, within each category, possibly pointing at different neurophysiopathological mechanisms, which also seem to be associated with different effects on sleep and other physiological functions.

Room 24

Michael Chee, MBBS (Singapore)

K02: Consumer sleep tech and sleep transformation

Consumer health monitoring devices continuously collect data about the nature, timing and variability of activities that influence personal sleep, mood, performance and vice versa. Alongside, the widespread adoption of health wearables by diverse persons across the globe can significantly increase cross-cultural understanding about inter-individual differences in real-world sleep patterns. Integrating such knowledge with data on salient outcome markers could democratize the formulation of sleep advice currently dominated by North American and Western European perspectives. Early adopters were drawn by the novel technology, but people are increasingly asking: ‘how does the data help?’. This opens doors for sleep experts to work with data scientists to craft analyses that result in actionable recommendations that could improve health, wellbeing, and performance. The presentation will cover contemporary implementations of sleep tech, use-case illustrations, and future possibilities.

Room 34

Dalva Poyares, MD, PhD (Brazil)

K03: Sleep and aging crosstalk in health and disease

This presentation will explore polysomnographic sleep patterns with aging and sleep disorders in the elderly. Insomnia and obstructive sleep apnea are prevalent sleep disorders among older adults and lead to consequences on health and well-being. Associated factors including body composition, sarcopenia and metabolic status will also be discussed.

2023 KEYNOTE SPEAKERS

Monday, October 23 | 2:00–2:45pm

Room 17

Jan Born, PhD (Germany)

K04: The memory function of sleep: Implications for aging and dementia

Whereas memories are optimally encoded and retrieved when the brain is awake, the consolidation and formation of long-term memory requires an offline mode of processing as optimally established only during sleep. Based on evidence from behavioral and neurobiological studies in humans and rodents, I will consider the formation of long-term memory during sleep as an “active systems consolidation” process in which the repeated neuronal replay of representations originating from the hippocampus during slow-wave sleep (SWS) leads to a gradual transformation and integration of representations into extrahippocampal, mainly neocortical networks. I will highlight three features of this process: (i) Hippocampal replay that, by capturing episodic memory aspects, drives consolidation of both hippocampus-dependent and non-hippocampus-dependent memory; (ii) brain oscillations hallmarking SWS and rapid-eye movement (REM) sleep, respectively, which provide mechanisms to regulate both information flow across distant brain networks and local synaptic plasticity; and (iii) qualitative transformations of memories during sleep-dependent systems consolidation resulting in abstract schemalike knowledge representations. Finally, based on the concept of active systems consolidation during sleep, I will describe how specific alterations of sleep contribute to memory impairments in healthy aging and in patients with Alzheimer dementia.

Room 24

Stanley Liu, MD, DDS (United States)

K05: Sleep surgery as restoring missed milestones in airway growth and development

Selecting effective surgical treatment for obstructive sleep apnea (OSA) continues to be challenging. While treatment outcomes have improved, decisions for surgery tend to be based on identifying anatomic OSA risk factors based on a snapshot in time.

If the diagnostic thinking shifts from seeing the anatomic risk factors as they are to how they have become the way they are, the potential for positive impact of surgery greatly expands. Through the presentation of a contemporary algorithm founded on a continuum of care with sleep medicine, the latest of precision surgery will be highlighted. And, in applying a developmental mindset to surgical decision-making to restore missed developmental milestones, we can achieve more with less surgery.

Room 34

Julio Fernandez-Mendoza, PhD (United States)

K06: Sleep in adolescence: Epidemiology and burden of insomnia, short sleep, and beyond

Adolescence is a period of maturational brain changes resulting in synaptic pruning and myelination. These developmental changes are reflected in the sleeping brain, as the circadian phase delays, spindle density increases, and slow wave activity and sleep depth decline with puberty. Thus, adolescence is also a critical developmental stage for the chronicity and new-onset of sleep disorders. Compared to pediatric sleep apnea, childhood-onset insomnia symptoms are highly persistent through adolescence, a natural course determined by social and biobehavioral factors. In addition, adolescents who report insomnia symptoms and sleep objectively short have been shown to be at a greater risk of worsening into an insomnia disorder later in young adulthood. This keynote address will show how the sleeping brain and maturing circadian clock can be studied in epidemiological samples with developmental designs and help uncover the burden of specific sleep phenotypes, including insomnia, short sleep and beyond.

2023 KEYNOTE SPEAKERS

Tuesday, October 24 | 8:00–8:45am

Room 17

Claudia Trenkwalder, MD (Germany)

K07: REM sleep behavior disorder

Idiopathic or isolated REM sleep behavior disorder (iRBD) is currently the most specific prodromal feature of α-synuclein pathology, which may manifest even a decade before motor symptoms of Parkinson’s disease (PD), multiple system atrophy (MSA) or dementia with Lewy bodies (DLB) occur.

Evidence from the last decade has established RBD as a diagnostic marker for DLB and occurs in up to 80% in patients with MSA. The early diagnosis of RBD combined with other non-motor features (e.g. hyposmia, constipation, depression and cognitive decline) characterizes the prodromal phase of a neurodegenerative syndrome, most likely an alpha-synucleinopathy with increasing research on imaging, CSF and tissue biomarkers.

There are still cases who do not convert within years into a neurodegenerative disease, and ethical considerations should be taken for diagnosis of iRBD.

The early diagnosis of iRBD, however, provides an unprecedented opportunity to directly observe prodromal neurodegenerative states for early intervention with neuroprotective therapy, if available in the future.

Room 34

Fan Jiang, MD, PhD (China)

K08: Early childhood development: Sleep and the developing brain

Early childhood marks an important period when normative transition of sleep-wake pattern occurs, characterized by decreasing daytime sleep and nighttime sleep consolidation. Meanwhile, baby’s newly developing brain is highly plastic and responsive to change of environment and experience. Cutting-edge studies have revealed the critical role of sleep in cognitive, language and socio-emotional development in early childhood. In addition to neuropsychological assessment, the rapid development of noninvasive brain function measure techniques permits careful exploration the association between sleep and early brain development. The keynote will elucidate the relevant evidence and innovative research projects on sleep and developing brain, and prioritize promoting sleep health as a scaling-up strategy to drive optimum early childhood development.

2023 KEYNOTE SPEAKERS

Tuesday, October 24 | 2:00–2:45pm

Room 34

Michael Irwin, MD (United States)

K09: Insomnia, inflammation, and depression prevention

Dr. Irwin will examine the role of insomnia on inflammation, affective mechanisms of emotion perception and reward sensitivity, and depression risk. He will evaluate the role of sleep and its homeostatic regulation of the immune system and will examine how sleep disturbance and inflammation interact and act in concert to impair emotion perception and sensitivity to reward, which mechanistically contribute to depression.

In randomized clinical trials, he will identify the efficiency of cognitive behavioral therapy for insomnia (CBT-I) and mindfulness interventions to treat insomnia disorder, reverse markers of inflammation, and reduce depression. Finally, he will describe the ability of insomnia treatment to prevent depression. In an innovative selective prevention trial, he will examine the efficacy of CBT-I to prevent incident and recurrent major depressive disorder in a 3-year follow-up of non-depressed older adults with insomnia, and the potential for inflammatory mechanisms to moderate the benefit of this targeted prevention strategy to reduce the public health burden of depression, even in vulnerable populations who are difficult to reach due to stigma of depression.

Room 17 Room 24

Federica Provini, MD, PhD (Italy)

K10: Jerky movements in sleep: Unusual variants or a new movement disorder?

Some sleep-related movements are well known and well classified, but new motor manifestations appearing only or preferentially during sleep are not thoroughly characterized yet. This lecture will focus on jerky movements during sleep, including intensified hypnic jerks, propriospinal myoclonus, nocturnal facio-mandibular myoclonus, neck myoclonus and excessive fragmentary myoclonus. Clinical relevance and polygraphic features will be discussed proving clear cut-offs to discern between unusual isolated phenomenon and true diseases.

Silke Ryan, MD, PhD (Ireland)

K11: Novel insights of the role of sleep disordered breathing on cardiovascular and metabolic function

Obstructive sleep apnea (OSA) represents a global public health burden conveying a significant risk for the development and control of numerous cardiovascular and metabolic diseases. Continuous positive airway pressure (CPAP) is the treatment of choice for the majority of patients but its benefit on cardiometabolic diseases is limited. Thus, a greater understanding of the mechanisms by which OSA leads to such comorbidities might identify novel therapeutic approaches. The pathophysiology of cardiometabolic complications remains incompletely understood. Intermittent hypoxia (IH), a hallmark feature of OSA, plays likely a key role and experimental studies using animal and cell culture studies suggest that IH mediates adverse disease processes through activation of multiple mechanistic pathways such as sympathetic excitation, inflammation and oxidative stress. This presentation will summarize our current state of knowledge in this field and highlight potential therapeutic avenues.

2023 KEYNOTE SPEAKERS

Wednesday, October 25

8:00–8:45am

Room 17

Kenneth Wright, PhD (United States)

K12: Microbiome and sleep

The human gut microbiome is important for human health and brain function. Dysbiosis or dysregulation of the human microbiome and/or its function is associated with many diseases including, but not limited to, cardiometabolic, immune, neurological and mental health disorders. This talk will: 1) discuss integrative aspects of circadian rhythms, sleep, and the human microbiome; 2) highlight how microbiome dysbiosis during circadian misalignment and insufficient sleep may contribute to dysregulated physiology and cognition; and 3) describe the potential for microbiome based countermeasures to improve resilience during sleep and circadian disruptions.

Wednesday, October 25

2:00–2:45pm

Room 17

Chandra Jackson, PhD (United States)

K13: Climate change and sleep health: A call to action to address impending exacerbation of inequities

Grounded in the socioecological model of health, this keynote address will describe how innovative research approaches such as the integration of data across the translational science spectrum can advance investigations related to climate change and sleep health inequities. Illustrative examples and a call to action for developed and developing countries will be offered.

Room 34

Laura Lewis, PhD (United States)

K14: Neural, vascular, and cerebrospinal fluid dynamics of the sleeping brain

When we fall asleep, most aspects of brain function and physiology are rapidly transformed. Understanding the neural basis of sleep requires imaging methods that can capture multiple aspects of brain physiology at fast timescales. We used new methods for fast imaging in the human brain to investigate the neural origins and consequences of sleep. We found that accelerated methods for fMRI can enable imaging subsecond neural dynamics throughout the human brain. We applied these methods to investigate the neural dynamics that occur at state transitions, and identified temporal sequences within thalamocortical networks that precede the moment of awakening from sleep. In addition, we developed a method to image cerebrospinal fluid flow, and discovered large waves of fluid flow that appear in the sleeping human brain. Together, these studies highlight the new biological information that can be extracted from fast fMRI data, and use this approach to discover neurophysiological dynamics unique to the sleeping brain.

Managing

Welcome and introduction

Göran Hajak | University of Regensburg, Germany

Targeting hyperarousal of chronic insomnia disorder: key learnings from daridorexant clinical research

Göran Hajak | University of Regensburg, Germany

Decision drivers for switching sleep medications in patients with chronic insomnia disorder

W. Vaughn McCall | Augusta University, USA

Recommendations on how to switch patients with chronic insomnia disorder to a new sleep medication

David Neubauer | Johns Hopkins University, USA

Real-world experience initiating daridorexant in patients with chronic insomnia disorder

Claudio Liguori | University of Rome Tor Vergata, Italy

Interactive panel discussion

All faculty

When: Monday, October 23 12:30 to 2:00 PM

Where: Room 33

Personalizing sleep apnea therapy for optimal outcomes

Chairperson: Teofilo Lee-Chiong, MD Medical Liaison Lead Philips

National Jewish Health, Denver, USA

Co-chair and speaker: Sleep apnea phenotypes: Determinants of therapy adherence and response to treatment

Manuel Sánchez-de-la-Torre, PhD

Ramon y Cajal Programme Researcher

Group of Precision Medicine in Chronic Diseases

IRBLleida. CIBERES

Nursing and Physiotherapy Department

University of Lleida, Spain

Polysomnographic subtypes of sleep apnea to guide CPAP therapy allocation

Ali Azarbarzin, PhD

Director, Sleep Apnea Health Outcomes

Group and Assistant Professor of Medicine, Harvard Medical School, USA

Strategies for remote interventions improving CPAP therapy management: toward precision care

Mikel Azpiazu, MD

Head of Apnea Virtual Lab, OSI Araba Sleep Unit, Araba University Hospital, Vitoria, Spain

Bioaraba Health Research Institute

P R E S E N T E D B Y

R E V E R Y L A B S

REVERY LABS

Revery Labs is a mental health gaming company on a mission to make wellness accessible to everyone

CONNECT WITH US:

TikTok: @pocketkado

Instagram: @pocketkado

Email: hello@pocketkado.com

JOIN OUR EVENT

POCKET KADO: CHANGING BEHAVIOR THROUGH GAMING

TUES, OCT 24

1 pm - 2 pm

Industry Symposium

Room 38

This symposium will dive into the development process of mobile apps from an expert team that has built apps at Google and Samsung and includes sleep experts from Stanford Our panel of renowned clinicians, technologists, and gaming industry experts will explain and explore the intricate mechanics behind Pocket Kado, an app that sits at the intersection of mobile gaming, sleep science, and visual design

2023 AWARDS

New Investigator Award for Oral and Poster Abstract Presentations

New Investigator Awards are distributed to qualifying presenters at each World Sleep congress. Oral abstract awards provide the opportunity for up to 18 individuals to present their abstracts during special new investigator oral abstract sessions. Poster awards are presented to authors of the top-ranking new investigator poster abstracts. Congratulations to the recipients of the New Investigator Awards at World Sleep 2023 in Rio de Janeiro!

2023 New Investigator Award Recipients

Abubaker Ibrahim (Austria)

Effects of Periodic Breathing on Sleep at High Altitude: A Randomized Placebo-Controlled CrossOver Study using Inspiratory CO2

Adrien Specht (United States)

Comprehensive Analysis of Circadian Protein Expression Patterns in Healthy Adults

Angelica Montini (Italy)

Metagenomic analysis in Restless Legs Syndrome

Beatrice Orso (Italy)

[18F]FDG-PET as a Biomarker for Phenoconversion Trajectories in idiopathic REM Behavior Disorder

Cynthia Tchio (United States)

Elucidating the Enigmas of Orphan GPCRs: Decoding GPR61’s Role in Sleep and Cardiometabolic Traits through a Novel Genomic Approach

Emma Louise Gale (United Kingdom)

Late night screen usage and screentime addiction as shared determinants of insomnia, obesity and wellbeing in 11–14-year-olds.

Federico Salfi (Italy)

Poor sleep quality and insomnia severity before infection predict long-term symptoms after COVID19.

Forrest Tin Wai Cheung (Hong Kong, SAR of China)

Group-based Cognitive Behavioural Therapy and Bright Light Therapy in Youths with Insomnia and Evening Chronotype: Interim Analysis of a Randomised Controlled Trial

Josh Fitton (Australia)

Does the Odds Ratio Product Predict Treatment Response in People with Co-Morbid Insomnia and Sleep Apnoea

Katie Cederberg (United States)

Proteomic Profiling in Periodic Limb Movements and Restless Legs Syndrome

Luca Baldelli (Italy)

Structural and functional frontal-executive dysfunction suggests compensatory mechanisms in patients with isolated REM Sleep Behavior Disorder: a clinical-MRI longitudinal study

Magnus Ingi Birkisson (Iceland)

Pediatric Sleep Apnea: Is objective evaluation, multidicipline approach and therapy-tracing needed to improve outcomes?

Malisa Burge (Australia)

Circadian photoreception impacts thoughts of self

Melissa Nevarez-Brewster (United States)

Poor Sleep Quality During Pregnancy Predicts

Neonatal White Matter Integrity and Subsequent Negative Emotionality in Infancy

Oriella Gnarra (Switzerland)

Sleep stage classification with a network of wearable and contactless devices

Priscila Tempaku (Brazil)

Sleep patterns according to a genetically determined ethnicity in the population of São Paulo

Rahul Gaurav (France)

Abnormal Nigral Iron Progression in Parkinson’s Disease and REM Sleep Behavior Disorder Using Quantitative Magnetic Resonance Imaging

Thomas Altree (Australia)

The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease: a randomised controlled trial

2023 AWARDS

Christian Guilleminault Young Investigator Award

The Christian Guilleminault Young Investigator Awards are presented to encourage young investigators in the field of sleep, especially in developing portions of the world, to advance sleep medicine and research worldwide. Up to 2 awards of $1,000 will be offered to qualifying individuals.

2023 Christian Guilleminault Young Investigator Award Recipients

Abubaker Ibrahim (Austria)

Effects of Periodic Breathing on Sleep at High Altitude: A Randomized Placebo-Controlled CrossOver Study using Inspiratory CO2

Emma Louise Gale (United Kingdom)

Late night screen usage and screentime addiction as shared determinants of insomnia, obesity and wellbeing in 11–14-year-olds

Elsevier Awards

Elsevier has established two scientific awards for new basic and clinical sleep specialists in honor of Christian Guilleminault and Elio Lugaresi. Two awards of $1,000 will be presented at World Sleep 2023.

2023 Young Investigator Award Recipients

Elio Lugaresi Award For Sleep Medicine

Andrée-Ann Baril (United States)

Lighter sleep is associated with higher enlarged perivascular spaces burden in middle-aged and elderly individuals

Christian Guilleminault Award for Sleep Research

Zhengyong Chen (Singapore)

Sleep quality and burnout: A Singapore study

Wayne Hening Young Investigator Awards

Wayne Hening Young Investigator Awards are presented to young investigators in the RLS/PLMS field. Up to five awards of $1,000 will be offered to qualifying individuals.

2023 Wayne Hening Young Investigator Award Recipients

Abubaker Ibrahim (Austria)

Effects of acute exposure to altitude on RLS

Angelica Montini (Italy)

Metagenomic Analysis in Restless Legs Syndrome

Beatriz da Silva Franco (Brazil)

Hypothalamic inflammation analysis in an animal model of iron deficiency for Restless Legs Syndrome

Katie Cederberg (United States)

Proteomic Profiling in Periodic Limb Movements and Restless Legs Syndrome

Maria P. Mogavero (Italy)

A Transcriptome Analysis of mRNAs in Patients with Restless Legs Syndrome

Elsevier Awards Committee Chair Antonio Culebras, MD (United States)

Elsevier Awards Committee Members Flavia B. Consens, MD (United States), Melissa C. Lipford, MD (United States), Elena Majano, MD (El Salvador), Liborio Parrino, MD (Italy), Federica Provini, MD (Italy), Bradley V. Vaughn, MD (United States)

JOIN THE NEXT CLASS OF LEADERS IN SLEEP MEDICINE AND SCIENCE

The International Sleep Research Training Program (ISRTP) is a mentorship program that pairs you with an accomplished leader in sleep research for one year of learning, collaboration, and connection with the global sleep community. ISRTP mentors represent many of the world’s leading sleep and circadian research institutions.

WHO IS ISRTP FOR?

ISRTP is designed for young and mid-career sleep researchers and physicians who wish to advance their research careers and contribute to the sleep field. Our mentees are the field’s future leaders.

TOPICS COVERED WITHIN THE MENTORSHIP

• Research study development, implementation, and replication

• Clinical exposure to management of sleep disorders

• Scientific communication skills, including presenting and publishing

• Obtaining and managing research funds

• Career development and sleep clinic entrepreneurship

BENEFITS AND OUTCOMES

• Funded travel and registration to attend two sleep meetings, including the World Sleep congress

• Focused development of your research interests and projects

• Career support in academic medicine

• Welcoming into an international sleep community

WONDERING IF ISRTP IS THE RIGHT FIT FOR YOU?

Contact info@worldsleepsociety.org at any time with questions or to schedule a 30-minute discussion with the program coordinator.

APPLICATION PERIOD FOR 2024-2025 MENTORSHIP

• December 1, 2023 – March 31, 2024

• Program begins July 1, 2024

• Apply at worldsleepsociety.org/isrtp

This educational initiative is supported by:

THANK YOU TO OUR ISRTP MENTORS

ISRTP mentors work at some of the world’s most prestigious and productive research institutions in sleep, and they dedicate their time, energy, and resources to help train ISRTP mentees.

Thomas Penzel, PhD Charité University Hospital Berlin

Joerg Steier, PhD King’s College London

Guy Leschziner, PhD King’s College London

Simon Kyle, PhD University Of Oxford

Birgit Högl, MD Medical University Of Innsbruck

Dieter Riemann, PhD University Medical Center Freiburg

Susan Redline, MD, MPH Harvard University

Allan Pack, MBChB, PhD University Of Pennsylvania

Masashi Yanagisawa, MD, PhD University Of Tsukuba

Clete Kushida, MD Stanford University

Program Director

Fang Han, MD Peking University People’s Hospital

Uma Deveraj, DNB, MBBS St. John’s Medical College Hospital

Uma Maheswari Krishnaswamy, MD St. John’s Medical College Hospital

Sean Drummond, PhD Monash University

Danny Eckert, PhD Flinders University

Brendon Yee, MCChB, PhD University Of Sydney

Karen Spruyt, PhD Université Paris Cité

A non-invasive, FDA-authorized daytime therapy for mild obstructive sleep apnea and snoring.

Join us for an exciting presentation and stop by Booth #196 to learn more about eXciteOSA

TITLE: S47: Neuromuscular electrical stimulation: A novel approach for treatment of obstructive sleep apnea

LOCATION: Symposium Room 27

DATE: Tuesday, October 24th TIME: 10:45 AM – 12:15 PM

PRESENTERS:

Dr. Alexandre Abreu Chair Dr. Adrian Williams

Dr. Marina Carrasco-Llatas

Dr. Atul Malhotra Chair Dr. Naresh Punjabi

Symposium supported by an unrestricted educational grant from Signifier Medical Technologies. eXciteOSA® is a registered trademark of Signifier Medical Technologies. ©2023 Signifier Medical Technologies. All rights reserved. 9/23

Industry Symposium

The Future of Sleep Diagnostics with Nox SAS and Level II Testing

Nox Medical is hosting dynamic discussions on Level II testing and the Nox SAS solution, a new way to record EEG, ECG, and EMG data during polysomnography sleep studies conducted with the Nox A1s PSG system.

Chairs:

Jason Ong, PhD, and Snorri Helgason

Najib Ayas, MD, MPH, FRCPC

Revisiting Level II Sleep Studies: A Theoretical Economic Decision Model.

Erna Sif Arnardóttir, PhD

Self-Applied PSG in the Research Setting: How Does it Compare to Gold Standard PSG?

Christoph Schöbel, MD

Level II PSG in Germany: What Does the Future Look Like?

Naresh M. Punjabi, MD, PhD

Level II and SAS - From Research to Clinical Practice - Is This the Future?

Industry Symposium

Tuesday, October 24, 2023 12:30-14:00 - Room 23

Lunch will be provided

Opening Remarks

Welcome to Rio

Program Overview Awards

Reception

Networking

Sponsored by

Sunday, October 22 6:30pm - 9:00pm | Room 34

For most current updates visit worldsleepcongress.com

ACCESSIBLE SLEEP MEDICINE TRAINING AROUND THE WORLD

World Sleep Academy is an initiative of World Sleep Society, a non-profit organization of global sleep specialists whose mission is to advance sleep health worldwide. The purpose of World Sleep Academy is to provide accessible training in sleep medicine to healthcare workers, particularly those in communities underserved by sleep medicine specialists.

World Sleep Academy is organized into three tiers of increasing complexity in sleep science and medicine topics. Courses are delivered entirely online and learning activities are predominantly asynchronous but supplemented with weekly live sessions with the lead faculty. Completing all three tiers of content takes one calendar year.

2022-23 Inaugural Class

Over 50 students representing 23 countries

Get Involved!

• Deliver an online lecture to students

To learn more visit worldsleepsociety.org/wsa

Thank you to the 2022-23 World Sleep Academy faculty

In appreciation for their dedicated work in curriculum development, assessment, and student engagement, the World Sleep Society is proud to acknowledge its faculty members. The Academy is only possible through their dedication.

Anna Wani (United States)

Anne Marie Morse (United States)

Aroonwan Preutthipan (Thailand)

Azezu Najafi (Iran)

Bingqian Zhu (China)

Cathy McCall (United States)

Elizaveta Somnolova (Canada)

Erin Flynn Evans (United States)

Federica Provini (Italy)

Harald Hrubos-Strøm (Norway)

Jeremy Landeo Gutierrez (United States)

Joanna Wrede (United States)

Jun Au (Hong Kong)

Karen Spruyt (France)

Keji Komolafe (Nigeria)

Leila Emami (Iran)

Lourdes DelRosso (United States)

Mary Tablizo (United States)

Melisa Moore (United States)

Raffaele Ferri (Italy)

Robert Thomas (United States)

Romy Hoque (United States)

Ruby Joseph (India)

Shelley Zak (United States)

Sheryl Cogdell (United States)

Sofia Konstantinopolou (United Arab Emirates)

Steve Carstensen (United States)

Tiago Vasconcelos Gonçalves (Brazil)

LATAM Day

5A Reunión – SIBECS (Sociedade Iberoamericana de Cirurgia do Sono)

Friday, October 20, 2023 • 10:00am – 4:30pm • Room A06

Edilson Zancanella (Brazil),

ROOM A06

10:00am - 10:05am

Introdução do Latam Day e Boas Vindas (Introducción del LATAM DAY y bienvenida)

10:05am - 12:00pm

Abordagem Inicial do Paciente com Apneia do Sono: O Que Não Posso Deixar Escapar?

(Abordaje inicial del paciente con apnea del sueño: ¿qué no me puedo perder?)

Chair: José Antonio Pinto (Brazil)

10:05am - 10:20am

Anamnese (Anamnesia)

Bruno Duarte (Brazil)

10:20am - 10:35am

Exame Físico com ênfase na avaliação das vias aéreas (Examen físico con énfasis en la evaluación de las vías respiratorias)

Danilo Sguillar (Brazil)

Diagnóstico da Apneia do Sono: Como Está a realidade na América Latina? (¿Cómo es la realidad en América Latina?)

10:35am - 12:00pm

10:35am - 10:50am

Argentina | Veronica Sartori

10:50am - 11:05am

Brasil | Fabio Lorenzetti

11:05am - 11:20am

México | Gabriel Cruz

11:20am - 11:35am

Colômbia | Steve Amado

11:35am - 11:50am

Chile | Felipe Castilho

11:50pm - 12:00pm

Discussão (Discusión)

Simpósio Satélite EMS - Consenso de insônia 2023: Do não farmacológico ao farmacológico. O que é recomendado? Não tratar não é uma opção!”

12:00pm - 1:00pm

Andrea Bacelar (Brazil), Luciano Drager (Brazil)

Quando O Avanço Mandibular É A Melhor Opção?

¿Cuándo es el avance mandibular la mejor opción?

1:00pm - 2:00pm

Chair: Thays Crosara (Brazil)

1:00pm - 1:15pm

Selecionando o paciente (Seleccionando al paciente)

Lilian Giannasi (Brazil)

1:15pm - 1:30pm

O que temos de novo no tratamento odontológico do paciente com apneia do sono? (¿Qué hay de nuevo en el tratamiento odontológico de los pacientes con apnea del sueño?)

Rafael Balsalobre (Brazil)

1:30pm - 1:45pm

Avanço mandibular vs. CPAP: Discutindo eficácia vs. efetividade (Avance mandibular vs. CPAP: discutiendo la eficacia vs. eficiencia)

Marco Machado (Brazil)

1:45pm - 2:00pm

Discussão (Discusión)

Quando A Cirurgia é a Melhor Opção? (¿Cuándo es la cirugía la mejor opción?)

2:00pm – 3:15pm

Chair: Fernanda Haddad (Brazil)

Co-chair: Ofer Jacobowitz (United States)

2:00pm - 2:15pm

Cirurgia Nasal (Cirugia Nasal)

Fernanda Haddad (Brazil)

2:15pm - 2:30pm

Cirurgia Faringea (Cirugía faríngea)

Michel Cahali (Brazil)

Chairs:

Carolina de Paula Soares (Brazil), Robson Capasso (United States), Steve Amado (Colombia)

ROOM A06

2:30pm - 2:45pm

AMM - Cirurgia Esquelética (Cirugía esquelética)

Otávio Ferraz (Brazil)

2:45pm - 3:00pm Neuro Estimulação (Neuroestimulación)

Ofer Jacobowitz (United States)

3:00pm - 3:15pm

Discussão (Discusión)

3:15pm - 3:30pm

Coffee Break

Estado da Arte da Terapia Miofuncional na América Latina (Estado del Arte de la Terapia Miofuncional en Latinoamérica)

3:30pm - 4:30pm

Chairs: Esther Bianchini (Brazil), Carmen Fernandes (Brazil)

3:30pm - 3:50pm

A experiência Brasileira (La experiencia brasileña)

Yasmin Frazão (Brazil)

3:50pm - 4:10pm

A experiência Colombiana (La experiencia colombiana)

Francia Arboleda (Colombia)

4:10pm - 4:30pm

Discussão (Discusión)

Assembleia da Associação Brasileira do Sono

4:40pm - 6:00pm

Friday, October 20, 2023 • 10:00am – 4:40pm • Room A07

10:00am - 10:10am

Introdução do Latam Day e Boas Vindas (Introducción Del Latam Day Y Bienvenida)

Parte 1: Highlights Dos Consensos Brasileiros

10:10am – 12:00pm

Chairs: Andrea Bacelar (Brazil), Silvia Conway (Brasil), Esther Bianchini (Brazil), Alexandre Pinto Azevedo (Brazil)

10:10am - 10:15am

Boas vindas / Importância dos Consensos e visão de internacionalização

Luciano Drager (Brazil)

10:15am - 10:30am

Metodologias dos Consensos

Gabriel Pires Natan (Brazil)

10:30am – 10:50am

Consenso Brasileirode Insônia (Consenso Brasileño Sobre Insomnio)

Márcia Assis (Brazil)

11:00am – 11:20am

Consenso Brasileiro de Fonoaudiologia (Consenso Brasileño de Terapia del Lenguaje)

Luciana Studart (Brazil)

11:20am - 11:30am

Discussão (Discusión)

11:30am - 12:00pm

O burden da Insônia e da privação do sono na América Latina (La carga del insomnio y la privación del sueño en América Latina)

Daniel Perez Chada (Argentina)

Simpósio Philips: Presente e futuro no tratamento da apneia do sono: Estrategias clinicas e tecnologia no tratamento com o uso do CPAP

12:00pm - 1:00pm

Aline Franco (Brazil), Cristina Frange (Brazil)

Otimizando O Tratamento Da Apneia Do Sono Com PAP (Optimización Del Tratamiento De La Apnea Del Sueño Con PAP)

1:00pm - 2:00pm

Chair: Evelyn (Brazil)

Co-chairs: Sonia Togeiro (Brazil), Cristina Frange (Brazil)

1:00pm - 1:15pm

Como escolher a melhor máscara para meu paciente? (¿Cómo elegir la mejor máscara de pestañas para mi paciente?) Pedro Genta (Brazil)

1:15pm - 1:30pm

CPAP, BIPAP e servo ventilador: Para quem? (CPAP, BIPAP y servoventilador: ¿Para quién?) Carlos Franceschini (Argentina)

1:30pm - 1:45pm

Estratégias para melhorar a adesão à PAP (Estrategias para mejorar la adherencia al PAP) Ricardo Duarte (Brazil)

1:45pm - 2:00pm

Discussão (Discusión)

Telemonitorização da Pressão Positiva no Tratamento da Apneia: Experiência na America Latina (Telemonitorización de la presión positiva en el tratamiento de la apnea: Experiencia en Latinoamérica)

2:00pm - 3:30

Chair: Geraldo Lorenzi-Filho (Brazil)

Co-chair: Aline Franco (Brazil)

2:00pm - 2:15pm

Argentina

Eduardo Borsini

2:15pm - 2:30pm

Chile Ariel Cisternas

ROOM A07

2:30pm - 2:45pm

Colômbia

Leslie Katherine Vargas

2:45pm - 3:00pm

México

Gabriel Cruz

3:00pm - 3:15pm

Dados do Brasil e insights comparativos

Luciano Drager

3:15pm - 3:30pm

Discussão (Discusión)

3:30pm - 3:50pm

Coffee Break

Discutindo a formação em sono na America

Latina: desafios e oportunidades (Discutiendo el entrenamiento del sueño en América Latina: desafíos y oportunidades)

3:50pm - 4:30pm

Chairs: Edilson Zancanella (Brazil), Alan Eckeli (Brazil)

3:50pm - 4:30pm

Debate: Diferenças curriculares, critérios dos boards, tempo de formação, possibilidades de rodízios (Diferencias curriculares, criterios de la Junta, tiempo de formación, posibilidades de rotaciones)

Simone Fagondes (Brazil), Ariel Cisternas (Chile), Gabriel Cruz (Mexico), Steve Amado (Colombia), Paula Mazzei (Argentina)

4:20pm - 4:30pm

Discussão (Discusión)

Assembleia da Associação Brasileira do Sono

4:40pm - 6:00pm | Room A06

About ABS

Founded in August 1985 with the name Sociedade Brasileira do Sono, the institution brings together all Brazilian professionals who study sleep, including basic experimental areas, biologists, polysomnography technicians, physiotherapists, speech therapists, psychologists, dentists, and physicians. The association is fundamentally multidisciplinary from its origins and the list of specialists who participate in the society does not stop growing.

Over the years, the society has adapted to the challenges and, since 2005 it has been renamed Associação Brasileira do Sono (ABS). It also brings together, under the same roof and with shared leadership, the sister societies: Associação Brasileira de Odontologia do Sono (ABROS) and Associação Brasileira de Medicina do Sono (ABMS), both created to meet the specific needs of dentists and physicians. ABS is recognized worldwide. The association promotes numerous activities, including courses, meetings with civil society and public policy managers, in addition to promoting constant dialogue with society on the most diverse topics related to sleep. The Associação Brasileira do Sono is also responsible for the scientific journal Sleep Science , a magazine published in English with worldwide recognition, receiving original scientific articles from all over the planet.

To learn more visit absono.com.br

Scientific Content

SCHEDULE AT A GLANCE

Friday, October 20

LATAM Day: Presented by Associação Brasileira do Sono (ABS)

Saturday, October 21

Courses | Affiliated Meetings

Sunday, October 22

Courses | Technologist Session | Affiliated Meetings

Poster Presentations | Opening Ceremony

Monday, October 23

Keynote Presentations | Symposia | Technologist Sessions

Oral Abstracts | Industry Symposia

Discussion Group Sessions | Poster Presentations

Tuesday, October 24

Keynote Presentations | Symposia | Technologist Sessions

Oral Abstracts | Industry Symposia

Discussion Group Session | Poster Presentations

Wednesday, October 25

Keynote Presentations | Symposia | Oral Abstracts

Discussion Group Sessions | Closing Ceremony

COURSE FACULTY

2023 Course Committee

Sonia

Andrea

Course faculty listed in alphabetical order.

Laura S. Acosta-Torres (Mexico)

Andrés Marín Agudelo (Colombia)

Sonia Ancoli-Israel (United States)

Patrick Arcache (Canada)

Hovig Artinian (United States)

Najib Ayas (Canada)

Ali Azarbarzin (United States)

Leticia Azevedo Soster (Brazil)

Andrea Bacelar (Brazil)

Safwan Badr (United States)

Lucie Barateau (France)

Kelly Baron (United States)

Felipe Beijamini (Brazil)

Gulcin Benbir Senel (Turkey)

Rakesh Bhattacharjee (United States)

Esther M. G. Bianchini (Brazil)

Saadoun Bin-Hasan (Kuwait)

Bjørn Bjorvatn (Norway)

Perran Boran (Turkey)

Thomas Bornhardt (Chile)

Pien Bosschieter (United States)

Doug Bradley (Canada)

Oliviero Bruni (Italy)

Michel Cahali (Brazil)

Rosana Cardoso Alves (Brazil)

Marina Carrasco-Llatas (Spain)

Diego Z. Carvalho (Brazil)

Ambrose Chiang (United States)

Stefan Clemens (United States)

Nancy Collop (United States)

Natalia Colorado (Colombia)

Silvia Conway (Brazil)

Leopoldo Correa (United States)

Naima Covassin (United States)

Michel A. Cramer Bornemann (United States)

Thays Crosara Cunha (Brazil)

Cibele Dal Fabbro (Brazil)

Yves Dauvilliers (France)

Luis de Lecea (United States)

Aditi Desai (United Kingdom)

Luciano Drager (Brazil)

Emmanuel During (United States)

Thomas Dye (United States)

Alan Eckeli (Brazil)

Danny Eckert (Australia)

Leila Emami (Iran)

Jorge Faber (Brazil)

Susana Falardo Ramos (Portugal)

Ugo Faraguna (Italy)

Julio Fernandez-Mendoza (United States)

Raffaele Ferri (Italy)

Julie Flygare (United States)

Nancy Foldvary-Schaefer (United States)

Stephany Fulda (Switzerland)

Diego Garcia-Borreguero (Spain)

Pedro Genta (Brazil)

Pierre Alexis Geoffroy (France)

Cathy Goldstein (United States)

Andréia Gomes Bezerra (Brazil)

Michael Grandner (United States)

Helena Hachul (Brazil)

Rosa Hasan (Brazil)

Clemens Heiser (Germany)

Honey Heussler (Australia)

Lai-In Ho (Hong Kong)

Sarah Honaker (United States)

Christine Hong (United States)

Romy Hoque (United States)

Harald Hrubos-Strøm (Norway)

Luciane Impelliziere Luna de Mello (Brazil)

Yuichi Inoue (Japan)

Ofer Jacobowitz (United States)

Aarti Jagannath (United Kingdom)

Susanna Jernelöv (Sweden)

Umakanth Katwa (United States)

Luísa Klaus Pilz (Germany)

Elizabeth Klerman (United States)

Leon Lack (Australia)

George Lago (Brazil)

Magda Lahorgue Nunes (Brazil)

Gilles Lavigne (Canada)

Michel Lecendreux (France)

Bastien Lechat (Australia)

Sergei Li (Russian Federation)

Claudio Liguori (Italy)

Stanley Liu (United States)

Geraldo Lorenzi Filho (Brazil)

Brendan Lucey (United States)

Andrea Maculano Esteves (Brazil)

Atul Malhotra (United States)

Mauro Manconi (Switzerland)

Melania Marques (Brazil)

Kiran Maski (United States)

Jean-Francois Masse (Canada)

Sanket Meghpara (United States)

Miguel Meira e Cruz (Portugal)

Silvia Miano (Switzerland)

Emmanuel Mignot (United States)

Maria Paola Mogavero (Italy)

Gustavo Moreira (Brazil)

Claudia Moreno (Brazil)

Fernando Morgadinho (Brazil)

Alexandria Muench (United States)

Erik Musiek (United States)

Arezu Najafi (Iran)

Indra Narang (Canada)

David Neubauer (United States)

Sara Nowakowski (United States)

Oluwatosin Olorunmoteni (Nigeria)

Nnamdi Orakpo (United States)

Mihaela Oros (Romania)

Judith Owens (United States)

Allan Pack (United States)

Laura Palagini (Italy)

Ji Woon Park (Korea, Republic of)

Diderot Parreira (Brazil)

Markku Partinen (Finland)

Sanjay Patel (United States)

Maria Paz Hidalgo (Brazil)

Yuksel Peker (Turkey)

Alvaro Pentagna (Brazil)

Thomas Penzel (Germany)

Jean Louis Pepin (France)

Daniel Picchietti (United States)

Alexandre Pinto de Azevedo (Brazil)

David Plante (United States)

Giuseppe Plazzi (Italy)

Dalva Poyares (Brazil)

Federica Provini (Italy)

Giada Rapelli (Italy)

R. Nonato Rodrigues (Brazil)

Till Roenneberg (Germany)

Antonio Romero (Spain)

Cristina Salles (Brazil)

Scott A. Sands (United States)

Kathleen Sarmiento (United States)

Markus Schmidt (Switzerland)

Christoph Schoebel (Germany)

Richard Schwab (United States)

Erna Sif Arnardóttir (Iceland)

Narong Simakajornboon (United States)

Stacey Simon (United States)

Srinivas Kishore Sistla (India)

Manuel Sobreira (Brazil)

Elizaveta Solomonova (Canada)

Virend Somers (United States)

Patrick Sorensen (United States)

Ambra Stefani (Austria)

Fernando Stelzer (Brazil)

Patrick Strollo (United States)

Sooyeon (Aly) Suh (Korea, Republic of)

David Tay (Singapore)

Eric Thuler (United States)

Meng-Cheng Tsou (Taiwan)

Ranilo Tuazon (Thailand)

Annie Vallières (Canada)

Olivier Vanderveken (Belgium)

Tiago Felipe Vasconcelos Goncalves (Brazil)

Aleksandar Videnovic (United States)

Tatiana Vidigal (Brazil)

Mieszko Wieckiewicz (Poland)

Yun Kwok Wing (Hong Kong)

John Winkelman (United States)

Chien-Ming Yang (Taiwan)

Jingying Ye (China)

Audrey Yoon (United States)

Gary Zammit (United States)

Edilson Zancanella (Brazil)

Phyllis Zee (United States)

Ancoli-Israel (United States)

Bacelar (Brazil)

Lourdes DelRosso (United States)

Raffaele Ferri (Italy)

2023 COURSES

Saturday,

October 21

8:00am – 5:00pm | Full Day

C01 Sleep apnea diagnosis and management: Current treatments

C02 Sleep related movement disorders / RLS

C03 Circadian dysfunction in health and disease

8:00am – 12:00pm | AM Half Day

C04 Basic sleep medicine: Updates on treatment options for common sleep disorders

C05 Making the transition from pediatric to adult sleep clinics in children with chronic sleep disorders

C06 Parasomnias

C07

From actigraphy to polysomnography, ambulatory devices for sleep measurement into the real world

9:00am – 5:00pm | Full Day

C08 Dental sleep medicine

1:00 – 5:00pm | PM Half Day

C09 Basic sleep medicine: Sleep deprivation consequences across the lifespan

C10 Establishing a pediatric sleep lab

C11 Sleep health in women

C12

Sunday,

October 22

8:00am – 5:00pm | FullDay

C13 Latest advances in sleep medicine

C14 Aging, neurodegeneration and sleep

C15 Best practices in pediatric sleep medicine

8:00am – 12:00pm | AM Half Day

C16 Basic sleep medicine: Polysomnography interpretation

C17 Narcolepsy and other CNS disorders of hypersomnolence: Diagnostic approach and management

C18 Insomnia treatment, Part 1: Pharmacological treatments

9:00am – 12:00pm

Non-pharmacological interventions for sleep disorders: nightmares, apnea, narcolepsy and PTSD

C19

Personalized dental sleep medicine for managing OSA and Sleep Bruxism: Relevance and importance of phenotyping for DSM clinicians

1:00 – 5:00pm | PM Half Day

C20 Basic sleep medicine: Video diagnosis of sleep disorders

C21 Sleep and the heart

C22 Sleep, psychiatry, and mental health

C23 Insomnia treatment, Part 2: Behavioral treatments

C24 Sleep surgery in the era of precision medicine

Find complete course details on following pages.

C01: Sleep apnea diagnosis and management: Current treatments

8:00am – 5:00pm | Room 23

Chairs: Pedro Genta (Brazil), Patrick Strollo (United States)

8:00am - 8:10am

Introduction

8:10am - 8:30am

Personalized approach to OSA management

Erna Sif Arnardóttir (Iceland)

8:30am - 8:50am

OSA endotypes / phenotypes

Richard Schwab (United States)

8:50am - 9:15am

Triple overlap

Patrick Strollo (United States)

9:15am - 9:40am

Home sleep testing

Geraldo Lorenzi Filho (Brazil)

9:40am - 10:00am

Coffee break

10:00am - 10:20am

Impact of mask selection on CPAP therapy outcomes

Pedro Genta (Brazil)

10:20am - 10:45am

Oral appliance therapy

Pien Bosschieter (United States)

10:45am - 11:05am

Hypoglossal stimulation: Evaluation and management

Patrick Strollo (United States)

11:05am - 11:30am

Upper airway surgery

Olivier Vanderveken (Belgium)

11:30am - 12:00pm

Open panel discussion / Q&A

12:00pm - 1:00pm

Lunch break

1:00pm - 1:20pm

Pharmacologic therapy for OSA

Danny Eckert (Australia)

1:20pm - 1:45pm

Co-Morbid insomnia and OSA

1:45pm - 2:05pm

OSA and the heart

Yuksel Peker (Turkey)

2:05pm - 2:30pm

OSA New Metrics: Hypoxic burden / arousal burden

Ali Azarbarzin (United States)

2:30pm - 2:50pm

Coffee break

2:50pm - 3:15pm

Surgical management of obesity

Luciano Drager (Brazil)

3:15pm - 3:30pm

Medical management of obesity

Sanjay Patel (United States)

3:30pm - 3:45pm

OSA genomic signatures

Allan Pack (United States)

3:45pm - 4:05pm

AI and health outcomes

Najib Ayas (Canada)

SCIENTIFIC PROGRAM

4:05pm - 4:25pm

Adherence to PAP therapy: Big data

Atul Malhotra (United States)

4:25pm - 5:00pm

Conclusion/Q&A/Open panel discussion

C02: Sleep related movement disorders / RLS

8:00am – 5:00pm | Room 23B

Chairs: Raffaele Ferri (Italy), Alan Eckeli (Brazil), Yuichi Inoue (Japan)

8:00am – 8:15am

Introduction

Alan Eckeli (Brazil), Raffaele Ferri (Italy), Yuichi Inoue (Japan)

8:15am – 9:00am

Diagnosing RLS

Diego Garcia-Borreguero (Spain)

9:00am – 9:45am

Objective findings in RLS

Stephany Fulda (Switzerland)

9:45am – 10:15am

Coffee break

10:15am – 11:00am

RLS in other conditions

Mauro Manconi (Switzerland)

11:00am – 11:45am

Treatment options for RLS

John Winkelman (United States)

11:45am – 12:00pm

Question and answer

12:00pm – 1:00pm

Lunch break

1:00pm – 1:45pm

Pathophysiology of RLS

Stefan Clemens (United States)

1:45pm – 2:30pm

Animal models of RLS

Andrea Maculano Esteves (Brazil)

2:30pm – 3:00pm

Coffee break

3:00pm – 3:30pm

RLS in children

Daniel Picchietti (United States)

3:30pm – 4:15pm

RLS in infants

Oliviero Bruni (Italy)

4:15pm – 5:00pm

Question and answer

SCIENTIFIC PROGRAM

C03: Circadian dysfunction in health and disease

8:00am – 5:00pm | Room 24

Chairs: Till Roenneberg (Germany),

Claudia Moreno (Brazil)

8:00am – 8:20am

Introduction

Claudia Moreno (Brazil), Till Roenneberg (Germany)

8:20am – 9:10am

Neurobiology and circadian rhythms

Aarti Jagannath (United Kingdom)

9:10am – 10:00am

The role of healthy circadian clock in disease: The circadian clinic model

Luísa Klaus Pilz (Germany)

10:00am – 10:20am

Coffee break

10:20am – 11:10am

Circadian dysfunction in neurodegenerative disorders

Phyllis Zee (United States)

11:10am – 11:45am

Question and answer

Till Roenneberg (Germany), Claudia Moreno (Brazil)

11:45am – 12:45pm

Lunch break

12:45pm – 1:35pm

Circadian rhythms in depression

Maria Paz Hidalgo (Brazil)

1:35pm – 2:25pm

Circadian rhythms in adolescents

Felipe Beijamini (Brazil)

2:25pm – 2:45pm

Coffee break

2:45pm – 3:35pm

Circadian hygiene and shift work

Claudia Moreno (Brazil)

3:35pm – 4:25pm

The impacts of daylight savings time on health and disease

Elizabeth Klerman (United States)

4:25pm – 5:00pm

Question and answer

Claudia Moreno (Brazil), Till Roenneberg (Germany)

C04: Basic sleep medicine: Updates on treatment options for common sleep disorders

8:00am – 12:00pm | Room 27

Chairs: Andrea Bacelar (Brazil), Safwan Badr (United States), Safwan Badr (United States)

8:00am – 8:05am

Introduction

8:05am – 8:50am

Orexin receptor antagonists for insomnia: Update and perspectives

Maria Paola Mogavero (Italy)

8:50am – 9:35am

Updates on the new guidelines for the treatment of Restless Legs Syndrome

Gulcin Benbir Senel (Turkey)

9:35am – 10:20am

Use of intravenous iron in the treatment of augmentation

Diego Garcia-Borreguero (Spain)

10:20am – 10:40am

Coffee break

10:40am – 11:10am

Updates on treatment of obstructive sleep

apnea with hypoglossal nerve stimulation

Edilson Zancanella (Brazil)

11:10am – 11:55am

Updates on the new guidelines for the treatment of REM behavior disorder

Hovig Artinian (United States)

11:55am – 12:00pm

Question and answer

C05: Making the transition from pediatric to adult sleep clinics in children with chronic sleep disorders

8:00am – 12:15pm | Room 27B

Chair: Narong Simakajornboon (United States)

8:00am – 8:15am

Overview of transitional medicine

Narong Simakajornboon (United States)

8:15am – 8:50am

Transition of obese adolescents with sleep disordered breathing

Umakanth Katwa (United States)

8:50am – 9:25am

Transition of patients with neuromuscular disorders and long term ventilation

Narong Simakajornboon (United States)

9:25am – 9:45am

Coffee break

9:45am – 10:20am

Transitional care in patients with Narcolepsy and central hypersomnia

Kiran Maski (United States)

10:20am – 10:45am

Transitional care in patients with Parasomnia

Thomas Dye (United States)

10:45am – 11:20am

Transitional care in patients with RLS and PLMD

Thomas Dye (United States)

11:20am – 11:55am

Lessons from developing countries

Mihaela Oros (Romania)

11:55am – 12:15pm

Question and answer

C06: Parasomnias

8:00am – 12:00pm | Room 28

Chairs: Rosa Hasan (Brazil), Emmanuel During (United States)

8:00am – 8:10am

Introduction

Rosa Hasan (Brazil)

8:10am – 8:55am

Differential diagnosis of complex nocturnal behaviors

Nancy Foldvary-Schaefer (United States)

8:55am – 9:40am

NREM parasomnias, sexsomnias and sleep related eating disorder in adults: What’s new?

Rosa Hasan (Brazil)

9:40am – 10:00am

Coffee break

10:00am – 10:45am

Forensic issues in parasomnias

Michel A. Cramer Bornemann (United States)

10:45am – 11:30am

REM sleep behavior disorder: A 40 year journey

Emmanuel During (United States)

11:30am – 12:00pm

Question and answer

Emmanuel During (United States), Rosa Hasan (Brazil)

C07: From actigraphy to polysomnography, ambulatory devices for sleep measurement into the real world

8:00am – 12:00pm | Room 28B

Chairs: Thomas Penzel (Germany), Kelly Baron (United States)

8:00am – 8:15am

Introduction

Thomas Penzel (Germany)

8:15am – 9:00am

Novel OSA-detecting wearables: Are they ready for prime time?

Ambrose Chiang (United States)

9:00am – 9:45am

Actigraphy in children and adolescents: From research to practice

Stacey Simon (United States)

9:45am – 10:05am

Coffee break

10:05am – 10:50am

Consumer facing wearables

Cathy Goldstein (United States)

10:50am – 11:35am

Non-contact devices for sleep and breathing monitoring

Christoph Schoebel (Germany)

11:35am – 12:00pm

Question and answer

Single stage vs. multi stage multilevel surgery for OSAS

8:00am – 10:00am | Room A06

Chairs: Vijaya Krishnan Paramasivan (India), Srinivas Kishore Sistla (India)

8:00am - 8:10am

Introduction

8:10am - 8:25am

Patient selection criteria for single-stage and multi-stage multilevel upper airway collapse

Sandeep Bansal (India)

8:25am - 8:40am

Surgical plan of single-stage and multi-stage multilevel upper airway collapse

Vijaya Krishnan Paramasivan (India)

8:40am - 8:55am

Pros and cons of single-stage and multi-stage multilevel upper airway collapse

Srinivas Kishore Sistla (India)

8:55am - 9:10am

Multilevel surgery or palatopharyngoplasty?

Less is more

Ofer Jacobowitz (United States)

9:10am - 9:25am

Complications of single-stage multilevel upper airway collapse

Srinivas Kishore Sistla (India)

9:25am - 9:40am

Outcome comparison of single-stage and multistage multilevel upper airway collapse

Clemens Heiser (Germany)

9:40am - 10:00am

Question and answer

C08: Dental sleep medicine

9:00am – 5:00pm | Room 24B

Chairs: Leopoldo Correa (United States), Cibele Dal Fabbro (Brazil), Audrey Yoon (United States)

PART 1: STRONGER AND WISER TOGETHER

9:00am – 9:10am

Introduction

Leopoldo Correa (United States), Audrey Yoon (United States)

9:10am – 9:20am

Colombia

Natalia Colorado (Colombia)

9:20am – 9:30am

Chile

Thomas Bornhardt (Chile)

9:30am – 9:40am

Brazil

Thays Crosara Cunha (Brazil)

9:40am – 9:50am

Mexico

Laura S. Acosta-Torres (Mexico)

9:50am – 10:00am

Canada

Jean-Francois Masse (Canada)

10:00am – 10:10am

Europe

Susana Falardo Ramos (Portugal)

10:10am – 10:20am

Portugal

Miguel Meira e Cruz (Portugal)

10:20am – 10:30am

Spain

Antonio Romero (Spain)

10:30am – 10:40am

United Kingdom

Aditi Desai (United Kingdom)

10:40am – 10:50am

Singapore

David Tay (Singapore)

10:50am – 11:00am

Taiwan

Meng-Cheng Tsou (Taiwan)

11:00am – 11:10am

Australia

Danny Eckert (Australia)

11:10am – 11:20am

Republic of Korea

Ji Woon Park (Korea, Republic of)

11:20am – 11:30am

Philippines

Ranilo Tuazon (Thailand)

11:30am – 11:40am

Russia

Sergei Li (Russian Federation)

11:40am – 12:00pm

Group discussion

Leopoldo Correa (United States), Audrey Yoon (United States)

12:00pm – 1:30pm

Lunch break

World Sleep 2023 Program Types

PART 2: THE CHALLENGES OF DENTAL SLEEP MEDICINE IN THE 21ST CENTURY AND EMERGING TRENDS

Co-therapy with oral appliance: Evidence of efficacy and effectiveness

1:30pm – 1:45pm

Pharmacological adjunct for OSA and cannabis

Melania Marques (Brazil)

1:45pm – 2:00pm

Alternative approach: Sleep position, acupuncture, nose device, and OSA

Cibele Dal Fabbro (Brazil)

2:00pm – 2:15pm

Children’s abnormal growth and development: Growth modification protocol for pediatric OSA

Audrey Yoon (United States)

2:15pm – 2:30pm

What to do with denture users with OSA

Patrick Arcache (Canada)

2:30pm – 2:45p

Oropharyngeal exercise for SDB

Esther M. G. Bianchini (Brazil)

2:45pm – 3:00pm

Question and answer

3:00pm – 3:15pm

Coffee break

Comorbidities challenging DSM management

3:15pm – 3:30pm

Orthodontic appliance for SDB: New trends and evidences

Christine Hong (United States)

SCIENTIFIC PROGRAM

3:30pm – 3:45pm

Comorbid insomnia and sleep apnea (COMISA)

Miguel Meira e Cruz (Portugal)

3:45pm – 4:00pm

What to do for OSA and sleep bruxism patients:

CPAP or OA or both

Gilles Lavigne (Canada)

4:00pm – 4:15pm

Treating Vincent Van Gogh’s OSA: Art meets artificial intelligence, orthodontics, and surgery

Jorge Faber (Brazil)

4:15pm – 4:30pm

OSA in women and menopause

Luciane Impelliziere Luna de Mello (Brazil)

4:30pm – 4:45pm

OSA with cardiovascular comorbidities

Geraldo Lorenzi Filho (Brazil)

4:45pm – 5:00pm

Question and answer

C09: Basic sleep medicine: Sleep deprivation consequences across the lifespan

1:00pm - 5:00pm | Room 27

Chairs: Andrea Bacelar (Brazil), Safwan Badr (United States)

1:00pm – 1:10pm

Introduction

1:10pm – 2:00pm

Consequences of sleep deprivation in childhood

Perran Boran (Turkey)

2:00pm – 2:50pm

Consequences of sleep deprivation in adults

Sanket Meghpara (United States)

2:50pm – 3:10pm

Coffee break

3:10pm – 4:00pm

Consequences of sleep deprivation in the elderly

Leila Emami (Iran)

4:00pm – 4:50pm

Consequences of sleep deprivation in night shift workers

Arezu Najafi (Iran)

4:50pm – 5:00pm

Question and answer

C10: Establishing a pediatric sleep lab

1:00pm - 6:00pm | Room 27B

Chairs: Saadoun Bin-Hasan (Kuwait), Magda Lahorgue Nunes (Brazil)

1:00pm – 1:05pm

Introduction

Saadoun Bin-Hasan (Kuwait), Magda Lahorgue

Nunes (Brazil)

1:05pm – 1:45pm

Setting up a pediatric sleep lab

Rakesh Bhattacharjee (United States)

1:45pm – 2:15pm

Safety issues in the sleep lab

Judith Owens (United States)

2:15pm – 3:15pm

Basics of pediatric scoring and interpretation

Rosana Cardoso Alves (Brazil)

3:15pm – 3:55pm

Diversity and health disparities

Fernando Stelzer (Brazil)

3:55pm – 4:35pm

Diagnostic testing and beyond: What is needed to conduct studies beyond basic PSG

Umakanth Katwa (United States)

4:35pm – 5:05pm

Dealing with long waiting list

Saadoun Bin-Hasan (Kuwait)

5:05pm – 5:35pm

Successful lab cases around the world

Leila Emami (Iran), Oluwatosin Olorunmoteni (Nigeria), Gustavo Moreira (Brazil)

5:35pm – 6:00pm

Question and answer

Saadoun Bin-Hasan (Kuwait), Magda Lahorgue Nunes (Brazil)

C11: Sleep health in women

1:00pm - 5:00pm | Room 28

Chairs: Sara Nowakowski (United States), Helena Hachul (Brazil)

1:00pm – 1:10pm

Introduction

Sara Nowakowski (United States), Helena Hachul (Brazil)

1:10pm – 1:55pm

Sleep and hormonal contraception

Andréia Gomes Bezerra (Brazil)

1:55pm – 2:40pm

Pain and sleep in women

Gilles Lavigne (Canada)

2:40pm – 3:00pm

Coffee break

3:00pm – 3:45pm

Perinatal sleep

Sooyeon (Aly) Suh (Korea, Republic of)

3:45pm – 4:30pm

Sleep and cancer in women

Alexandria Muench (United States)

4:30pm – 5:00pm

Question and answer

C12: Non-pharmacological interventions for sleep disorders: nightmares, apnea, narcolepsy and PTSD

1:00pm - 5:00pm | Room 28B

Chairs: Silvia Conway (Brazil), Elizaveta Solomonova (Canada)

1:00pm – 1:10pm

Introduction

Silvia Conway (Brazil)

1:10pm – 1:55pm

CPAP adherence: Psychological variables and interventions

Giada Rapelli (Italy)

1:55pm – 2:40pm

Non-pharmacological intervention for narcolepsy and cataplexy

Andrés Marín Agudelo (Colombia)

2:40pm – 3:00pm

Coffee break

3:00pm – 3:45pm

Post traumatic stress disorder and sleep

Silvia Conway (Brazil)

3:45pm – 4:30pm

Disturbed dreaming

Elizaveta Solomonova (Canada)

4:30pm – 5:00pm

Question and answer

Elizaveta Solomonova (Canada)

Latin American Sleep Association Meeting

1:00pm - 5:00pm | Room A06

Chairs: Ariel Cisternas (Chile), Karem Parejo (Colombia)

1:00pm – 1:05pm

Bienvenida

Ariel Cisternas (Chile)

1:05pm – 1:20pm

Inauguración

Karem Parejo (Colombia)

1:20pm – 1:40pm

Apnea del Sueño, prevalencia y estudios diagnósticos

Gabriel Cruz (Mexico)

1:40pm – 2:00pm

Estudio y manejo de los trastornos del movimiento

Karem Parejo (Colombia)

2:00pm – 2:20pm

Estudios predictores de trastornos del sueño pediátricos

Pablo Brockmann (Chile)

2:20pm – 3:00pm

Coffee break

3:00pm – 3:20pm

Disponibilidad de dispositivos de presión positiva

Juan Facundo Nogueira (Argentina)

3:20pm – 3:40pm

Terapia miofuncional para trastornos respiratorios del sueño

Vanessa Ieto (Brazil)

3:40pm – 4:00pm

Terapia cognitivo conductual para el insomnio

Sandra Sacks (Chile)

4:00pm – 4:20pm

Avances en técnicas quirúrgicas para trastornos respiratorios del sueño

Steve Amado (Colombia)

4:20pm – 4:40pm

Medicina del sueño en Odontología: Limitaciones y Oportunidades

Leopoldo Correa (United States), Laura S.

Acosta-Torres (Mexico)

4:40pm – 5:00pm

Cocktail de cierre

C13: Latest advances in sleep medicine

8:00am - 5:00pm | Room 23

Chairs: Nancy Collop (United States), Yves Dauvilliers (France)

8:00am – 8:10am

Introduction

Nancy Collop (United States), Yves Dauvilliers (France)

8:10am – 8:55am

Sleep and aging: Usual suspects, new mechanisms

Luis de Lecea (United States)

8:55am – 9:40am

Sleep as a premarker of risk of dementia

Brendan Lucey (United States)

9:40am – 10:00am

Coffee break

10:00am – 10:45am

Advanced physiological monitoring at night to diagnose sleep disorders

Emmanuel Mignot (United States)

10:45am – 11:30am

Updates in diagnosis and management of central hypersomnolence disorders

Yves Dauvilliers (France)

11:30am – 12:00pm

Question and answer

12:00pm – 1:00pm

Lunch break

1:00pm – 1:45pm

Understanding of long-term complications in sleep apnea

Nancy Collop (United States)

1:45pm – 2:30pm

Obstructive sleep apnea treatment: Update

Atul Malhotra (United States)

2:30pm – 2:50pm

Coffee break

2:50pm – 3:35pm

Restless sleep and restless legs syndrome: Update on children and adults

Romy Hoque (United States)

3:35pm – 4:20pm

COVID-19’s and the impact on sleep and circadian rhythms

Markku Partinen (Finland)

4:20pm – 5:00pm

Question and answer

C14: Aging, neurodegeneration and sleep

8:00am - 5:00pm | Room 23B

Chairs: Sonia Ancoli-Israel (United States), Claudio Liguori (Italy)

8:00am - 8:15am

Introduction

Claudio Liguori (Italy)

Sonia Ancoli-Israel (United States)

8:15am - 9:00am

The relationship between aging and sleep and circadian rhythms

Sonia Ancoli-Israel (United States)

SCIENTIFIC PROGRAM

9:00am - 9:45am

Sleep fragmentation, macro and microstructural sleep, and Alzheimer’s Disease neurodegeneration

Erik Musiek (United States)

9:45am - 10:05am

Coffee break

10:05am - 10:50am

Are insomnia and excessive daytime sleepiness risk factors for neurodegeneration?

Diego Z. Carvalho (Brazil)

10:50am - 11:35am

Sleep disordered breathing, PAP treatment and Neurodegeneration

Claudio Liguori (Italy)

11:35am - 12:10pm

Question and answer

12:10pm - 1:40pm

Lunch break

1:40pm - 2:25pm

Circadian biology and misalignment in neurodegenerative disorders

Aleksandar Videnovic (United States)

2:25pm - 2:45pm

Coffee break

2:45pm - 3:25pm

Wearables for measuring sleep in Neurodegenerative disorders: A new opportunity for clinicians and researchers

Ugo Faraguna (Italy)

3:25pm - 4:25pm

Video-Session: 1. REM sleep behavior disorder - A disorder on the intersection of neurology, neuroscience and sleep medicine

Video-Session: 2. NREM Parasomnias in Neurodegenerative disorders and the differential diagnosis with RBD

Ambra Stefani (Austria), Federica Provini (Italy)

4:25pm - 5:00pm

Question and answer

C15: Best practices in pediatric sleep medicine

8:00am - 5:00pm | Room 24

Chair: Judith Owens (United States)

8:00am – 8:30am

Introduction

8:30am – 9:15am

Insomnia in young children

Sarah Honaker (United States)

9:15am – 10:00am

Insomnia in adolescents

Silvia Miano (Switzerland)

10:00am – 10:20am

Coffee break

10:20am – 11:05am

Parasomnias

Magda Lahorgue Nunes (Brazil)

11:05am – 11:50am

Narcolepsy and central hypersomnias

Giuseppe Plazzi (Italy)

11:50am – 12:15pm

Question and answer

12:15pm – 1:15pm

Lunch break

1:15pm – 2:00pm

Sleep disordered breathing

Umakanth Katwa (United States)

2:00pm – 2:45pm

Movement disorders

Daniel Picchietti (United States)

2:45pm – 3:30pm

Circadian rhythm disorders

Honey Heussler (Australia)

3:30pm – 3:50pm

Coffee break

3:50pm – 4:35pm

Sleep in special populations

Michel Lecendreux (France)

4:35pm – 5:00pm

Question and answer

C16: Basic sleep medicine: Polysomnography interpretation

8:00am - 12:00pm | Room 27

Chairs: Andrea Bacelar (Brazil), Safwan Badr (United States)

8:00am – 8:15am

Introduction

8:15am – 8:45am

Polysomnographic findings in insomnia

George Lago (Brazil)

8:45am – 9:15am

Polysomnographic findings in hypersomnia

Fernando Morgadinho (Brazil)

9:15am – 9:45am

Polysomnographic findings in circadian rhythm disorders

R. Nonato Rodrigues (Brazil)

9:45am – 10:05am

Coffee break

10:05am – 10:35am

Polysomnographic findings in sleep related movement disorders

Fernando Stelzer (Brazil)

10:35am – 11:05am

Polysomnographic findings in sleep related breathing disorders

Cristina Salles (Brazil)

11:05am – 11:35am

Polysomnographic findings in parasomnia

Manuel Sobreira (Brazil)

11:35am – 12:00pm

Question and answer

C17: Narcolepsy and other CNS disorders of hypersomnolence: Diagnostic approach and management

8:00am - 12:00pm | Room 27B

Chairs: Kiran Maski (United States), Lucie Barateau (France), Julie Flygare (United States)

8:00am – 8:10am

Introduction

Kiran Maski (United States)

8:10am – 8:45am

The science of narcolepsy and hypersomnolence disorders

Markus Schmidt (Switzerland)

8:45am – 9:20am

ICSD 3 TR revisions for CNS disorders of hypersomnolence

David Plante (United States)

SCIENTIFIC PROGRAM

9:20am – 9:50am

Pediatric hypersomnolence disorders: Diagnosis and management

Kiran Maski (United States)

9:50am – 10:10am

Coffee break

10:10am – 10:55am

CNS hypersomnolence treatment updates

Lucie Barateau (France)

10:55am – 11:30am

Narcolepsy not alone: Social impacts and management approaches

Julie Flygare (United States)

11:30am – 12:00pm

Question and answer

C18: Insomnia treatment, part 1: Pharmacological treatments

8:00am - 12:00pm | Room 28B

Chairs: David Neubauer (United States), Dalva Poyares (Brazil)

8:00am - 8:10am

Introduction

8:10am - 8:55am

Fundamentals of insomnia pharmacotherapy

David Neubauer (United States)

8:55am - 9:40am

Risks and benefits of off-label prescribing for insomnia

John Winkelman (United States)

9:40am - 10:00am

Coffee break

10:00am - 10:45am

Hypnotic long-term effectiveness outcomes

Gary Zammit (United States)

10:45am - 11:30am

Advantages and disadvantages of combining

CBT-I with sleep-promoting medications

Yun Kwok Wing (Hong Kong)

11:30am - 12:00pm

Question and answer

T01: Technologist program

8:00am - 5:00pm | Room A01

Chairs: Edilson Zancanella (Brazil), Carlos Teixeira (Portugal), Magneide Brito (Brazil)

Technical specifications for PSG

8:00am - 8:30am

Hook up adults - specifications and definitions

Rogério Santos Silva (Brazil)

8:30am - 8:50am

Hook up children and pediatrics details

Magneide Brito (Brazil)

8:50am - 9:00am

Question and answer

9:00am - 9:15am

Calibration

Pedro Amorim (Portugal)

9:15am - 9:30am

Artifacts and troubleshooting

Carlos Teixeira (Portugal)

9:30am - 9:45am

Tips and tricks

Daniela Ferreira (Portugal)

9:45am - 10:00am

Question and answer

10:00am - 10:15am

Coffee break

10:15am - 10:30am

Respiratory sensors specifications

Paolo Matrigiani (Italy)

10:30am - 10:45am

Lab PAP titration (adults)

Aurélio Rochael Almeida (Brazil)

10:45am - 11:00am

Lab PAP titration (children)

Carlos Teixeira (Portugal)

11:00am - 11:15am

Home PAP titration

Federica Cinelli (Italy)

11:15am - 11:30am

HSAT

Simone Prezotti (Brazil)

11:30am - 11:50am

MLST/MWT

Carlos Teixeira (Portugal)

11:50am - 12:00pm

Question and answer

12:00pm - 1:30pm

Lunch break

1:30pm - 1:45pm

New criteria from AASM manual version 3

Scoring sleep staging and arousals

Dennis Sartori (Brazil)

1:45pm - 2:00pm

Scoring sleep staging (children)

Federica Cinelli (Italy)

2:00pm - 2:15pm

Movement events

Fernando Stelzer (Brazil)

2:15pm - 2:30pm

Respiratory events (beside AHI - adults)

Paolo Matrigiani (Italy)

2:30pm - 2:45pm

Respiratory events (beside AHI - children)

Magneide Brito (Brazil)

2:45pm - 3:00pm

Coffee break

New technologies on sleep monitoring: What is the future? Consumer sleep technologies in sleep medicine: Where we are and what are the perspectives

3:00pm - 3:20pm

Consumer sleep technologies in sleep medicine: What are the perspectives?

Carolina de Paula Soares (Brazil)

3:20pm - 3:40pm

Wearable technology

Paulo Mei (Brazil)

3:40pm - 4:00pm

Nearable technology

Lucas Barracas (Brazil)

4:00pm - 4:20pm

Technology in the sleep revolution project

Kristin Anna Olafsdottir (Iceland)

4:20pm - 4:35pm

Standardization of sleep analysis: The grey areas in scoring

Heidur Gretarsdottir (Iceland)

SCIENTIFIC PROGRAM

4:35pm - 4:50pm

Frontal EEG: New approach in recording and scoring pediatric data

Sigridur Sigurðardottir (Iceland)

4:50pm - 5:00pm

Question and answer

Sleep, technology and economy: Golden triangle for future healthcare

8:30am – 12:00pm | Room A06

Chairs: Rayleigh Chiang (Taiwan), Maria-Cecilia

Lopes (Brazil)

8:30am – 8:30am

Session 1

Maria-Cecilia Lopes (Brazil), Rayleigh Chiang (Taiwan)

8:30am – 8:35am

Introduction

8:35am – 8:55am

Sleep as a need, an opportunity in the digital world

Karen Spruyt (France)

8:55am – 9:15am

CPAP across the life span

Debora Petrungaro Migueis (Brazil)

9:15am – 9:35am

Sleep and technology for teenagers

Maria-Cecilia Lopes (Brazil)

9:35am – 9:55am

Actimetry measures on sleep

Alan Eckeli (Brazil)

9:55am – 10:10am

Question and answer

10:10am – 10:20am

Coffee break

10:20am – 10:20am

Session 2

Thomas Penzel (Germany), Ofer Jacobowitz (United States)

10:20am – 10:40am

Future challenges for sleep medicine regarding technology

Thomas Penzel (Germany)

10:40am – 11:00am

Unmet needs in sleep apnea market

Claudia Albertini (Brazil)

11:00am – 11:20am

Evaluation on sleep monitoring devices

Ambrose Chiang (United States)

11:20am – 11:40am

Sleep health economics

Rayleigh Chiang (Taiwan)

11:40am – 11:55am

Question and answer

11:55am – 12:00pm

Adjourn

C19: Personalized dental sleep medicine for managing OSA and Sleep Bruxism: Relevance and importance of phenotyping for DSM clinicians

9:00am - 12:00pm | Room 24B

Chairs: Gilles Lavigne (Canada), Mieszko Wieckiewicz (Poland)

9:00am – 9:55am

What is phenotyping in sleep medicine and dentistry?

Tatiana Vidigal (Brazil)

9:55am – 10:05am

Coffee break

10:05am – 10:55am

Applying phenotyping and patient satisfaction in managing OSA: Personalized dental sleep medicine of tomorrow

Scott A. Sands (United States)

10:55am – 11:45am

Applying phenotyping and opportunities to increase patient satisfaction in managing sleep bruxism: Personalized dental sleep medicine of tomorrow

Mieszko Wieckiewicz (Poland)

11:45am – 12:00pm

Future of dental sleep medicine: Challenge, opportunity, threat, innovation.

Gilles Lavigne (Canada)

C20: Basic sleep medicine: Video diagnosis of sleep disorders

1:00pm - 5:00pm | Room 27

Chairs: Andrea Bacelar (Brazil), Safwan Badr (United States)

1:00pm – 1:05pm

Introduction

1:05pm – 1:45pm

Video diagnosis of parasomnia vs. seizure disorder

Romy Hoque (United States)

1:45pm – 2:25pm

Video diagnosis of sleep related movement disorders

Leticia Azevedo Soster (Brazil)

2:25pm – 2:45pm

Coffee break

2:45pm – 3:25pm

Video diagnosis of REM behavior disorder

Alvaro Pentagna (Brazil)

3:25pm – 4:05pm

Video diagnosis of sleep disordered breathing

Tiago Felipe Vasconcelos Goncalves (Brazil)

4:05pm – 4:45pm

Use of home video monitoring in the diagnosis of sleep disorders

Harald Hrubos-Strom (Norway)

4:45pm – 5:00pm

Question and answer

SCIENTIFIC PROGRAM

C21: Sleep and the heart

1:00pm - 5:15pm | Room 27B

Chairs: Luciano Drager (Brazil), Virend Somers (United States)

1:00pm – 1:05pm

Introduction

Virend Somers (United States)

1:05pm – 1:50pm

Short sleep duration as a risk factor for obesity, hypertension and cardiovascular mortality

Naima Covassin (United States)

1:50pm – 2:35pm

Long sleepers: Friend or foe?

Atul Malhotra (United States)

2:35pm – 3:20pm

The cardiovascular impact of Co-morbid OSA and insomnia (COMISA): New kids on the block

Jean Louis Pepin (France)

3:20pm – 3:40pm

Coffee break

3:40pm – 4:25pm

Is the apnea-hypopnea index (AHI) the best marker to better define the cardiovascular consequences of OSA?

Yuksel Peker (Turkey)

4:25pm – 5:10pm

The impact of sleep apnea on cardiovascular outcomes: Lessons from randomized trials for paving the road ahead

Doug Bradley (Canada)

5:10pm – 5:15pm

Question and answer

C22: Sleep, psychiatry, and mental health

1:00pm - 5:00pm | Room 28

Chairs: Laura Palagini (Italy), Alexandre Pinto de Azevedo (Brazil)

1:00pm - 1:10pm

Introduction

Laura Palagini (Italy), Alexandre Pinto de Azevedo (Brazil)

1:10pm – 1:55pm

Disturbed, insufficient and misaligned sleep as determinants of mental health in adolescents and young adults

Julio Fernandez-Mendoza (United States)

1:55pm – 2:40pm

Sleep and circadian rhythm dysregulation key factors in mood disorders across the lifespan

Pierre Alexis Geoffroy (France)

2:40pm – 2:55pm

Question and answer

2:55pm – 3:15pm

Coffee break

3:15pm – 4:00pm

Sleep disturbances and suicide risk, what we need to do in clinical practice

Michael Grandner (United States)

4:00pm – 4:45pm

Sleep, insomnia and anxiety

Laura Palagini (Italy)

4:45pm – 5:00pm

Question and answer

Laura Palagini (Italy), Alexandre Pinto de Azevedo (Brazil)

C23: Insomnia treatment, part 2: Behavioral treatments

1:00pm - 5:00pm | Room 28B

Chairs: Annie Vallières (Canada), Leon Lack (Australia)

1:00pm – 1:10pm

Introduction

Annie Vallières (Canada), Leon Lack (Australia)

1:10pm – 1:40pm

Insomnia: Diagnostic and treatment challenges associated with a heterogenic disorder

Bjørn Bjorvatn (Norway)

1:40pm – 2:10pm

An overview of evidence based cognitive behavioral treatments for insomnia

Michael Grandner (United States)

2:10pm – 2:40pm

CBT for insomnia in people with comorbid mental disorders

Susanna Jernelöv (Sweden)

2:40pm – 3:00pm

Coffee break

3:00pm – 3:30pm

To appreciate the high prevalence and morbidity of co-morbid insomnia and OSA and the effectiveness of CBTi in improving PAP adherence and overall sleep health outcomes

Leon Lack (Australia)

3:30pm – 4:00pm

Cognitive and behavioral strategies for the management of hypnotic discontinuation

Chien-Ming Yang (Taiwan)

4:00pm – 5:00pm

Question and answer

Annie Vallières (Canada), Leon Lack (Australia)

C24: Sleep surgery in the era of precision medicine

1:00pm - 5:00pm | Room 24B

Chairs: Stanley Liu (United States), Edilson Zancanella (Brazil)

PART 1

1:00pm - 1:30pm

Why sleep surgery?

Edilson Zancanella (Brazil)

1:30pm - 1:45pm

Drug-induced sleep endoscopy

Marina Carrasco-Llatas (Spain)

1:45pm - 2:00pm

Nasal surgery

Ofer Jacobowitz (United States)

2:00pm - 2:15pm

Predicting velopharyngeal surgical outcome

Jingying Ye (China)

2:15pm - 2:30pm

Expansion pharyngoplasty

Michel Cahali (Brazil)

2:30pm - 2:45pm

Mandibular distraction for pediatric OSA

Lai-In Ho (Hong Kong)

2:45pm - 3:00pm

Tongue base procedures

Srinivas Kishore Sistla (India)

3:00pm - 3:20pm

Coffee break

SCIENTIFIC PROGRAM

PART 2

3:20pm - 3:36pm

Optimizing maxillomandibular advancement outcome

Diderot Parreira (Brazil)

3:36pm - 3:52pm

Multi-level surgery and outcome

Olivier Vanderveken (Belgium)

3:52pm - 4:08pm

Maxillary determinants of TORS outcome

Eric Thuler (United States)

4:08pm - 4:24pm

Hypoglossal nerve stimulation landscape

Clemens Heiser (Germany)

4:24pm - 4:40pm

Sleep psychiatry’s impact on sleep surgery outcomes

Nnamdi Orakpo (United States)

4:40pm - 5:00pm

Question and answer

IPSA Member Meeting

5:00pm - 6:00pm | Room 24

Chair: Judith Owens (United States)

World Dentofacial Sleep Society (WDSS) member meeting

5:00pm - 6:00pm | Room 24B

Chairs: Audrey Yoon (United States), Leopoldo Correa (United States)

Poster abstract | Group 1

5:00pm – 6:00pm | Exhibit Hall

Opening ceremony

6:30pm – 9:00pm | Room 34

IRLSSG 2023: Annual Meeting

8:30am - 5:00pm | Room A07 Program Committee: Alan Eckeli (Brazil), Elias Karroum (United States), Denise Sharon (United States), Ambra Stefani (Austria), John Winkelman (United States)

IRLSSG 2023: Richard P Allen keynote presentation

8:30am - 9:15am | Room A07

Chair: John Winkelman (United States)

8:30am - 8:40am

Introduction

John Winkelman (United States), Alan Eckeli (Brazil)

8:40am - 9:15am

Augmentation in RLS: First described and never solved. An homage for Richard Allen

Claudia Trenkwalder (Germany)

IRLSSG 2023: Clinical manifestations and pathogenesis of comorbidities in RLS

9:15am - 10:15am | Room A07

Chairs: Rosalia Silvestri (Italy), Alan Eckeli (Brazil)

9:15am - 9:30am

Central nervous system and comorbidities

Rosalia Silvestri (Italy)

9:30am - 9:45am

Peripheral nervous system comorbidities

Cornelius Bachmann (Germany)

9:45am - 10:00am

Psychiatric comorbidities

Yves Dauvilliers (France)

10:00am - 10:15am

Role of inflammation

Angelica Montini (Italy)

IRLSSG 2023: Review of the role of the endogenous opioid and melanocortin systems

10:15am - 10:30am | Room A07

Chair: Alan Eckeli (Brazil)

10:15am - 10:30am

Review of the role of the endogenous opioid and melanocortin systems

Arthur S. Walters (United States)

IRLSSG 2023: New omics-based perspectives in RLS and PLMS

10:45am - 11:50am | Room A07

Chairs: Raffaele Ferri (Italy), Emmanuel Mignot (United States)

10:45am - 10:50am

Introduction

Raffaele Ferri (Italy)

2023 Wayne Hening Young Investigator Award Recipient

10:50am - 11:10am

New insight into RLS pathophysiology suggested by transcriptomics and WHYIA abstract: A transcriptome analysis of mRNAs in patients with RLS

Maria Paola Mogavero (Italy)

11:10am - 11:25am

Proteomics and glycomics of RLS: Hints for possible novel targeted therapeutic interventions

Yehia Mechref (United States)

2023 Wayne Hening Young Investigator Award Recipient

11:25am - 11:45am

Omics profiling in PLMS and WHYIA abstract: Proteomic profiling in PLMS and RLS

Katie Cederberg (United States)

11:45am - 11:50am

Question and answer

SCIENTIFIC PROGRAM

IRLSSG 2023: Wayne Hening Young Investigator Award winners’ presentations

11:50am - 12:35pm | Room A07

11:50am - 12:05pm

Hypothalamic inflammation analysis in an animal model of iron deficiency for RLS

Beatriz da Silva Franco (Brazil)

12:05pm - 12:20pm

Metagenomic analysis in RLS

Angelica Montini (Italy)

12:20pm - 12:35pm

Effects of acute exposure to altitude on RLS

Abubaker Ibrahim (Austria)

IRLSSG 2023: Business meeting

12:45 - 1:25pm | Room A07

IRLSSG 2023: The WHO- Iron deficiency guidelines: How to harmonize clinical investigations

1:35pm - 2:05pm | Room A07

Chair: Osman Ipsiroglu (Canada)

1:35pm - 2:05pm

Round table

James Connor (United States), Elias Karroum (United States), Scout McWilliams (Canada), Rosalia Silvestri (Italy)

IRLSSG 2023: Further evidence on contrasting painful and painless RLS

2:05pm - 2:20pm | Room A07

2:05pm - 2:20pm

Further evidence on contrasting painful and painless RLS

Elias Karroum (United States)

IRLSSG 2023: Neuromodulation in RLS

2:20pm - 3:25pm | Room A07

Chair: Mauro Manconi (Switzerland)

2:20pm - 2:32pm

Transcutaneous spinal DCS stimulation

Cornelius Bachmann (Germany)

2:32pm - 2:44pm

Peroneal nerve stimulation

John Winkelman (United States)

2:44pm - 2:56pm

Non-invasive vagal nerve stimulation

Sarah Hartley (France)

2:56pm - 3:08pm

Acute and chronic epidural spinal cord stimulation in RLS and PLMS

Mauro Manconi (Switzerland)

3:08pm - 3:20pm

Deep brain stimulation in RLS alone in or comorbidity with Parkinson Disease

William Ondo (United States)

3:20pm - 3:25pm

Question and answer

(continued next page)

IRLSSG 2023: Autonomic nervous system modulation in RLS

3:40pm - 3:55pm | Room A07

Chair: Elias Karroum (United States)

3:40pm - 3:55pm

Autonomic nervous system modulation in RLS

Ravi Gupta (India)

IRLSSG 2023: Development and validation of RLS diary

3:55pm - 4:10pm | Room A07

Chair: Elias Karroum (United States)

3:55pm - 4:10pm

Development and validation of RLS diary

Anupama Gupta (India)

IRLSSG 2023: Round table: Renaming augmentation of RLS to e.g., “Dopaminergic medication aggravated RLS”

4:10pm - 4:40pm | Room A07

Chair: Walter Paulus (Germany)

4:10pm - 4:40pm

Discussants

Diego Garcia-Borreguero (Spain), Denise Sharon (United States), Claudia Trenkwalder (Germany), Birgit Högl (Austria), Luigi Ferini-Strambi (Italy), Yuichi Inoue (Japan)

IRLSSG 2023: IRLSSG projects

4:40pm - 5:25pm | Room A07

Chair: Elias Karroum (United States)

4:40pm - 4:55pm

Inter-rater reliability of manual leg movement scoring: Where 30+ experts agree and where not Stephany Fulda (Switzerland)

4:55pm - 5:05pm

Spark *PLMD

John Winkelman (United States)

5:05pm - 5:15pm

Pediatric PLMD

Daniel Picchietti (United States)

5:15pm - 5:25pm

Future of RLS treatment

Diego Garcia-Borreguero (Spain) Saturday, October 21, 2023 | 7:00pm - 10:00pm

Save The Date

8th Congress of the International Pediatric Sleep Association

IPSA 2024 will provide an opportunity for physicians, clinicians, basic scientists, clinical investigators, educators and sleep health advocates from around the globe to present the latest cutting-edge research and explore innovative solutions to current challenges in pediatric sleep. All of this and more in beautiful Glasgow, Scotland!

2024 Keynote Speakers

Samuele Cortese, MD, PhD (United Kingdom)

University of Southampton

ADHD and Sleep: Future challenges

Kelton Minor, PhD (United States)

Columbia University Data Science Institute

Nighttime Warming and Human Sleep: A Planetary Experiment

Stijn Verhulst, MD, PhD (Belgium)

Antwerp University Hospital

Obesity and obstructive sleep apnea in children: How do they affect each other?

SCIENTIFIC PROGRAM

K01: Raffaele Ferri: Measuring and analyzing movements in sleep

8:00am – 8:45am | Room 17

8:00am – 8:02am

Introduction

Monica Andersen (Brazil)

8:02am – 8:45am

Keynote presentation

Raffaele Ferri (Italy)

K02: Michael Chee: Consumer sleep tech and sleep transformation

8:00am – 8:45am | Room 24

8:00am – 8:02am

Introduction

Judith Owens (United States)

8:02am – 8:45am

Keynote presentation

Michael Chee (Singapore)

K03: Dalva Poyares: Sleep and aging crosstalk in health and disease

8:00am – 8:45am | Room 34

8:00am – 8:02am

Introduction

Thomas Penzel (Germany)

8:02am – 8:45am

Keynote presentation

Dalva Poyares (Brazil)

S01: Novel digital measures to analyze polysomnography: Are we ready for clinical implementation?

9:00am – 10:30am | Room 07

Chairs: Matteo Cesari (Austria), Diego Mazzotti (United States)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Novel EEG measures to assess sleep disruption

Bastien Lechat (Australia)

9:18am – 9:34am

Novel respiratory measures beyond AHI

Timo Leppänen (Finland)

9:34am – 9:50am

Assessment of sleep structure using heart rate variability and body movements: Performance and applications

Sebastiaan Overeem (Netherlands)

9:50am – 10:06am

Data-driven methods to capture movements and muscular activity during sleep

Matteo Cesari (Austria)

10:06am – 10:22am

A path towards clinical implementation of novel polysomnographic measures

Diego Mazzotti (United States)

10:22am – 10:30am

Question and answer

SCIENTIFIC PROGRAM

S02: Anatomic studies of disease onset and spread across neurodegenerative disorders reveal mechanisms for disease-specific sleep/ wake phenotypes

9:00am – 10:30am | Room 17

Chair: Thomas Neylan (United States)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Awakening: Differential sleep/wake patterns across tauopathies

Christine Walsh (United States)

9:18am – 9:34am

Are the noradrenergic/orexigenic systems influencing sleep patterns within early and lateonset Alzheimer’s Disease?

Neus Falgàs Martínez (Spain)

9:34am – 9:50am

Abnormal resting state EEG rhythms in Alzheimer’s, Parkinson’s, and Lewy Body diseases

Susanna Lopez (Italy)

9:50am – 10:06am

Subjective and objective characteristics of sleep in the early stages of Alzheimer’s Disease

Conrado Borges (Brazil)

10:06am – 10:22am

Neuropathological studies of sleep, wake, and circadian regulating nuclei across tauopathies reveal mechanisms for divergent sleep wake phenotypes

Lea Grinberg (United States)

10:22am – 10:30am

Question and answer

S03: Glioneurosomnia: New insights into glioneuronal mechanisms of sleep

9:00am – 10:30am | Room 23

Chairs: Michael Lazarus (Japan), Radhika Basheer (United States)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Astroglial signaling in sleep homeostasis

Marcos Frank (United States)

9:22am – 9:42am

ATP and adenosine in homeostatic sleep response: A ‘neuroglial’ interplay

Radhika Basheer (United States)

9:42am – 10:02am

Adenosine regulation of sleep and circadian rhythms

Sridhar Vasudevan (United Kingdom)

10:02am – 10:22am

Glioneuronal mechanisms integrating sleep homeostasis and motivation

Michael Lazarus (Japan)

10:22am – 10:30am

Question and answer

SCIENTIFIC PROGRAM

S04: Value-based sleep: Global and health economic perspectives

9:00am – 10:30am | Room 24

Chair: Emerson Wickwire (United States)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Value-based sleep in the US: Health economic findings from Medicare claims

Emerson Wickwire (United States)

9:18am – 9:34am

Obstructive sleep apnea and positive airway pressure: A global market access perspective and case study in Brazil

Claudia Albertini (Brazil)

9:34am – 9:50am

The value of sleep to the U.S. military: Operational, medical, and economic considerations

Vincent F. Capaldi (United States)

9:50am – 10:06am

Economic burden of insufficient sleep and insomnia in Canada

Jean-Philippe Chaput (Canada)

10:06am – 10:22am

The value of artificial intelligence for sleep medicine

Nate F. Watson (United States)

10:22am – 10:30am

Question and answer

T02: Pediatric sleep scoring

9:00am – 10:30am | Room 25

Chair: Paolo Matrigiani (Italy)

9:00am - 9:05am

Introduction

9:05am - 9:25am

PSG in children: They’re not just little adults

Carlos Teixeira (Portugal)

9:25am - 9:45am

Pediatric sleep scoring rules

Federica Cinelli (Italy)

9:45am - 10:05am

Pediatric respiratory rules

Daniela Ferreira (Portugal)

10:05am - 10:25am

Practical scoring session

10:25am - 10:30am

Question and answer

S05: Exploring craniofacial and social factors to understand the heterogeneity of obstructive sleep apnea management in children

Room 27 | 9:00am – 10:30am

Chairs: Nathalia Fernandes Fagundes (Brazil), Carlos Flores-Mir (Canada)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Towards a simplified diagnostic approach of pediatric OSA – Challenges and progress to date

David Gozal (United States)

SCIENTIFIC PROGRAM

9:18am – 9:34am

The journey of pediatric OSA patients while seeking for care

Nathalia Fernandes Fagundes (Brazil)

9:34am – 9:50am

Pediatric OSA and craniofacial characteristics

Carlos Flores-Mir (Canada)

9:50am – 10:06am

Comorbid Insomnia and OSA within the pediatric age-range: Clinical features and implications

Miguel Meira e Cruz (Portugal)

10:06am – 10:22am

Rapid maxillary expansion in the growing patient with SDB: Where do we stand today?

Jorge Faber (Brazil)

10:22am – 10:30am

Question and answer

O01: Sleep disordered breathing: New diagnostic and treatment strategies

9:00am – 10:30am | Room 28

Chairs: Danny Eckert (Australia), Robert Thomas (United States)

9:00am - 9:13am

A single overnight infusion of TAK-925, a selective orexin 2 receptor agonist, reduces obstructive sleep apnea severity

Danny Eckert (Australia)

9:13am - 9:26am

Effortless detection of sleep apnea using a smart bed

Farzad Siyahjani (United States)

9:26am - 9:39am

Central sleep apnea treated by a constant low dose CO2 supplied by a novel device

Yuanming Luo (United States)

9:39am - 9:52am

Real world assessment of reduction of obstructive sleep apnea events by continuous positive airway pressure using a continuous large U.S. sample by home under-mattress devices

Clete Kushida (United States)

9:52am - 10:05am

Screening obstructive sleep apnea (OSA) in hospitalized patients admitted for acute ischemic stroke using Belun Ring: An interim analysis

Ambrose Chiang (United States)

10:05am - 10:18am

Sleep apnea screening through a news portal using the STOP-Bang questionnaire. A proof of concept

Daniel Perez-Chada (Argentina)

S06: Screening and monitoring of idiopathic REM sleep behavior disorder and prodromal Lewy body disease – the promise of digital health

9:00am – 10:30am | Room 33

Chairs: Emmanuel During (United States), Yun Kwok Wing (Hong Kong)

9:00am – 9:02am

Introduction

9:02am – 9:22am

How to implement actigraphy in REM sleep behavior disorder screening and monitoring

Ambra Stefani (Austria)

9:22am – 9:42am

The sleep-wake rhythm dysregulation measured by actigraphy in idiopathic REM sleep behavior disorder and Lewy body diseases

Claudio Liguori (Italy)

SCIENTIFIC PROGRAM

9:42am – 10:02am

REM sleep behavior disorder and Lewy body disorders monitoring: From questionnaire to digital assessment

Yun Kwok Wing (Hong Kong)

10:02am – 10:22am

Digital health in Lewy body neurodegeneration

Emmanuel During (United States)

10:22am – 10:30am

Question and answer

S07: You sleep how you eat?

9:00am – 10:30am | Room 34

Chairs: Kingman Strohl (United States), Dominik Pesta (Germany)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Brown fat cells and their influence on sleep and wake

Nikolaus Netzer (Germany)

9:18am – 9:34am

Eating disbehavior in adolescents and unhealthy sleep

Roland Popp (Germany)

9:34am – 9:50am

Diets and lifestyle therapies : Are they effective to promote better sleep

Dominik Pesta (Germany)

9:50am – 10:06am

Chronotype and eating behavior: The best time for dinner

Stephan Pramsohler (Germany)

10:06am – 10:22am

Energy drinks give you wings and beer makes you tired: Is there more than the usual suspects that really influences our sleep?

Kingman Strohl (United States)

10:22am – 10:30am

Question and answer

S08: Updates in restless sleep disorder (RSD) research

9:00am – 10:30am | Room 37

Chairs: Raffaele Ferri (Italy), Oliviero Bruni (Italy)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Scoring updates for RSD and large muscle group movements

Raffaele Ferri (Italy)

9:22am – 9:42am

Clinical features of RSD with emergent evidence

Oliviero Bruni (Italy)

9:42am – 10:02am

Neurocognitive aspects in RSD

Hovig Artinian (United States)

10:02am – 10:22am

Nocturnal epileptic seizures and RSD

Gulcin Benbir Senel (Türkiye)

10:22am – 10:30am

Question and answer

SCIENTIFIC PROGRAM

S09: Obstructive sleep apnea in coronary artery disease: to treat or not to treat?

9:00am – 10:30am | Room 38

Chairs: Sanja Jelic (United States), Luciano Drager (Brazil)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Overview of the recent RCTs and controversies within the field: The cardiologist’s perspective

Chi-Hang Ronald Lee (Singapore)

9:18am – 9:34am

Recognizing potential pro-inflammatory effects of PAP therapy in OSA

Sanja Jelic (United States)

9:34am – 9:50am

Airway obstruction, cardiovascular reactivity, and PAP treatment

Ali Azarbarzin (United States)

9:50am – 10:06am

Sleepy vs non-sleepy OSA in patients with CAD: Does it matter?

Yuksel Peker (Türkiye)

10:06am – 10:22am

Future perspectives for PAP RCTs in patients with CAD and OSA

Luciano Drager (Brazil)

10:22am – 10:30am

Question and answer

O02: Evidence-based approaches for optimizing pharmacologic treatment for narcolepsy

9:00am - 10:30am | Room A06

Chairs: Yves Dauvilliers (France), Michael J. Thorpy (United States)

9:00am - 9:13am

Efficacy and safety of pitolisant in children above 6 years with narcolepsy with and without cataplexy

Yves Dauvilliers (France)

9:13am - 9:26am

Preliminary results from a phase 1 study of ALKS 2680, an Orexin-2 receptor agonist, in healthy participants and patients with narcolepsy or idiopathic hypersomnia

Brendon Yee (Australia)

9:26am - 9:39am

Safety, tolerability, pharmacodynamics, and pharmacokinetics of oral TAK-861 in an acute sleep phase delay paradigm in healthy male subjects

Melissa Naylor (United States)

9:39am - 9:52am

Individualized dosing strategies for oxybate: Insights from the real-world TENOR study

Wayne Macfadden (United States)

9:52am - 10:05am

Improvement in sleep latency with once-nightly sodium oxybate: Analysis from the phase 3

REST-ON clinical trial

Michael J. Thorpy (United States)

10:05am - 10:18am

Sodium oxybate treatment patterns in narcolepsy patients: A propensity score–matched cohort study subanalysis

Lois Krahn (United States)

SCIENTIFIC PROGRAM

O03: Insomnia treatments

9:00am - 10:30am | Room A07

Chairs: Josée Savard (Canada), Annie Vallières (Canada)

9:00am - 9:13am

Acceptance and commitment therapy versus cognitive behavioral therapy for insomnia: A randomized controlled trial

Renatha El Rafihi-Ferreira (Brazil)

9:13am - 9:26am

The feasibility and efficacy of mindfulness-based therapy for insomnia among young and middleaged black women in the United States (US)

Soohyun Nam (United States)

9:26am - 9:39am

Randomized controlled trial of effectiveness and cost-effectiveness of internet-based cognitive behavioral therapy for insomnia in clinical settings: Preliminary results

Polina Pchelina (Russian Federation)

9:39am - 9:52am

Integration of cognitive-behavioral therapy for insomnia in routine cancer care: Preliminary results of an implementation study

Josée Savard (Canada)

9:52am - 10:05am

Mindfulness-based stress reduction compared with cognitive behavioral therapy to improve sleep and mental health in university students with insomnia

Amélie Vézina (Canada)

10:05am - 10:18am

Effectiveness of e-based cognitive behavioral therapy for insomnia on enhancing depression and insomnia outcome in Chinese youth with both diagnoses

Sijing Chen (Hong Kong)

S10: Time to make a change! Sleep extension intervention research from theory to practice

10:45am – 12:15pm| Room 07

Chairs: Kelly Baron (United States), Sooyeon (Aly) Suh (Korea, Republic of)

10:45am – 10:47am

Introduction

10:47am – 11:07am

Using technology to motivate and achieve extended sleep among adults at risk for cardiovascular disease

Kelly Baron (United States)

11:07am – 11:27am

Development of the BED-PRO intervention

Sooyeon (Aly) Suh (Korea, Republic of)

11:27am – 11:47am

Incentive interventions for motivating sleep behavior change among young and middle aged adults

Stijn Massar (Singapore)

11:47am – 12:07pm

Sleep extension: Effects among populations with diabetes or at risk for metabolic disorders

Sirimon Reutrakul (United States)

12:07pm – 12:15pm

Question and answer

SCIENTIFIC PROGRAM

S11: Circadian medicine: Pathway to clinical translation

10:45am – 12:15pm | Room 17

Chair: Shantha Rajaratnam (Australia)

10:45am – 10:47am

Introduction

10:47am - 11:07am

Mechanisms for circadian rhythm sleep-wake disorders

Phyllis Zee (United States)

11:07am - 11:27am

Health consequences of circadian disruption

Frank Scheer (United States)

11:27am - 11:47am

Towards a novel circadian nosology

Charles Czeisler (United States)

11:47am - 12:07pm

International association of circadian health clinics

Jade Murray (Australia)

12:07pm – 12:15pm

Question and answer

S12: Global sleep health disparities and culturally-tailored sleep health promotion solutions among marginalized children and adolescents from cultures around the world

10:45am – 12:15pm | Room 23

Chairs: Sarah Honaker (United States), Judith Owens (United States)

10:45am – 10:47am

Introduction

10:47am – 11:03am

Pediatric sleep disparities among black children and implementation of digital sleep interventions to support sleep health

Alicia Chung (United States)

11:03am – 11:19am

Sleep and adjustment in foster environments (SAFE): Efficacy and acceptability of a traumainformed sleep intervention for children in foster care

Candice Alfano (United States)

11:19am – 11:35am

Understanding, researching, and improving sleep health in First Nations Australians

Sarah Blunden (Australia)

11:35am – 11:51am

Pediatric sleep disparities in Nigeria and the perceptions of adolescents, their parents, teachers, and pediatricians

Oluwatosin Olorunmoteni (Nigeria)

11:51am – 12:07pm

Sleep health and mental wellbeing in adolescents living in high childhood adversity exposure context in Kenya

Sarah Honaker (United States)

12:07pm – 12:15pm

Question and answer

SCIENTIFIC PROGRAM

S13: Transdiagnostic crossover in the treatment of insomnia and affective disorders

10:45am – 12:15pm | Room 24

Chairs: Esmée Verwijk (Netherlands), William McCall (United States)

10:45am – 10:47am

Introduction

10:47am – 11:03am

Fundamental brain mechanisms underlying the link between insomnia and affective disorders and the need for a transdiagnostic treatment approach

Eus van Someren (Netherlands)

11:03am – 11:19am

The response of insomnia to electroconvulsive therapy in severe depression and its role in relapse: A multi center approach

Esmée Verwijk (Netherlands)

11:19am – 11:35am

The impact and limitations of antidepressant medications in addressing insomnia cooccurring with depressive and anxiety disorders

William McCall (United States)

11:35am – 11:51am

Effectiveness of cognitive behavior therapy for insomnia and circadian rhythm support in insomnia and psychiatric comorbidity profiles

Joyce Reesen (Netherlands)

11:51am – 12:07pm

The use of digital CBT in cases of insomnia comorbid with affective disorders

Gabriel Natan Pires (Brazil)

12:07pm – 12:15pm

Question and answer

T03: Adult sleep scoring

10:45am – 12:15pm | Room 25

Chair: Carlos Teixeira (Portugal)

10:45am - 10:50am

Introduction

10:50am - 11:10am

Sleep scoring guidelines

Pedro Amorim (Portugal)

11:10am - 11:30am

Respiratory events guidelines

Daniela Ferreira (Portugal)

11:30am - 11:50am

Movements and cardiac guidelines

Helene Vitali (Italy)

11:50am - 12:10pm

Practical scoring session

12:10pm - 12:15pm

Question and answer

S14: Outcome evaluations of cutting-edge non-PAP treatments: research trials to clinical practice

10:45am – 12:15pm | Room 27

Chair: Alejandra Lastra (United States)

10:45am – 10:47am

Introduction

10:47am – 11:07am

Transoral neuromuscular stimulation: Latest updates

Atul Malhotra (United States)

11:07am – 11:27am

Treatment outcomes, predictions for OAT effectiveness, and assessment tools

Pien Bosschieter (United States)

SCIENTIFIC PROGRAM

11:27am – 11:47am

Pathophysiological endotyping in patients treated with upper airway stimulation for obstructive sleep apnea

Olivier Vanderveken (Belgium)

11:47am – 12:07pm

One size does not fit all: The role of hybrid therapy modes in obstructive sleep apnea

Alejandra Lastra (United States)

12:07pm – 12:15pm

Question and answer

S15: Multi-night and innovative diagnostic pathways for obstructive sleep apnoea: Implications for diagnostic accuracy, health outcomes and clinical care

10:45am – 12:15pm | Room 28

Chairs: Danny Eckert (Australia), Indu Ayappa (United States)

10:45am – 10:47am

Introduction

10:47am – 11:07am

New technology for OSA diagnosis and management

Jean Louis Pepin (France)

11:07am – 11:27am

Night-to-night variability in OSA severity and disease misdiagnosis and misclassification

Naresh Punjabi (United States)

11:27am – 11:47am

Multi-night objective measurement of sleep structure and timing to complement OSA diagnosis and better understand its consequences

Hannah Scott (Australia)

World Sleep 2023 Program Types

11:47am – 12:07pm

High night-to-night variability of OSA severity is associated with hypertension: Evidence for a distinct clinical phenotype

Bastien Lechat (Australia)

12:07pm – 12:15pm

Question and answer

S16: Targeting sleep to improve mental health

10:45am – 12:15pm | Room 34

Chairs: Christoph Nissen (Switzerland), Tiina Paunio (Finland)

10:45am – 10:47am

Introduction

10:47am - 11:07am

Sleep in schizophrenia

Tiina Paunio (Finland)

11:07am - 11:27am

Impact of sequential CBT-I and medications on fatigue and psychological symptoms

Charles Morin (Canada)

11:27am - 11:47am

Become your own SLEEPexpert: A pragmatic behavioral treatment program for insomnia in acute psychiatric care

Elisabeth Hertenstein (Switzerland)

11:47am - 12:07pm

Auditory closed-loop modulation of slow wave sleep to treat major depressive disorder

Kristoffer Fehér (Switzerland)

12:07pm – 12:15pm

Question and answer

SCIENTIFIC PROGRAM

O04: RLS, PLMS and other Movement disorders

10:45am - 12:15 | Room A06

Chairs: John Winkelman (United States), Guillermo Ramis (Spain)

10:45am - 10:58am

Physiological movements during sleep in healthy adults and across all ages: Videopolysomnographic analysis reveals difference in sex and specific motor patterns

Angelica Montini (Italy)

10:58am - 11:11am

Neurotransmitter regulation as common pathways between sleep phenotypes, restless leg syndrome and Tourette syndrome

Mayara Paschalidis (Brazil)

11:11am - 11:24am

Correlation between the circadian parameters of temperature and movement with subjective sleep assessment in patients in waiting list for liver transplant

Guillermo Ramis (Spain)

11:24am - 11:37am

Detecting periodic leg movements during sleep (PLMS) in restless legs syndrome (RLS) using the NTX100 tonic motor activation (TOMAC) system

Stephanie Rigot (United States)

11:37am - 11:50am

National RLS opioid registry: Three-year safety, dose stability, and efficacy

John Winkelman (United States)

11:50am - 12:03pm

Isolated and symptomatic RBD in Parkinson’s disease share a common neurophysiological pattern: A pilot TMS study

Giuseppe Lanza (Italy)

O05: Basic research: Human

10:45am - 12:25pm | Room A07

Chairs: Christelle Peyron (France), Nadia Gosselin (Canada)

10:45am - 10:58am

Wake oscillation amplitudes and quantities change independently with time awake

Sophia Snipes (Switzerland)

10:58am - 11:11am

Association between sleep spindles and thalamic grey matter volume following moderate to severe traumatic brain injury

Narges Kalantari (Canada)

11:11am - 11:24am

K-complex and heart rate dynamics during varying arousal levels in human NREM sleep Manuel Carro-Domínguez (Switzerland)

11:24am - 11:37am

Factors associated with sleep-wake state discrepancy among healthy adults

Rachel Ran Wang (Hong Kong)

11:37am - 11:50am

A pilot study to evaluate efficacy of brief behavioral and sleep hygiene education with mindfulness intervention on sleep duration, timing, quality, anxiety, depression, and quality of life in adolescents

Ingibjorg Magnusdottir (Iceland)

11:50am - 12:03pm

Effects of daily fluctuations in sleep and intraindividual sleep variability on mood, motivation and sleepiness in university students: A wearable and digital diary approach

Alyssa S. C. Ng (Singapore)

12:03pm - 12:16pm

Moderate RBD symptoms in narcoleptic versus iRBD mice

Christelle Peyron (France)

SCIENTIFIC PROGRAM

Philips: Personalizing Sleep Apnea Therapy for Optimal Outcomes

12:30pm – 2:00pm | Room 33

Chairs: Teofilo Lee-Chiong (United States), Manuel Sánchez-de-la-Torre (Spain)

Polysomnographic subtypes of sleep apnea to guide CPAP therapy allocation

Ali Azarbarzin (United States)

Sleep Apnea Phenotypes: Determinants of therapy adherence and response to treatment

Manuel Sánchez-de-la-Torre (Spain)

Strategies for remote interventions improving CPAP therapy management: toward precision care

Mikel Azpiazu (Spain)

Medscape Education Global: Narcolepsy and Idiopathic Hypersomnia: Unraveling the Connection Between Orexin/Hypocretin and Patient Struggles

12:30pm – 2:00pm | Room 37

Organized by Medscape Education Global Supported by independent funding from Takeda

12:30pm - 12:35pm

Welcome and introduction

Yves Dauvilliers (France)

12:35pm - 12:50pm

A Quickfire Take: What Goes Wrong in Narcolepsy and Idiopathic Hypersomnia?

Lucie Barateau (France), Thomas Scammell (United States)

12:50pm - 1:20pm

Connecting the Symptoms: From Pathophysiology to Nighttime and Daytime Disruption

Giuseppe Plazzi (Italy)

1:20pm - 1:35pm

The Experience of Narcolepsy and Idiopathic Hypersomnia: Patient Perspectives

Yves Dauvilliers (France), Lucie Barateau (France), Thomas Scammell (United States), Giuseppe Plazzi (Italy)

1:35pm - 1:50pm

Audience Question and Answer

1:50pm - 2:00pm

Concluding Remarks

Yves Dauvilliers (France)

ResMed: Unravelling the OSA Patient Journey: Awareness, Diagnosis and Treatment

12:30pm – 2:00pm | Room 38

Chairs: Claudia Albertini (Brazil), Adam V. Benjafield (Australia)

Raising Sleep Apnea Awareness: A Global Necessity

George Lago (Brazil)

Simplified Solutions: Optimizing Sleep Apnea Diagnosis

Eduardo Borsini (Argentina)

Managing Sleep Apnea: A Lifelong Journey to Health

Luciano Drager (Brazil)

SCIENTIFIC PROGRAM

Asleep: AI-driven Innovations in Sleep Health: With Sound of Sleep

12:45pm - 2:00pm | Room 07

Chairs: Clete Kushida (United States), Daewoo Kim (Korea, Republic of)

Part 1: Sleep and AI Introduction

Part 1: Our aim is to present evidence demonstrating the effectiveness and thorough validation of sound-based AI models for sleep monitoring.

12:45pm - 12:55pm

Enhancing Sleep Medicine: Leveraging AI for Advanced Diagnosis and Treatment

Clete Kushida (United States)

12:55pm - 1:20pm

AI and Sleep: The Power of Sound-based Analysis for Accurate Sleep Insights

Daewoo Kim (Korea, Republic of), Seulki Park (Korea, Republic of)

Part 2: Collaborate and Innovate

Part 2: We hope to explore potential collaborations for data-driven research and expand the application of our AI model to sleep medicine.

1:20pm - 1:35pm

AI in Sleep Medicine: Diagnosis, CPAP, and Beyond

1:35pm - 1:45pm

Data Analysis from SleepRoutine: Exploring Korean Sleep Patterns

Ki-Young Jung (Korea, Republic of)

1:45pm - 1:55pm

Collaborate and Innovate: Leveraging AI in Sleep Research and Business Ventures

Dongheon Lee (Korea, Republic of)

German Research Foundation: Science Lunch on Funding Opportunities and Collaboration Programs for Research in and with Germany

1:00pm - 1:45pm | Room 28

K04: Jan Born: The memory function of sleep: Implications for aging and dementia

2:00pm – 2:45pm | Room 17

2:00pm - 2:02pm

Introduction

Clete Kushida (United States)

2:02pm – 2:45pm

Keynote presentation

Jan Born (Germany)

K05: Stanley Liu: Sleep surgery as restoring missed milestones in airway growth and development

2:00pm – 2:45pm | Room 24

2:00pm - 2:02pm

Introduction

Edilson Zancanella (Brazil)

2:02pm – 2:45pm

Keynote presentation

Stanley Liu (United States)

K06: Julio Fernandez-Mendoza: Sleep in adolescence: Epidemiology and burden of insomnia, short sleep, and beyond

2:00pm – 2:45pm | Room 34

2:00pm - 2:02pm

Introduction

Charles Morin (Canada)

2:02pm – 2:45pm

Keynote presentation

Julio Fernandez-Mendoza (United States)

SCIENTIFIC PROGRAM

S17: Predictors of response to cognitive behavioral therapy for insomnia

3:00pm – 4:30pm | Room 07

Chairs: William McCall (United States), Julio Fernandez-Mendoza (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Insomnia phenotypes based on objective sleep duration: Pathophysiology, morbidity and response to CBT-I

Julio Fernandez-Mendoza (United States)

3:18pm – 3:34pm

Awake or asleep? The relationship between sleep misperception and CBT-I

Andrea Galbiati (Italy)

3:34pm – 3:50pm

Predictors and moderators of treatment response to digital CBT for insomnia

Christopher Miller (United Kingdom)

3:50pm – 4:06pm

Night-to-night sleep variability moderates treatment responsiveness to brief behavioral therapy of insomnia

Wai Chan (China)

4:06pm – 4:22pm

The potential role of daytime autonomic nervous system assays in subtyping insomnia for the purposes of treatment planning

William McCall (United States)

4:22pm – 4:30pm

Question and answer

S18: Going beyond the AHI: New insights from advanced analyses of polysomnograms

3:00pm – 4:30pm | Room 17

Chairs: Najib Ayas (Canada), Ali Azarbarzin (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Introduction: Why do we need to go beyond the AHI?

Ali Azarbarzin (United States)

3:18pm – 3:34pm

Hypoxic burden and heart rate response to events: Are we almost ready for prime time?

Wen-Hsin Hu (United States)

3:34pm – 3:50pm

Unlocking the brain with PSG: Review of EEG microarchitecture metrics

Mohammadreza Hajipour (Canada)

3:50pm – 4:06pm

Deep physiologic endotyping with PSG: A step towards precision care?

Bradley Edwards (Australia)

4:06pm – 4:22pm

Separating central from obstructive events: More than meets the eye

Indu Ayappa (United States)

4:22pm – 4:30pm

Question and answer

SCIENTIFIC PROGRAM

S19: How do we fall asleep? Integrating physiological, behavioral and cognitive signatures

3:00pm – 4:30pm | Room 23

Chairs: Martin Dresler (Netherlands), Thomas Andrillon (France)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Local sleep-like slow waves predict the consequences of cognitive fatigue

Thomas Andrillon (France)

3:18pm – 3:34pm

Neural and cognitive dynamics of perceptual and cognitive decision making in the process of falling asleep

Tristan Bekinschtein (Argentina)

3:34pm – 3:50pm

Modeling the departure from conscious wakefulness in terms of a low dimensional manifold

Enzo Tagliazucchi (Argentina)

3:50pm – 4:06pm

Electrophysiological markers of the sleep onset period and clinical applications

Mélanie Strauss (France)

4:06pm – 4:22pm

The sleep onset period: A genius gap?

Delphine Oudiette (France)

4:22pm – 4:30pm

Question and answer

S20: The N/OFQ – NOP receptor system and its putative roles in nociception, analgesia, mood disorders and sleep

Room 24 | 3:00pm – 4:30pm

Chair: Thomas Kilduff (United States)

3:00pm – 3:05pm

Introduction

3:05pm – 3:25pm

The N/OFQ – NOP receptor system: Research milestones in biology, pharmacology and translational medicine

Girolamo Calo’ (Italy)

3:25pm – 3:45pm

Nociceptin/orphanin FQ receptor ligands for the treatment of anxiety and depression

Elaine Gavioli (Brazil)

3:45pm – 4:05pm

Activation of the nociception/orphanin-FQ receptor promotes NREM sleep and EEG slow wave activity

Thomas Kilduff (United States)

4:05pm – 4:25pm

Sunobinop: A novel selective partial agonist at nociception/orphanin-FQ peptide (NOP) with sleep promoting and wake suppressing actions

Garth Whiteside (United States)

4:25pm – 4:30pm

Question and answer

SCIENTIFIC PROGRAM

S21: New insights in upper airway examination during DISE

3:00pm – 4:30pm | Room 27

Chair: Clemens Heiser (Germany)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

The sense and non-sense of specific manoeuvers during drug-induced sleep endoscopy

Madeline Ravesloot (Netherlands)

3:22pm – 3:42pm

Obstructive sleep apnea phenotyping during drug-induced sleep endoscopy for personalized medicine

Olivier Vanderveken (Belgium)

3:42pm – 4:02pm

Visual and physiologic assessment of upper airway collapse during drug-induced sleep endoscopy

Eric Thuler (United States)

4:02pm – 4:22pm

DISE-PhOP during drug-induced sleep endoscopy manoeuvres

Emily Schoustra (Netherlands)

4:22pm – 4:30pm

Question and answer

O06: Evaluation and treatment of pediatric sleep

3:00pm – 4:30pm | Room 28

Chairs: Chun Ting Au (Canada), Paul Gringras (United Kingdom)

3:00pm - 3:13pm

Children with sleep enuresis: Does alarm, desmopressin, or combined treatment impact their sleep profile?

Leticia Azevedo Soster (Brazil)

3:13pm - 3:26pm

Sleep in children from northeastern Brazil with congenital Zika syndrome: Assessment using polysomnography

Valeria Marquis (Brazil)

3:26pm - 3:39pm

Association between sleep apnoea-specific hypoxic burden and blood pressure in children with OSA

Chun Ting Au (Canada)

3:39pm - 3:52pm

Consumption of exogenous melatonin among US children

Lauren Hartstein (United States)

3:52pm - 4:05pm

Closed-loop auditory stimulation enhances total slow wave activity and proportionally shortens sleep duration in a young cohort

Stephanie Jones (United States)

4:05pm - 4:18pm

Telehealth sleep intervention for young children with autism: Recent findings from a randomized clinical trial

Cynthia Johnson (United States)

SCIENTIFIC PROGRAM

S22: Adolescent sleep health: A global public health challenge

3:00pm – 4:30pm | Room 33

Chairs: Mary Carskadon (United States), Judith Owens (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Overview of bioregulatory components of sleep behavior in adolescents

Mary Carskadon (United States)

3:18pm – 3:34pm

An overview of sleep and health indicators in adolescents

Rachel Seng Charoenthammanon (Singapore)

3:34pm - 3:50pm

Deficits in neurobehavioral function in sleeprestricted adolescents

June Lo (Singapore)

3:50pm - 4:06pm

Sleep-deprived teens: Impacts on mental health, risk taking behavior and society

Wendy Troxel (United States)

4:06pm - 4:16pm

WHO and adolescent sleep health priorities

Judith Owens (United States)

4:16pm - 4:30pm

Question and answer

S23: Light, sleep, and health: Lessons from field and experimental studies

3:00pm – 4:30pm | Room 34

Chairs: Minjee Kim (United States), Kathryn Reid (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Can we reclaim darkness at night? The impacts of light at night on human health

Minjee Kim (United States)

3:18pm – 3:34pm

The role of light in health-disease balance

Till Roenneberg (Germany)

3:34pm – 3:50pm

The effects of light on sleep and healthy physiology: From mechanisms to behaviour

Stuart Peirson (United Kingdom)

3:50pm – 4:06pm

Light, sleep and circadian rhythm interactions: New mechanistic insights to novel drug targets

Aarti Jagannath (United Kingdom)

4:06pm – 4:22pm

How to optimize the lighting environment to minimize circadian disruption: Application of the scientific knowledge to real-life settings

Christian Cajochen (Switzerland)

4:22pm – 4:30pm

Question and answer

SCIENTIFIC PROGRAM

S24: Obesity hypoventilation syndrome

3:00pm – 4:30pm | Room 37

Chairs: Thomas Penzel (Germany), Ingo Fietze (Germany)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Prevalence and predictors of obesity hypoventilation syndrome

Ozen Basoglu (Türkiye)

3:18pm – 3:34pm

Diagnosis and screening of obesity hypoventilation syndrome

Marta Kaminska (Canada)

3:34pm – 3:50pm

Cardiovascular complication of obesity hypoventilation syndrome

Christoph Schoebel (Germany)

3:50pm – 4:06pm

Post operative bariatric surgery outcome in obesity hypoventilation syndrome

Roop Kaw (United States)

4:06pm – 4:22pm

Treatment of obesity hypoventilation syndrome

Babak Amra (Iran)

4:22pm – 4:30pm

Question and answer

S25: Disordered sleep in chronic HIV infection

3:00pm – 4:30pm | Room 38

Chairs: Malcolm von Schantz (United Kingdom), Karine Scheuermaier (South Africa)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Unravelling the mechanisms of poor sleep in people with HIV

Caroline Sabin (United Kingdom)

3:18pm – 3:34pm

Poor sleep and chronic misalignment in people living with HIV is independently associated with higher immune activation

Karine Scheuermaier (South Africa)

3:34pm – 3:50pm

Delayed circadian phase in people living with HIV

Malcolm von Schantz (United Kingdom)

3:50pm – 4:06pm

Prevalence of obstructive sleep apnea and association with cardiometabolic risk in South Africans living with HIV

Nomathemba Chandiwana (South Africa)

4:06pm – 4:22pm

The interaction between HIV, obstructive sleep apnea, and hypertension

Naresh Punjabi (United States)

4:22pm – 4:30pm

Question and answer

SCIENTIFIC PROGRAM

O07: Alternate treatments for sleep breathing disorders

3:00pm - 4:30pm | Room A06

Chairs: Clete Kushida (United States), Gilles Lavigne (Canada)

3:00pm - 3:13pm

Non-ablative laser treatment for snoring and obstructive sleep apnea - A controlled randomized double-blind clinical trial

Valeria Mendes (Brazil)

3:13pm - 3:26pm

The effect of combined hypoglossal nerve stimulation with palatine tonsillectomy on treatment response in obstructive sleep apnea patients with oropharyngeal lateral wall collapse

Daniel Vena (United States)

3:26pm - 3:39pm

Upper airway stimulation in patients with obstructive sleep apnea and high body mass index (BMI)

Pien Bosschieter (United States)

3:39pm - 3:52pm

A multicenter clinical trial for the treatment of sleep-disordered breathing with a nonpermanent orthodontic slow expansion oral appliance in children

Clete Kushida (United States)

3:52pm - 4:05pm

Long-term oral appliance therapy effectiveness for obstructive sleep apnea: An update of the ORANGE study

Yanlong Chen (Canada)

4:05pm - 4:18pm

Upper airway outcomes on pediatric OSA after interceptive orthodontic treatment with MAD twin block appliance: A clinical study

Susana Falardo Ramos (Portugal)

O08: Circadian/chronobiology: Inter-country, social class, age, and genetic influences

3:00pm - 4:30pm | Room A07

Chairs: Adrian Willoughby (Singapore), Erik Herzog (United States)

3:00pm - 3:13pm

Sleep disturbances associated with DEAF1 pathogenic variants

Pedro Guerreiro (Brazil)

3:13pm - 3:26pm

Effects of evening smartphone use on sleep and declarative memory consolidation in adolescents and young adults

Christopher Höhn (Austria)

3:26pm - 3:39pm

Diurnal patterns of heart rate variability and associations with markers of mental health in South Africans living in a low-income setting

Arron Correia (South Africa)

3:39pm - 3:52pm

Favorable profile of NREM oscillations is associated with evening preference and high circadian rhythmicity

Irina Filchenko (Switzerland)

3:52pm - 4:05pm

Country differences in nocturnal sleep patterns in working age adults revealed by wearable sleep technology

Adrian Willoughby (Singapore)

4:05pm - 4:18pm

Systematic light exposure to prevent fatigue and sleep disturbances in prostate cancer patients (PC-LIGHT Study)

Lisa Wu (United States)

SCIENTIFIC PROGRAM

S26: Sleep health in the context of African countries

4:45pm – 6:15pm | Room 07

Chair: Dale Rae (South Africa)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

Sleep quality and cardiometabolic disease risk in urban and rural Nigerian students

Oluwatosin Olorunmoteni (Nigeria)

5:03pm – 5:19pm

Sleep and mental health in low- and highincome South African adults and students

Gosia Lipinska (South Africa)

5:19pm – 5:35pm

The sleep health of African-origin adults living in a low-income community: Associations with cardiometabolic disease and mental health

Dale Rae (South Africa)

5:35pm – 5:51pm

Associations between sleep parameters, noncommunicable diseases and HIV status in older, rural South Africans

Francesc Xavier Gómez-Olivé (South Africa)

5:51pm - 6:07pm

Sleep quality, obstructive sleep apnoea and circadian phase in older rural South Africans with and without HIV

Karine Scheuermaier (South Africa)

6:07pm – 6:15pm

Question and answer

S27: Sleep disordered breathing and pregnancy: From severe morbidity, to long term and transgenerational outcomes

4:45pm – 6:15pm | Room 17

Chair: Ghada Bourjeily (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

SDB epidemiology in pregnancy

Yu Sun Bin (Australia)

5:07pm – 5:27p

SDB and severe maternal morbidity

Ghada Bourjeily (United States)

5:27pm – 5:47pm

Maternal SDB and long term outcomes

Phyllis Zee (United States)

5:47pm – 6:07pm

Transgenerational impact of maternal SDB

Riva Tauman (Israel)

6:07pm – 6:15pm

Question and answer

SCIENTIFIC PROGRAM

S28: Latitudinal effects on circannual sleep chronobiology and seizure emergencies

4:45pm – 6:15pm | Room 23

Chairs: Marcus Ng (Canada), Milena Pavlova (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Sleeping patterns in Earth’s arctic regions

Milena Pavlova (United States)

5:07pm – 5:27pm

Sleeping patterns in Taiwan

Jeffrey Liou (Taiwan)

5:27pm – 5:47pm

Circannual seizure emergencies in the Canadian arctic

Marcus Ng (Canada)

5:47pm – 6:07pm

Seizures and seizure emergencies in warm climates

Myriam Abdennadhe (United States)

6:07pm – 6:15pm

Question and answer

S29: Sleep and thermoregulation: From comparative neurophysiology to translational perspectives

4:45pm – 6:15pm | Room 24

Chairs: Markus Schmidt (Switzerland), Peter Meerlo (Netherlands)

4:45pm – 4:50pm

Introduction

4:50pm – 5:06pm

Sleep, thermoregulation and resource optimization

Markus Schmidt (Switzerland)

5:06pm – 5:22pm

Circuitry integrating sleep and body temperature

William Wisden (United Kingdom)

5:22pm – 5:38pm

Comparative studies in birds and mammals

Sjoerd van Hasselt (Netherlands)

5:38pm – 5:54pm

Dynamics of brain temperature in birds and reptiles, BOLD activity, and CSF flow during avian sleep

Gianina Ungurean (Germany)

5:54pm – 6:10pm

Translational perspectives: Role of ambient temperature in gating REM sleep and cataplexy expression in narcolepsy

Bianca Viberti (Switzerland)

6:10pm – 6:15pm

Question and answer

SCIENTIFIC PROGRAM

S30: Surgery for obstructive sleep apnea: What to do when it fails?

4:45pm – 6:15pm | Room 27

Chairs: Stanley Liu (United States), Srinivas Kishore Sistla (India)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

Drug-induced sleep endoscopy: Which way does it point?

Marina Carrasco-Llatas (Spain)

5:03pm – 5:19pm

Transoral robotic surgery for OSA : The success may be in the Maxilla

Eric Thuler (United States)

5:19pm – 5:35pm

Hypoglossal nerve stimulation: Surgery and patient factors that contribute to outcome

Clemens Heiser (Germany)

5:35pm – 5:51pm

Skeletal surgery for OSA : Sex and ethnic differences

Yufeng Chen (Taiwan)

5:51pm – 6:07pm

UPPP/pharyngoplasty

Edilson Zancanella (Brazil)

6:07pm – 6:15pm

Question and answer

S31: Appropriate selection of dual orexin receptor antagonists (DORAs) and GABAergic drugs for improving therapeutic efficacy on insomnia disorder and its related conditions

4:45pm – 6:15pm | Room 28

Chairs: Yuichi Inoue (Japan), Andrew S Huhn (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended release for subjective- and objective insomnia

Yuichi Inoue (Japan)

5:07pm – 5:27pm

Benefits and limitations of combining CBTi with medication for the management of insomnia

Yun Kwok Wing (Hong Kong)

5:27pm – 5:47pm

Comparison of real-world data regarding the abuse potential of dual orexin receptor antagonists and benzodiazepine receptor agonists

Hiroshi Kadotani (Japan)

5:47pm – 6:07pm

The Effects of a Dual-orexin Antagonist on Sleep, Stress, and Drug Craving during Opioid Withdrawal

Andrew S Huhn (United States)

6:07pm – 6:15pm

Question and answer

SCIENTIFIC PROGRAM

O09: Young Investigator Award: Content to be determined

4:45pm – 6:15pm | Room 33

Chair: Shelly Weiss (Canada)

4:45pm - 4:58pm

The effects of low-dose morphine on sleep and breathlessness in chronic obstructive pulmonary disease: a randomised controlled trial

Thomas Altree (Australia)

4:58pm - 5:11pm

Elucidating the Enigmas of Orphan GPCRs: Decoding GPR61’s Role in Sleep and Cardiometabolic Traits through a Novel Genomic Approach

Cynthia Tchio (United States)

5:11pm - 5:24pm

Late night screen usage and screentime addiction as shared determinants of insomnia, obesity and wellbeing in 11–14-year-olds

Emma Louise Gale (United Kingdom)

5:24pm - 5:37pm

Group-based Cognitive Behavioural Therapy and Bright Light Therapy in Youths with Insomnia and Evening Chronotype: Interim Analysis of a Randomised Controlled Trial

Forrest Tin Wai Cheung (Hong Kong)

5:37pm - 5:50pm

Pediatric Sleep Apnea: Is objective evaluation, multi-discipline approach and therapy-tracing needed to improve outcomes?

Magnus Ingi Birkisson (Iceland)

5:50pm - 6:03pm

Effects of Periodic Breathing on Sleep at High

Altitude: A Randomized Placebo-Controlled Cross-Over Study using Inspiratory CO2

Abubaker Ibrahim (Austria)

D01: Digital CBT to treat insomnia: What are we learning from worldwide experiences to implement these new treatment in different health care systems?

4:45pm – 6:15pm | Room 34

Chair: Pierre Philip (France)

The following issues will be addressed during this discussion group:

• What is the current place of digital CBT-I around the world?

• Who is digital CBT-I intended for?

• How does the healthcare system influence the development of CBT-I

• Are there contra-indications or risks associated with digital CBT-I?

• What are the main challenges to overcome to make CBT-I a routine treatment?

• What other treatment delivery format could be used aside from digital therapeutics?

4:45pm - 6:15pm

Discussants

Pierre Philip (France), Charles Morin (Canada), Christopher Miller (United Kingdom), Øystein Vedaa (Norway), Susanna Jernelöv (Sweden)

SCIENTIFIC PROGRAM

S32: Mechanisms of sleep fragmentation in aging and neurodegeneration

4:45pm – 6:15pm | Room 37

Chairs: Luis de Lecea (United States), Claudio Liguori (Italy)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

Hyperexcitability of arousal circuits drives sleep fragmentation in aging

Shi-bin Li (China)

5:03pm – 5:19pm

Hypocretin/orexin and Tau Neuropathology

Laura Jacobson (Australia)

5:19pm – 5:35pm

Why is orexin/hypocretin a tailored target for sleep disorders? The responses from animal model studies

Sigrid Veasey (United States)

5:35pm – 5:51pm

Hypocretin/orexin, sleep and neurodegeneration

Erik Musiek (United States)

5:51pm – 6:07pm

What can we expect by targeting orexin/ hypocretin in disease prevention?

Claudio Liguori (Italy)

6:07pm – 6:15pm

Question and answer

S33: Novel insights into the pathogenesis of OSA and the effect of weight loss treatment on the upper airway using sophisticated MR imaging

4:45pm – 6:15pm | Room 38

Chair: Richard Schwab (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Bariatric surgery in women with obstructive sleep apnea: Effect on the upper airway

Carolina de Paula Soares (Brazil)

5:07pm – 5:27pm

Dynamic MRI of the upper airway in patients undergoing weight loss

Liyue Xu (China)

5:27pm – 5:47pm

Multi-organ Imaging: Assessment of cardiometabolic abnormalities in OSA

Daniel Cuthbertson (United Kingdom)

5:47pm – 6:07pm

State dependent biomechanical behavior of pharyngeal structures in apneics and controls

Richard Schwab (United States)

6:07pm – 6:15pm

Question and answer

SCIENTIFIC PROGRAM

O10: Psychiatric disorders affecting sleep/wake

4:45pm – 6:15pm | Room A06

Chairs: Laura Palagini (Italy), Leila Emami (Iran)

4:45pm - 4:58pm

Phenotyping sleep disturbances in children and adolescents with autism spectrum disorder based on clinical assessment and SDSC scoring

Osman Ipsiroglu (Canada)

4:58pm - 5:11pm

Neural correlates of targeted memory reactivation in PTSD patients are associated with symptom reduction

Anna Christina van der Heijden (Netherlands)

5:11pm - 5:24pm

Sleep polygenic scores and pleiotropic effect of psychiatric genetic polymorphisms in accelerometer-based sleep measures in children from a Brazilian population-based birth cohort

Marina Carpena (Brazil)

5:24pm - 5:37pm

High trait anxiety is associated with worse sleep depth and more wake intrusions in the Wisconsin sleep cohort

Matthew K. P. Gratton (United States)

5:37pm - 5:50pm

Evaluating machine learning algorithms for prediction of response to ramelteon for sleep disturbances in patients with schizophrenia

Archana Mishra (India)

5:50pm - 6:03pm

Insomnia and circadian rhythms in patients who attempted suicide: Potential correlations with inflammatory markers and suicidal lethality

Laura Palagini (Italy)

O11: Sleep health, epidemiology and morbidity/burden

4:45pm – 6:15pm | Room A07

Chairs: Yue Leng (United States), Marie-Pierre St-Onge (United States)

4:45pm - 4:58pm

A prospective study of sleep duration irregularity and risk of cardiovascular disease in the UK Biobank

Tianyi Huang (United States)

4:58pm - 5:11pm

Causal relationship between snoring and Alzheimer’s disease: Longitudinal cohort and mendelian randomization study

Yue Leng (United States)

5:11pm - 5:24pm

The influence of sleep apnea surgery on incidence of cardiovascular diseases: Insights from a national database

Camila Maciel de Oliveira (United States)

5:24pm - 5:37pm

Impact of obstructive sleep apnea-related surgery on cardiovascular outcomes: Evidence from a 5-Year follow-pp in a cardiovascular disease-free cohort

Robson Capasso (United States)

5:37pm - 5:50pm

Novel metabolic disturbance following noiseinduced sleep fragmentation: A pilot study

Michael Smith (Sweden)

5:50pm - 6:03pm

Associations of sleep pattern with survival and life expectancy of cancer patients

Shanshan Tian (China)

Poster abstract | Group 2

6:00pm – 7:00pm | Exhibit hall

Gala dinner

7:00pm – 11:00pm

Join the World Sleep Community

1,000+ members | 48 society members | 78 countries represented

Mission

The mission of World Sleep Society is to advance sleep health worldwide. World Sleep Society fulfills this mission by encouraging and facilitating sleep health education, research, and patient care throughout the world, particularly in places underserved by sleep medicine.

Operating Programs

World Sleep Society operates the following programs that promote sleep and circadian research, education, and awareness.

PRACTICE RECOMMENDATIONS CONGRESS

BEST OF SLEEP MEDICINE & RESEARCH BIENNIAL MEETING

RECOMMENDATIONS FOR DIAGNOSIS & TREATMENT

International Sleep Disorder Specialist

EXAM ASSESSING SLEEP MEDICINE COMPETENCE

rld Sleep Day

Hosted by World Sleep Society

ANNUAL AWARENESS EVENT WITH CALL TO ACTION

+1-507-316-0084

info@worldsleepsociety.org

worldsleepsociety.org

HEALTHIER SLEEP MAGAZINE FOR PATIENTS & PUBLIC

MENTORING & TRAINING SLEEP RESEARCH LEADERS

WSS Member Meeting

7:00am – 8:00am | Room 33

K07: Claudia Trenkwalder: REM sleep behavior disorder

8:00am – 8:45am | Room 17

8:00am – 8:02am

Introduction

Raffaele Ferri (Italy)

8:02am – 8:45am

Keynote presentation

Claudia Trenkwalder (Germany)

K08: Fan Jiang: Early childhood development: Sleep and the developing brain

8:00am – 8:45am | Room 34

8:00am – 8:02am

Introduction

Shelly Weiss (Canada)

8:02am – 8:45am

Keynote presentation

Fan Jiang (China)

S34: Sleep disordered breathing (SDB) is in our face: Do we treat at first signs of SDB in preschool children or do we wait?

9:00am – 10:30am | Room 07

Chairs: David Gozal (United States), Jeevanan Jahendran (Malaysia)

9:00am – 9:10am

Introduction

9:10am – 9:28am

ENT assessment tools for assessment of structural integrity of the pediatric upper airway in preschool children

Jeevanan Jahendran (Malaysia)

9:28am – 9:46am

Assessment of craniofacial bone growth in preschool children: Current best practice

Almiro J. Machado Júnior (Brazil)

9:46am – 10:04am

Speech language pathologist assessment tools for evaluation of functional integrity of the pediatric upper airway patency in preschool children

Esther M. G. Bianchini (Brazil)

10:04am – 10:22am

Pediatric sleep problems: A public health challenge

Sharon Moore (Australia)

10:22am – 10:30am

Question and answer

S35: Sleep health inequities around the world

9:00am – 10:30am | Room 17

Chairs: Dayna Johnson (United States), Hrayr Attarian (United States)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Sleep deserts in the USA: The role of economics and racism

Dayna Johnson (United States)

9:22am – 9:42am

Sleep health during economic and political turmoil, the Venezuelan experience

Claudio Cardenas (Venezuela)

9:42am – 10:02am

Sleep health among displaced populations

Hrayr Attarian (United States)

10:02am – 10:22am

Practice of sleep medicine in resource limited settings: Lessons from Zambia

Kondwelani Mateyo (Zambia)

10:22am – 10:30am

Question and answer

S36: Circuit control of sleep in health and disease

9:00am – 10:30am | Room 23

Chair: John Peever (Canada)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Functional dissection of hypothalamic circuits regulating pre-sleep behaviors

Ada Eban-Rothschild (United States)

9:22am – 9:42am

Brain circuitry regulating stress and sleep

William Wisden (United Kingdom)

9:42am – 10:02am

Contribution of thalamic networks to natural sleep and their involvement in neuropsychiatric disorders

Carolina Gutierrez (Switzerland)

10:02am – 10:22am

Circuit control of REM sleep in health and disease

John Peever (Canada)

10:22am – 10:30am

Question and answer

S37: The neuroscience of dreaming: Novel insights from EEG and fMRI studies

9:00am – 10:30am | Room 24

Chairs: Lucia Talamini (Netherlands), Sarah Schoch (Netherlands)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Delineating patterns of semantic features and memory incorporation in dreams collected in the sleep lab

Michelle Carr (United States)

9:22am – 9:42am

EEG correlates of visual and affective ‘day residues’ in hypnagogic dream reports

Sidarta Ribeiro (Brazil)

9:42am – 10:02am

Theta phase-targeted emotional memory reactivation during REM sleep: Effects on theta dynamics, memory consolidation and dreams

João Patriota (Netherlands)

10:02am – 10:22am

Neuroimaging of dreaming

Mariana Pereira (Netherlands)

10:22am – 10:30am

Question and answer

S38: Optimizing dental sleep practice in the management of sleep disordered breathing

9:00am – 10:30am | Room 27

Chair: Thomas Bornhart (Chile)

9:00am – 9:02am

Introduction

9:02am – 9:22am

The evolving field of dental sleep medicine

Leopoldo Correa (United States)

9:22am – 9:42am

Dental sleep medicine in academic institutions

Laura S. Acosta-Torres (Mexico)

9:42am – 10:02am

Insomnia, circadian rhythms and dental sleep medicine

Miguel Meira e Cruz (Portugal)

10:02am – 10:22am

Sleep bruxism and orofacial pain in dental sleep practice

Antonio Romero (Spain)

10:22am – 10:30am

Question and answer

S39: Update on narcolepsy spectrum and idiopathic hypersomnia

9:00am – 10:30am | Room 28

Chairs: Yves Dauvilliers (France), Emmanuel Mignot (United States)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Environment and narcolepsy: A key role of influenza?

Emmanuel Mignot (United States)

9:18am – 9:34am

Hypersomnolence phenotype according to age and sex

Giuseppe Plazzi (Italy)

9:34am – 9:50am

Novel PSG approaches to diagnose narcolepsy

type 1 and borderland disorders

Emmanuel Mignot (United States)

PROGRAM

9:50am – 10:06am

Daytime sleep features and characteristics to identify narcolepsy and borderland disorders

Lucie Barateau (France)

10:06am – 10:22am

Perspectives on diagnosis and management: Towards personalized medicine

Yves Dauvilliers (France)

10:22am – 10:30am

Question and answer

S40: Can CPAP reduce cardiovascular risk? New approaches overcoming the null results of randomized controlled trials

9:00am – 10:30am | Room 33

Chairs: Raphael Heinzer (Switzerland), Jordi de Batlle (Spain)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Predictors of incident CV events and response to CPAP in OSA

Raphael Heinzer (Switzerland)

9:18am – 9:34am

Artificial intelligence and risk stratification in OSA: Benefits and limitations

Margaux Blanchard (France)

9:34am – 9:50am

Impact of CPAP treatment on cardiovascular outcomes: Results from real world data

Jordi de Batlle (Spain)

9:50am – 10:06am

Characterization of the heterogeneous impact of OSA and response to CPAP treatment in cardiovascular disease

Manuel Sánchez-de-la-Torre (Spain)

10:06am – 10:22am

New strategies for the evaluation of the potential of CPAP treatment in cardiovascular pathology

Oren Cohen (United States)

10:22am – 10:30am

Question and answer

S41: Sleep and circadian disturbances associated with COVID

9:00am – 10:30am | Room 34

Chairs: Claudia Moreno (Brazil), Phyllis Zee (United States)

9:00am - 9:02am

Introduction

9:02am - 9:22am

Impact of sleep disturbance on infectious disease risk, vaccination responses, and inflammatory risk: Implications for COVID risk and recovery

Michael Irwin (United States)

9:22am - 9:42am

Results from the International COVID Sleep Study (ICOSS): A multinational collaborative study

Bjørn Bjorvatn (Norway)

9:42am - 10:02am

Intersections of post-COVID sleep disturbance, cognitive impairments and fatigue: From observation to intervention

Matthew Maas (United States)

10:02am - 10:22am

Impact of COVID-19 pandemic on sleep habits, health-related issues and help-seeking: Results from different demographic groups

Claudia Moreno (Brazil)

10:22am - 10:30am

Question and answer

S42: Sleep and circadian alterations in the Alzheimer’s disease (AD) trajectory: The impact of sex and gender aspects

9:00am – 10:30am | Room 37

Chairs: Rosalia Silvestri (Italy), Biancamaria Guarnieri (Italy)

9:00am - 9:02am

Introduction

9:02am - 9:22am

The social determinants of sleep health in middle-aged and older adults

Ugo Faraguna (Italy)

9:22am - 9:42am

Sleep regularity in AD in both sexes: Unmet needs regarding gender

Biancamaria Guarnieri (Italy)

9:42am - 10:02am

Sleep and circadian alterations in AD: An update according to sex

Rosalia Silvestri (Italy)

10:02am - 10:22am

Optimizing sleep-wake rhythms to prevent dementia: Different interventions according to sex and/or gender?

Sonia Ancoli-Israel (United States)

10:22am - 10:30am

Question and answer

S43: Recent advances in understanding the effects of sleep deprivation and sleep deficiency on executive functioning and decision making

9:00am – 10:30am | Room 38

Chairs: Hans Van Dongen (United States), Katie Almones (Brazil)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Post-acute sequelae of SARS-CoV-2 infection: Sleep complaints and executive dysfunction in a cohort of older adults

Katie Almondes (Brazil)

9:22am – 9:42am

Difficulties balancing goal-directed and habitual behavior: Sleep-immune interactions as drivers of attenuated behavioral control

Leonie Balter (Sweden)

9:42am – 10:02am

We’re in this together: Studying the impact of sleep loss on team decision making

Siobhan Banks (Australia)

10:02am – 10:22am

Brain-juggling when sleep deprived: Impairments in bottom-up vigilant attention versus top-down attentional control

Hans Van Dongen (United States)

10:22am – 10:30am

Question and answer

PROGRAM

T04: MSLT/MWT scoring

9:00am – 10:30am | Room 25

Chair: Paolo Matrigiani (Italy)

9:00am - 9:05am

Introduction

9:05am - 9:25am

MSLT protocol and some considerations

Carlos Teixeira (Portugal)

9:25am - 9:45am

MWT protocol and some considerations

Helene Vitali (Italy)

9:45am - 10:25am

Practical scoring session

10:25am - 10:30am

Question and answer

O12: Insomnia: Phenotypes and mechanisms

9:00am – 10:30am | Room A06

Chairs: Yuichi Inoue (Japan), Julio Fernandez-Mendoza (United States)

9:00am - 9:13am

Sleep-wake state discrepancy: Clinical characteristics and effect of cognitive behavioral therapy for insomnia (CBTi)

Darah-Bree Bensen-Boakes (Australia)

9:13am - 9:26am

The impact of data-driven subtypes of insomnia disorder on the efficacy of cognitive-behavioral therapy for Insomnia

Dongbin Lyu (China)

9:26am - 9:39am

Assessment of circadian rhythm markers and clock genes expression in patients with chronic insomnia

Ana Alvaro (Portugal)

9:39am - 9:52am

Sleep schedule variability moderates outcome trajectories the initial two years after digital cognitive behavioral therapy for insomnia

Cecilie L. Vestergaard (Norway)

9:52am - 10:05am

Insomnia is associated with Low FEV1 and FEV1/ FVC: RHINESSA study

Rajesh Shigdel (Norway)

10:05am - 10:18am

Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended release for insomnia disorder subtypes Yuichi Inoue (Japan)

O13: Circadian/chronobiology: Night shift, social jet lag, and personalization

9:00am – 10:30am | Room A07

Chairs: Catia Reis (Portugal), Tracey Sletten (Australia)

9:00am - 9:13am

Circadian-based lighting substantially improves vigilance in simulated night shift work conditions compared to standard lighting Hannah Scott (Australia)

9:13am - 9:26am

The relationship between circadian type and physical activity on markers of nightshift adaptation: A randomized controlled trial Dayna F. Easton (Australia)

9:26am - 9:39am

Weekend sleep extension (catch-up sleep) is associated with lower incidence of coronary calcium score: The ELSA-Brasil study

Luciano Drager (Brazil)

9:39am - 9:52am

Subjective sleep quality and sleepiness dynamics on a group of military submariners: Before, during and after a mission

Catia Reis (Portugal)

9:52am - 10:05am

Implementation of two biomathematical models for personalising sleep timing recommendations in shift workers

Prerna Varma (Australia)

10:05am - 10:18am

Influence of social jet lag on weight loss and food intake in bariatric patients: A one-year follow-up study

Aline Cunha Carvalho (Brazil)

S44: From bench to bedpartner: Exploring socio-biological, cultural, and couple influences on sleep and sleep disorders treatment

10:45am – 12:15pm | Room 07

Chair: Wendy Troxel (United States)

10:45am – 10:47am

Introduction

10:47am – 11:07am

The social and sleep share a two-way sheet: Exploring reciprocal interactions between oxytocin, social behaviour, and sleep using preclinical models

Joel Raymond (Australia)

11:07am – 11:27am

Sociocultural, economic, geographical and couples’ determinants of positive airway pressure (PAP) adherence

Jean Louis Pepin (France)

11:27am – 11:47am

Putting the “we” in PAP adherence treatment: A novel couples’ based intervention to promote PAP adherence and sleep health

Wendy Troxel (United States)

11:47am – 12:07pm

A dyadic behavioral sleep intervention program for persons living with Dementia and their family caregivers: Lessons learned from a pilot study

Yeonsu Song (United States)

12:07pm – 12:15pm

Question and answer

S45: Implementation of digital CBT for insomnia to improve sleep and mental health: From research to clinical practice

10:45am – 12:15pm | Room 17

Chairs: Charles Morin (Canada), Sijing Chen (Hong Kong)

10:45am – 10:47am

Introduction

10:47am – 11:07am

Impact of digital CBTi on sleep and mental health symptoms

Charles Morin (Canada)

11:07am – 11:27am

The application and efficacy of digital cognitive behavioral therapy for insomnia during the COVID-19 pandemic

Ngan Yin Chan (Hong Kong)

11:27am – 11:47am

The effectiveness of dCBT-I in reducing mental health problems in the general population and in secondary mental health care

Øystein Vedaa (Norway)

11:47am – 12:07pm

Effectiveness of e-CBT-I on improving sleep and mental health in youth with insomnia

Sijing Chen (Hong Kong)

12:07pm – 12:15pm

Question and answer

S46: Clinical trials in sleep – disordered breathing: What have we learned and where do we go from here?

10:45am – 12:15pm | Room 24

Chairs: Doug Bradley (Canada),

Geraldo Lorenzi Filho (Brazil)

10:45am – 10:47am

Introduction

10:47am – 11:03am

Results of the ADVENT-HF trial: Implications for treatment of sleep-disordered breathing by adaptive servo-ventilation in heart failure

Doug Bradley (Canada)

11:03am – 11:19am

Effects of treating obstructive sleep apnea on drug resistant hypertension

Geraldo Lorenzi Filho (Brazil)

11:19am – 11:35am

Effects of treating obstructive sleep apnea on cardiovascular endpoints in patients with acute coronary syndrome

Manuel Sánchez-de-la-Torre (Spain)

11:35am – 11:51am

Pharmacologic approaches to treatment of obstructive sleep apnea

Luigi Taranto Montemurro (United States)

11:51am – 12:07pm

Hypoglossal nerve stimulation for therapy of obstructive sleep apnea

Patrick Strollo (United States)

12:07pm – 12:15pm

Question and answer

T05: Telemonitoring and challenges with adherence

10:45am – 12:15pm | Room 25

Chair: Carlos Teixeira (Portugal)

10:45am - 11:05am

Polysomnography: Critical aspects for diagnosing Comisa and their relevance for therapeutical adherence

Miguel Meira e Cruz (Portugal)

11:05am - 11:10am

Introduction

11:10am - 11:30am

The correct choice of mask, the best approach for good adherence

Paolo Matrigiani (Italy)

11:30am - 11:50am

Technical aspects of positive airway therapy

Alessio Guidone (Italy)

11:50am - 12:10pm

Telemonitoring: Is it always that easy?

Maria José Guimarães (Portugal)

12:10pm - 12:15pm

Question and answer

S47: Neuromuscular electrical stimulation: A Novel approach for treatment of obstructive sleep apnea

10:45am – 12:15pm | Room 27

Chairs: Alexandre Abreu (United States), Atul Malhotra (United States)

Session supported by an unrestricted educational grant from Signifier Medical Technologies

10:45am – 10:47am

Introduction

10:47am – 11:07am

Review of neuromuscular electrical stimulation for treatment in clinical medicine

Adrian Williams (United Kingdom)

11:07am – 11:27am

Effect of NMES on upper airway physiology in obstructive sleep apnea

Atul Malhotra (United States)

11:27am – 11:47am

Effects of NMES in patients with mild obstructive sleep apnea

Marina Carrasco-Llatas (Spain)

11:47am – 12:07pm

NMES in OSA: Results of a double-blind shamcontrolled randomized clinical trial

Naresh Punjabi (United States)

12:07pm – 12:15pm

Question and answer

S48: Sleep medicine in Latin America: New perspectives in pediatrics

10:45am – 12:15pm | Room 28

Chairs: Vivian Leske (Argentina)

10:45am – 10:47am

Introduction

10:47am – 11:03am

Sleep disordered breathing in Brazilian children: What is our current reality

Magali Lumertz (Brazil)

11:03am – 11:19am

Sleep medicine in Peru: Post pandemic challenges and changes

Edwin Herrera (Peru)

11:19am – 11:35am

Environmental and air pollution: Impact on sleep in Chile

Maria Jose Elso (Chile)

11:35am – 11:51am

Respiratory patterns during sleep at high altitude

Maria Angelica Bazurto Zapata (Colombia)

11:51am – 12:07pm

Home ventilation for chronic pediatric SDB: Experience and new perspectives from a large tertiary center in Buenos Aires, Argentina

Vivian Leske (Argentina)

12:07pm – 12:15pm

Question and answer

S49: The human clock challenged by daily urban life

10:45am – 12:15pm | Room 34

Chair: Ana Silva (Uruguay)

10:45am – 10:47am

Introduction

10:47am – 11:07am

Modulations of the human circadian phase in two ecological conditions: The Antarctic summer and dance training in shifts

Ana Silva (Uruguay)

11:07am – 11:27am

Consequences of shift work on the clock: Adaptation and disruption

Dorothee Fischer (Germany)

11:27am – 11:47am

Circadian clocks in the brain: In utero development and disruption

Erik Herzog (United States)

11:47am – 12:07pm

The emergence and implementation of circadian medicine: It’s about time!

Elizabeth Klerman (United States)

12:07pm – 12:15pm

Question and answer

S50: Latest perspectives on local sleep: From basic to clinical research

10:45am – 12:15pm | Room 38

Chairs: Elena Krugliakova (Netherlands), Sophia Snipes (Switzerland)

10:45am – 10:47am

Introduction

10:47am – 11:03am

A cortical perspective on sleep regulation

Lukas Krone (United Kingdom)

11:03am – 11:19am

Local changes in sleep slow oscillations after stroke

Eric Landsness (United States)

11:19am – 11:35am

Closed-loop stimulation to enhance sleep and its function: Why and how to target local instead of global sleep oscillations

Simon Ruch (Switzerland)

11:35am – 11:51am

Local sleep deficits in children with ADHD during sleep and wake

Elena Krugliakova (Netherlands)

11:51am – 12:07pm

Awake while asleep: Sleep-like brain activity in wakefulness predicts attention and cognitive performance

Thomas Andrillon (France)

12:07pm – 12:15pm

Question and answer

O14: Sleep disordered breathing: Treatment outcomes and consequences

10:45am - 12:15pm | Room A06

Chairs: Najib Ayas (Canada), Diego Mazzotti (United States)

10:45am - 10:58am

Arousal threshold modifies the effects of CPAP therapy on neurocognition in men and women in the APPLES study

Scott A. Sands (United States)

10:58am - 11:11am

Positive airway pressure therapy predicts lower mortality and major adverse cardiovascular events incidence in Medicare beneficiaries with obstructive sleep apnea

Diego Mazzotti (United States)

11:11am - 11:24am

Lemborexant treatment improves polysomnographic sleep parameters in adults with mild, moderate, or severe obstructive sleep apnea

Margaret Moline (United States)

11:24am - 11:37am

The benefits of 4-month CPAP therapy for management of moderate-to-severe sleeprelated breathing disorders on the sleep quality, daytime alertness, quality of life, fatigue, and mental health and participation in the community among people with chronic spinal cord injury

Julio Furlan (Canada)

11:37am - 11:50am

Factors associated with the occurrence of sleepiness at the wheel and related accidents and near-misses in patients treated by continuous positive airway pressure therapy

Julien Coelho (France)

11:50am - 12:00pm

Acute effect of continuous positive airway pressure (CPAP) on weight in patients with obstructive sleep apnea

Giovani F. Lima (Brazil)

O15: Basic research: Animal and mechanisms

10:45am - 12:15pm | Room A07

Chairs: Nirinjini Naidoo (United States), Wenjing Wang (China)

10:45am - 10:58am

Two slow-wave sub-types with distinctive morphological features are associated with specific thalamic activation patterns: an EEGfMRI investigation

Damiana Bergamo (Italy)

10:58am - 11:11am

Discovery of a highly potent and orally available orexin 2 receptor-selective agonist, TAK-861, as a novel therapeutic agent for narcolepsy and other hypersomnia disorders

Haruhide Kimura (Japan)

11:11am - 11:24am

The role of the thalamic reticular nucleus in the gating mechanism of tinnitus: Explored through sleep spindles

MinChul Park (New Zealand)

11:24am - 11:37am

Closed-loop auditory stimulation (CLAS) of slowwave sleep in mouse models of neurodegeneration

Inês Dias (Switzerland)

11:37am - 11:50am

Real time monitoring of Xbp1 activity reveals distinct responses to different stress modalities

Nirinjini Naidoo (United States)

11:50am - 12:03pm

Hippocampal neurons change spike rates before the episodes of central sleep apnea

Alexandra Limanskaya (Russian Federation)

Nox Medical:

The Future of Sleep Diagnostics with Nox SAS and Level II Testing

12:30pm – 2:00pm | Room 23

Chairs: Jason Ong (United States), Snorri Helgason (Iceland)

12:30pm - 12:40pm

Introduction

Jason Ong (United States), Snorri Helgason (Iceland)

12:40pm - 12:55pm

Revisiting Level II Sleep Studies: A Theoretical Economic Decision Model

Najib Ayas (Canada)

12:55pm - 1:10pm

Self-applied PSG in the Research Setting: How does it compare to Gold Standard PSG?

Erna Sif Arnardóttir (Iceland)

1:10pm - 1:25pm

Level II PSG in Germany: What does the future look like?

Christoph Schoebel (Germany)

1:25pm - 1:40pm

Level II and SAS: From Research to Clinical Practice - Is this the Future?

Naresh Punjabi (United States)

S51: Orexin in sleep/wake and respiratory control

12:30pm – 2:00pm | Room 28

Chairs: Phyllis Zee (United States), Raffaele Ferri (Italy)

S51 is a Takeda-Sponsored Scientific Session.

12:30pm - 12:35pm

Introduction

12:35pm - 1:00pm

Translation of preclinical science to clinical trials

Thomas Scammell (United States)

1:00pm - 1:25pm

Orexin pathways in the regulation of respiration

Danny Eckert (Australia)

1:25pm - 1:50pm

Role of orexin signaling in sleep and wake regulation

Emmanuel Mignot (United States)

1:50pm - 2:00pm

Question and answer

An Expert Panel Presentation by Avadel CNS

Pharmaceuticals, LLC: Evolving the Therapeutic Landscape for Narcolepsy

12:30pm – 2:00pm | Room 33

This presentation is intended for US healthcare professionals only. Product not approved outside of the US.

Speakers

Yves Dauvilliers (France), Michael J. Thorpy (United States), Clete Kushida (United States), Anne Morse (United States)

Idorsia Pharmaceuticals: Managing chronic insomnia disorder - what have we learned from clinical trials and real-world practice?

12:30pm – 2:00pm | Room 37

Chair: Göran Hajak (Germany)

Welcome and introduction

Göran Hajak (Germany)

Targeting hyperarousal of chronic insomnia disorder: key learnings from daridorexant clinical research

Göran Hajak (Germany)

Decision drivers for switching sleep medications in patients with chronic insomnia disorder

W. Vaughn McCall (United States)

Recommendations on how to switch patients with chronic insomnia disorder to a new sleep medication

David Neubauer (United States)

Real world experience initiating daridorexant in patients with chronic insomnia disorder

Claudio Liguori (Italy)

Panel discussion

Göran Hajak (Germany), W. Vaughn McCall (United States), David Neubauer (United States), Claudio Liguori (Italy)

Closing

Göran Hajak (Germany)

Samsung

12:45pm - 2:00pm | Room 07

Philips: Remote Management of Sleep Apnea patients

1:00pm – 1:45pm | Room 27

Chairs: Edilson Zancanella (Brazil), Teofilo Lee-Chiong (United States)

Introduction to remote management

Edilson Zancanella (Brazil)

Sleep Apnea Management in the Digital Age: Tips and Tools

Mikel Azpiazu (Spain)

Pocket Kado: Changing behavior through gaming

1:00pm - 2:00pm | Room 38

Speakers

Fiona Barwick (United States), Khoa Tran (United States), Ryan Kelly (United States)

K09: Michael Irwin: Insomnia, inflammation, and depression prevention

2:00pm – 2:45pm | Room 17

Chair: Yun Kwok Wing (Hong Kong)

2:00pm – 2:02pm

Introduction

Yun Kwok Wing (Hong Kong)

2:02pm – 2:45pm

Keynote presentation

Michael Irwin (United States)

K10: Federica Provini: Jerky movements in sleep: Unusual variants or a new movement disorder?

2:00pm – 2:45pm | Room 24

2:00pm – 2:02pm

Introduction

Birgit Hogl (Austria)

2:02pm – 2:45pm

Keynote presentation

Federica Provini (Italy)

K11: Silke Ryan: Novel insights of the role of sleep disordered breathing on cardiovascular and metabolic function

2:00pm – 2:45pm | Room 34

2:00pm – 2:02pm

Introduction

Winfried Randerath (Germany)

2:02pm – 2:45pm

Keynote presentation

Silke Ryan (Ireland)

S52: Seeing the sound of sleep

3:00pm – 4:30pm |Room 07

Chairs: Stanley Liu (United States), Clete Kushida (United States)

3:00pm - 3:02pm

Introduction

3:02pm - 3:22pm

A predictive model of OSA severity using backscattered ultrasound imaging of the posterior tongue

Peiyu Chao (Taiwan)

3:22pm - 3:42pm

Digitizing sound patterns from drug-induced sleep endoscopy that correlates with airway collapse patterns

Fushun Hsu (Taiwan)

3:42pm - 4:02pm

Detecting OSA and sleep staging with acoustic artificial intelligence (AI)

Daewoo Kim (Korea, Republic of)

4:02pm - 4:22pm

Gamification of cognitive behavioral therapy in the treatment of insomnia

Ryan Kelly (United States)

4:22pm - 4:30pm

Question and answer

S53: Lucid dreaming: State of the art and current developments

3:00pm – 4:30pm | Room 17

Chairs: Nico Adelhöfer (Netherlands), Martin Dresler (Netherlands)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Towards a robust neuroscience of lucid dreaming

Nico Adelhöfer (Netherlands)

3:22pm – 3:42pm

Induction of lucid dreaming in laboratory and home settings

Mahdad Jafarzadeh Esfahani (Netherlands)

3:42pm – 4:02pm

Asleep and aware: Transient windows of responsiveness to the external world during human sleep

Delphine Oudiette (France)

4:02pm – 4:22pm

Vestibular function and lucid dreaming: The case of flying dreams

Claudia Picard-Deland (Canada)

4:22pm – 4:30pm

Question and answer

S54: Surveying the role of glia in sleep behaviour

3:00pm – 4:30pm | Room 23

Chair: Jason Gerstner (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Glia clocks - missing part of the sleep regulation

Milena Damulewicz (Poland)

3:18pm – 3:34pm

Mechanisms regulating Drosophila sleep via neurotransmitter transport and metabolism in distinct glial cell types

Don van Meyel (Canada)

3:34pm – 3:50pm

Linking mammalian cortical astrocytes to sleep regulation

Kira Poskanzer (United States)

3:50pm – 4:06pm

Glial regulation of lipid homeostasis at the blood brain barrier

Julie Williams (United States)

4:06pm – 4:22pm

A role for glia in regulating sleep across phylogeny

Jason Gerstner (United States)

4:22pm – 4:30pm

Question and answer

S55: Comorbid insomnia and OSA: Recent advances on the pathophysiological mechanisms, health outcomes and treatment approaches

3:00pm – 4:30pm | Room 24

Chair: Pedro Genta (Brazil)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Epidemiology and clinical characteristics of COMISA

Ana Krieger (United States)

3:22pm – 3:42pm

Physiological endotypes of obstructive sleep apnea among COMISA patients

Bradley Edwards (Australia)

3:42pm – 4:02pm

Treatment of COMISA based on CBT-i and CPAP

Jason Ong (United States)

4:02pm – 4:22pm

Long-term health outcomes of COMISA

Arlener D. Turner (United States)

4:22pm – 4:30pm

Question and answer

S56: Development of hypocretin/orexin receptor agonists: A progress report

3:00pm – 4:30pm | Room 27

Chairs: Thomas Kilduff (United States), Sarah Wurts Black (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Hypocretin/orexin at 25: From discovery to therapeutic target to marketed compounds

Thomas Kilduff (United States)

3:22pm – 3:42pm

Approaches to the discovery and development of hypocretin/orexin receptor agonists

Sarah Wurts Black (United States)

3:42pm – 4:02pm

E2086, a novel selective Orexin-2 receptor agonist

Margaret Moline (United States)

4:02pm – 4:22pm

Impact of hypocretin/orexin receptor agonists in the future management of narcolepsy type 1 and 2

Yves Dauvilliers (France)

4:22pm – 4:30pm

Question and answer

S57: Real world data on the benefit of treating OSA: Contributions beyond clinical trials

3:00pm – 4:30pm | Room 28

Chairs: Chi-Hang Ronald Lee (Singapore), Virend Somers (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

The benefits of PAP therapy on the burden of chronic conditions: From diabetes to heart failure

Atul Malhotra (United States)

3:22pm – 3:42pm

OSA phenotypes and effects of CPAP on cardiovascular morbidity in the Americas

Diego Mazzotti (United States)

3:42pm – 4:02pm

CPAP treatment and mortality: Contributions from the ALASKA study

Renaud Tamisier (France)

4:02pm – 4:22pm

Real-Word data for the cardiovascular benefits of surgical treatment of OSA

Robson Capasso (United States)

4:22pm – 4:30pm

Question and answer

S58: Sleep alterations: The red flag for psychiatric disorders

3:00pm – 4:30pm | Room 33

Chairs: Laura Palagini (Italy),

Pierre Alexis Geoffroy (France)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Maturational disruptions indexed by the sleeping brain: Psychopathology from childhood to young adulthood

Julio Fernandez-Mendoza (United States)

3:22pm – 3:42pm

Sleep disturbances and mood spectrum disorders: The lifespan point of view

Laura Palagini (Italy)

3:42pm – 4:02pm

Potential role of sleep instability in mental disorders and suicide risk

Michael Grandner (United States)

4:02pm – 4:22pm

Role of dreaming in the suicide crisis

Pierre Alexis Geoffroy (France)

4:22pm – 4:30pm

Question and answer

S59: Sleep and violence in adolescents and adults

3:00pm – 4:30pm | Room 34

Chair: Elizabeth Klerman (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Brain, sleep, and violence

Teresa Paiva (Portugal)

3:22pm – 3:42pm

Characterizing gun violence by time, day of the week, holidays, and month in six US cities

2015-2021

Elizabeth Klerman (United States)

3:42pm – 4:02pm

Associations between sleep duration and violent behaviors among US high school students

Aarti Sathyanarayana (United States)

4:02pm – 4:22pm

Violence, sleep and culture of peace: Interventions for threatened journalists and human rights defenders in Mexico

Roberto Mercadillo (Mexico)

4:22pm – 4:30pm

Question and answer

S60: Maintaining health and performance in challenging spatial and temporal environments

3:00pm – 4:30pm | Room 37

Chair: Dorothee Fischer (Germany)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Light as a countermeasure to sleep inertia: Applications for space flight

Cassie J Hilditch (United States)

3:18pm – 3:34pm

Individualising sleep and circadian models for shift workers

Julia Stone (Australia)

3:34pm – 3:50pm

Optimizing work schedules in extended flight operations

Dorothee Fischer (Germany)

3:50pm – 4:06pm

Behavior: A missing piece of healthy light exposure

Anna Biller (Germany)

4:06pm – 4:22pm

Finding order in chaos: Mental health and sleep during the COVID-19 pandemic

Luísa Klaus Pilz (Germany)

4:22pm – 4:30pm

Question and answer

D02: Different expressions of pediatric insomnia during development

3:00pm – 4:30pm | Room 38

Chair: Raffaele Ferri (Italy)

The following issues will be addressed during this discussion group:

• Has pediatric insomnia specific features?

• Which link exists between pediatric insomnia and psychiatric comorbidities?

• Which are the features of insomnia during the first years of life?

• Which are the features of insomnia during school age?

• Which are the features of insomnia during adolescence?

3:00pm – 4:30pm

Discussants

Karen Spruyt (France), Oliviero Bruni (Italy), Hovig Artinian (United States), Silvia Miano (Switzerland)

T06: Discussion group: Sleep technologists around the world

3:00pm – 4:30pm | Room 25

Chair: Paolo Matrigiani (Italy)

Sleep technologist in the “old continent”What’s the situation in the European contest, comparison with worldwide reality

Carlos Teixeira (Portugal)

Sleep disorders: A technician management

Annalisa Rubino (Italy)

Sleep technologist in research activity

Helene Vitali (Italy)

Knowing to transmit: Communication as a fundamental moment of mass awareness

Paolo Matrigiani (Italy)

The role of video in monitoring sleep-related motor behaviors: From in lab VPSG to home videos towards new technologies

Francesco Mignani (Italy)

The act-out dreams in narcolepsy: A mix between reality and fantasy

Giulia Neccia (Italy)

Sleep breathing disorders: Sinergy between sleep technologist and speech therapy

Federica Testa (Italy)

O16: Sleep role in behavior and cognition: Mechanisms

3:00pm - 4:30pm | Room A06

Chairs: Sara Aton (United States), Joseph De Koninck (Canada)

3:00pm - 3:13pm

Subjective sleepiness better predicts effort-related cardiovascular response than sleep duration per se

Larissa N. Wuest (Switzerland)

3:13pm - 3:26pm

Vigilance during recurrent variable and stable short sleep schedules in young adults

Tiffany Koa (Singapore)

3:26pm - 3:39pm

Thalamus: Hub for autonomic regulation, sleep and cognition

Irina Filchenko (Switzerland)

3:39pm - 3:52pm

The spectrum of conscious experiences during NREM sleep: There is more than what meets the eye

Adriana Michalak (Italy)

3:52pm - 4:05pm

Reactivation of memory-encoding dentate gyrus neurons during memory consolidation is associated with subregion-specific, learning- and sleep-mediated biosynthetic changes

Sara Aton (United States)

4:05pm - 4:18pm

The missing link between acoustically evoked K-complexes and verbal memory consolidation during sleep

Sven Leach (Switzerland)

O17: New Investigator Award

3:00pm - 4:30pm | Room A07

Chair: Thomas Penzel (Germany)

3:00pm - 3:13pm

[18F]FDG-PET as a Biomarker for Phenoconversion Trajectories in idiopathic REM Behavior Disorder

Beatrice Orso (Italy)

3:13pm - 3:26pm

Proteomic Profiling in Periodic Limb Movements and Restless Legs Syndrome

Katie Cederberg (United States)

3:26pm - 3:39pm

Structural and functional frontal-executive dysfunction suggests compensatory mechanisms in patients with isolated REM Sleep Behavior Disorder: a clinical-MRI longitudinal study

Luca Baldelli (Italy)

3:39pm - 3:52pm

Abnormal Nigral Iron Progression in Parkinson’s Disease and REM Sleep Behavior Disorder Using Quantitative Magnetic Resonance Imaging

Rahul Gaurav (France)

3:52pm - 4:05pm

Metagenomic analysis in Restless Legs Syndrome

Angelica Montini (Italy)

4:05pm - 4:18pm

Sleep patterns according to a genetically determined ethnicity in the population of São Paulo

Priscila Tempaku (Brazil)

S61: Central disorders of hypersomnolence, beyond narcolepsy type 1

4:45pm – 6:15pm | Room 07

Chair: Lucie Barateau (France),

Kiran Maski (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Biomarkers of idiopathic hypersomnia: What do we know?

Anna Heidbreder (Austria)

5:07pm – 5:27pm

What can nighttime sleep characteristics teach us about narcolepsy type 2 and idiopathic hypersomnia?

Kiran Maski (United States)

5:27pm – 5:47pm

Narcolepsy type 2, A real entity?

Lucie Barateau (France)

5:47pm – 6:07pm

The importance of phenotypes in noncataplectic hypersomnolence

David Plante (United States)

6:07pm – 6:15pm

Question and answer

S62: Genetics of obstructive sleep apnea: Where are we?

4:45pm – 6:15pm | Room 17

Chair: Allan Pack (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Quantitative trait and case control GWAS of obstructive sleep apnea

Anne Justice (United States)

5:07pm – 5:27pm

GWAS of sleep apnea: Utilizing electronic health record and genetic data to identify biomarkers

Hanna Ollila (Finland)

5:27pm – 5:47pm

Genome-wide association study of obstructive sleep apnea in the million veteran program: Genetic heterogeneity by sex

Daniel Gottlieb (United States)

5:47pm – 6:07pm

Where are we? Where are we going?

Allan Pack (United States)

6:07pm – 6:15pm

Question and answer

S63: Frequent nightmares: A parasomnia at the heart of sleep regulation and emotional regulation

4:45pm – 6:15pm | Room 23

Chair: Péter Simor (Hungary),

Edward Franz Pace-Schott (United States)

4:45pm – 4:47pm

Introduction

4:47pm - 5:03pm

Augmenting imagery rehearsal therapy through targeted memory reactivation to treat nightmare disorder: Clinical outcomes and proposed mechanism

Lampros Perogamvros (Switzerland)

5:03pm - 5:19pm

Nightmare content as a window into mental health and well-being

Pilleriin Sikka (United States)

5:19pm - 5:35pm

Disturbed dreaming and psychotic-like experiences

Elizaveta Solomonova (Canada)

5:35pm - 5:51pm

Nightmare disorder and hyperarousal: Vulnerable periods in sleep-state transitions

Péter Simor (Hungary)

5:51pm - 6:07pm

Waking autonomic and functional brain correlates of nightmare frequency in trauma exposed individuals

Edward Franz Pace-Schott (United States)

6:07pm – 6:15pm

Question and answer

S64: Supporting healthy sleep in hospital and at home – Time to stop sleep walking and wake up to the challenge!

4:45pm – 6:15pm | Room 24

Chair: Shelly Weiss (Canada), Megan Thomas (Canada)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

Introduction to symposium: Setting the stage for promoting healthy sleep in hospitalized pediatric patients

Shelly Weiss (Canada)

5:03pm – 5:19pm

Sleep in pediatric hospitals: Child and parent experience and nurse and administrator views Robyn Stremler (Canada)

5:19pm – 5:35pm

Sleep for health in hospital and at home (Shhh) during the COVID-19 pandemic: Focusing on the positive and dreaming of what could be Megan Thomas (Canada)

5:35pm – 5:51pm

Never wake a sleeping baby: Understanding the change makers at a local and national level in support of hospitalized patient sleep

Nicola Orlov (United States)

5:51pm – 6:07pm

In their own words: Barriers and facilitators to sleeping in the hospital among adolescent and young adult patients

Andrea Fidler (United States)

6:07pm – 6:15pm

Question and answer

S65: New trends and perspectives in the identification and treatment of sleep disordered breathing by dental professionals

4:45pm – 6:15pm | Room 27

Chair: Audrey Yoon (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Metabolic biomarkers as a OSA screening tool for adults and children

Susana Falardo Ramos (Portugal)

5:07pm – 5:27pm

Multisystemic effects of treating obstructive sleep apnea with oral appliance therapy

Ji Woon Park (Korea, Republic of)

5:27pm – 5:47pm

Breaking the mold: The benefits and limitations of orthodontic surgery-first approach in OSA treatment

Jorge Faber (Brazil)

5:47pm – 6:07pm

Innovations in dentistry for sleep disordered breathing

Tracey Nguyen (United States)

6:07pm – 6:15pm

Question and answer

S66: Sleep in women from pregnancy to menopause: An ISRTP symposium

4:45pm – 6:15pm | Room 28

Chair: Bingqian Zhu (China), Riva Tauman (Israel)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Racial and ethnic disparities in sleep and sleep disturbances during pregnancy

Bilgay Izci-Balserak (Türkiye)

5:07pm – 5:27pm

Sleep and mood disorders during the perinatal period in the Life-ON cohort study

Silvia Riccardi (Switzerland)

5:27pm – 5:47pm

Association between sleep health and gestational diabetes

Bingqian Zhu (China)

5:47pm – 6:07pm

Objective and subjective sleep characteristics of peri-menopausal women

Hyeon Jin Kim (Korea, Republic of)

6:07pm – 6:15pm

Question and answer

S67: Insufficient sleep and adipose tissue dysfunction: Insights from experimental sleep restriction studies

4:45pm – 6:15pm | Room 33

Chair: Virend Somers (United States), Dalva Poyares (Brazil)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Effects of experimental sleep restriction on weight gain and regional adiposity

Naima Covassin (United States)

5:07pm – 5:27pm

Alterations in brown adipose tissue in response to sleep curtailment

Marie-Pierre St-Onge (United States)

5:27pm – 5:47pm

Adipose tissue cellular signaling and function: Impact of experimentally-induced sleep loss

Prachi Singh (United States)

5:47pm – 6:07pm

Epigenetic and transcriptomic features of metabolic perturbations elicited by sleep restriction

Jonathan Cedernaes (Sweden)

6:07pm – 6:15pm

Question and answer

S68: WSS Global Sleep Health Taskforce: Evaluating the utility of wearables/nearables to measure sleep health on a global scale

4:45pm – 6:15pm | Room 34

Chair: Diane Lim (United States), Peter Eastwood (Australia)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

The urgent need to collect sleep health data across the globe

Peter Eastwood (Australia)

5:03pm – 5:19pm

Utility of the APPLE WATCH in sleep research

Cathy Goldstein (United States)

5:19pm – 5:35pm

Utility of the OURA RING, FITBIT and PHONE APP in sleep research

Ju Lynn Ong (Singapore)

5:35pm – 5:51pm

Utility of the DREEM HEADBAND in sleep research

Emmanuel Mignot (United States)

5:51pm – 6:07pm

Utility of HIGH-HEAT CAPACITY MATTRESS in sleep research

Matthew Salanitro (Germany)

6:07pm – 6:15pm

Question and answer

S69: Dopaminergic augmentation of RLS symptoms: From animal models to new treatment perspectives

4:45pm – 6:15pm | Room 37

Chair: Diego Garcia-Borreguero (Spain), Rosalia Silvestri (Italy)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

A quarter century of long-term treatment failure: Is it time to rename augmentation?

Walter Paulus (Germany)

5:03pm – 5:19pm

What do we know regarding its mechanism?

Stefan Clemens (United States)

5:19pm – 5:35pm

The potential therapeutic role of D1 antagonists

William Ondo (United States)

5:35pm – 5:51pm

Opioids for augmentation: Good or evil?

John Winkelman (United States)

5:51pm – 6:07pm

New RLS drugs avoiding augmentation?

Diego Garcia-Borreguero (Spain)

6:07pm – 6:15pm

Question and answer

S70: Management of clinical sleep disorders in shift workers: Current knowledge and unique needs for consideration in research, practice and industry contexts

4:45pm – 6:15pm | Room 38

Chair: Shantha Rajaratnam (Australia), Roert Adams (Australia)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Cognitive behavioral therapy for shift workers with insomnia

Heli Jarnefelt (Finland)

5:07pm – 5:27pm

Leveraging technology for personalized medicine approaches to addressing night shift work

Anthony Reffi (United States)

5:27pm – 5:47pm

Managing sleep problems in the occupational context for shift workers

Tracey Sletten (Australia)

5:47pm – 6:07pm

Diagnosis and management of sleep disorders in shift workers: Barriers, enablers and solutions from the patient’s perspective

Amy Reynolds (Australia)

6:07pm – 6:15pm

Question and answer

O18: Sleep health and social/racial/ethnic disparities

4:45pm - 6:15pm | Room A06

Chairs: Chandra Jackson (United States), Symielle A. Gaston (United States), Arezu Najafi (Iran)

4:45pm - 4:58pm

Extreme bedroom temperatures in relation to sleep health among United States women: Differences by race/ethnicity and socioeconomic status

Symielle A. Gaston (United States)

4:58pm - 5:11pm

Social determinants of sleep problems among multiethnic Americans in the NIH all of us research program

Judite Blanc (United States)

5:11pm - 5:24pm

Racial/ethnic disparities in sleep health among adolescents in South Korea: The role of substance use behaviors

Bomin Jeon (United States)

5:24pm - 5:37pm

Unpacking the enigma of long sleep and cardiovascular disease in South African adults

Philippa Forshaw (South Africa)

5:37pm - 5:50pm

Obstructive sleep apnea and long sleep are associated with increased genetic risk of incident Diabetes Mellitus: The Hispanic community health study/study of Latinos

Yana Hrytsenko (United States)

5:50pm - 6:03pm

Racial/ethnic disparities in objective sleep measures from polysomnographic studies in the U.S.

Min-Woong Sohn (United States)

O19: Technology: Measuring sleep

4:45pm - 6:15pm | Room A07 Chairs: Josimar Chire (Brazil), Diego Alvarez-Estevez (Spain)

4:45pm - 4:58pm

Exploring non-invasive sensor methods for sleep apnea detection: Image and audio processing approaches

Josimar Chire (Brazil)

4:58pm - 5:11pm

DReAMy: A library for the automatic analysis and annotation of dream reports with multilingual large language models

Lorenzo Bertolini (United Kingdom)

5:11pm - 5:24pm

Self-supervised learning of accelerometer data provides new insights for sleep and its association with mortality

Hang Yuan (United Kingdom)

5:24pm - 5:37pm

Insights on sleep wearables: Investigating sleep, sleep-related healthcare, and perceived impacts associated with the use of sleep trackers in Canada

Karianne Dion (Canada)

5:37pm - 5:50pm

Variability across sleep centers in Europe: A follow-up study

Heidur Gretarsdottir (Iceland)

5:50pm - 6:03pm

Enhancing inter-database generalization and dataprivacy safe-warding in automatic sleep staging using decentralized deep-learning strategies

Diego Alvarez-Estevez (Spain)

Poster abstract group 3

6:00pm – 7:00pm | Exhibit hall

About

World Sleep Day is an annual awareness day that celebrates sleep and calls our community and the public to action regarding sleep health.

Each year, World Sleep Society members organize over 200 activities in their local, regional, and national communities around the world.

• Volunteer to serve on the World Sleep Day Committee

K12: Kenneth Wright: Microbiome and sleep

Room 17 | 8:00am – 8:45am

8:00am – 8:02am

Introduction

Peter Eastwood (Australia)

8:02am – 8:45am

Keynote presentation

Kenneth Wright (United States)

S71: Melatonin use in children, experiences around the world and reports from Melatonin

Task Force of IPSA

9:00am – 10:30am | Room 07

Chair: Narong Simakajornboon (United States), Guanghai Wang (China)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Melatonin in children with neurodevelopmental problems: Outcome of clinical trials and UK prescribing audit

Paul Gringras (United Kingdom)

9:18am – 9:34am

Melatonin use among children in Australia

Sarah Blunden (Australia)

9:34am – 9:50am

Pattern of melatonin use among physicians in Italy

Oliviero Bruni (Italy)

9:50am – 10:06am

Melatonin use in the United States and the challenges in talking to patients and families about melatonin

Judith Owens (United States)

10:06am – 10:22am

Final report from Melatonin Task Force of the International Pediatric Sleep Association

Narong Simakajornboon (United States)

10:22am – 10:30am

Question and answer

S72: Challenges in the treatment of narcolepsy

9:00am – 10:30am | Room 17

Chair: Yaroslav Winter (Germany), Lucio Huebra (Brazil)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Therapeutic challenges to treat narcolepsy in South America

Lucio Huebra (Brazil)

9:22am – 9:42am

Treatment of narcolepsy during pregnancy and lactation

Fernando Morgadinho (Brazil)

9:42am – 10:02am

Treatment of narcolepsy in children: Challenges and perspectives

Anne Morse (United States)

10:02am – 10:22am

How to deal with tolerance to modafinil: Drug holidays and bridging strategies

Yaroslav Winter (Germany)

10:22am – 10:30am

Question and answer

SCIENTIFIC PROGRAM

S73: Sleep and sleep-associated disorders: Novel mechanistic insights from human and animal studies

9:00am – 10:30am | Room 23

Chair: Giancarlo Vanini (United States), Pablo

Torterolo (Uruguay)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Respiratory modulation of the gamma frequency band of the EEG during wakefulness, sleep and in ketamine model of psychosis

Pablo Torterolo (Uruguay)

9:22am – 9:42am

The preoptic dual control of the wake-sleep cycle and thermoregulatory responses

Natalia Machado (United States)

9:42am – 10:02am

Hypocretinergic neurotransmission system in the oral pontine tegmentum: Impact on sleepwake cycle and narcolepsy traits

Miguel Garzón (Spain)

10:02am – 10:22am

Role of periaqueductal gray input from preoptic glutamatergic neurons in the regulation of sleep-wake states and anxiety-like behaviors

Giancarlo Vanini (United States)

10:22am – 10:30am

Question and answer

S74: Sleep and autonomic dysfunction: A bidirectional relationship

9:00am – 10:30am | Room 24

Chair: Mitchell Miglis (United States)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Sleep and the autonomic nervous system: Why does it matter?

Mitchell Miglis (United States)

9:22am – 9:42am

Insomnia and autonomic dysfunction: New insights into an age-old disorder

Daniela Grimaldi (United States)

9:42am – 10:02am

Sleep apnea and cardiovascular autonomic dysfunction

Virend Somers (United States)

10:02am – 10:22am

Dysautonomia in the Alpha-Synucleinopathies: Does it define worse phenotypes?

Luca Baldelli (Italy)

10:22am – 10:30am

Question and answer

S75: Sleep and cancer: A two-way street

9:00am – 10:30am | Room 27

Chair: Gilles Lavigne (Canada), David Gozal (United States)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Molecular mechanisms of cancer-induced sleep disruption: Chicken or the egg?

Jeremy C. Borniger (United States)

9:22am – 9:42am

Sleep apnea and cancer: Decrypting complex interactions

David Gozal (United States)

9:42am – 10:02am

Clinical aspects and implications of CPAP and opioids in cancer patients with OSA

Gilles Lavigne (Canada)

10:02am – 10:22am

Cancer patients with OSA: Alternatives when CPAP is not possible

Cibele Dal Fabbro (Brazil)

10:22am – 10:30am

Question and answer

O20: Risk factors for impact on brain function and patient-reported consequences of narcolepsy

9:00am – 10:30am | Room 28

Chairs: Kiran Maski (United States), Lucie Barateau (France)

9:00am - 9:13am

Evaluation of a novel, orally available orexin 2 receptor agonist, on wakefulness and cataplexy in a mouse model of Type 1 narcolepsy

Brian Raymer (United States)

9:13am - 9:26am

Microglial activation in Narcolepsy Type 1

Lucie Barateau (France)

9:26am - 9:39am

Surface-based morphometry and neurodevelopment in type 1 narcolepsy patients

Mengmeng Wang (China)

9:39am - 9:52am

Disrupted nighttime sleep and sleep-dependent memory consolidation in pediatric narcolepsy type 1

Kiran Maski (United States)

9:52am - 10:05am

Identification of the genetic risk factors for narcolepsy in Brazilian patient’s cohort paired with health controls of National Register of Bone Marrow Donors (REDOME): Preliminary results

Christianne Martins Correa da Silva Bahia (Brazil)

10:05am - 10:18am

Validity and reliability of the pediatric narcolepsy patient-reported outcomes scale (PN-PROS)

Kiran Maski (United States)

PROGRAM

S76: Sleep and performance in unique work environments

9:00am – 10:30am | Room 33

Chairs: Nicole Stuart (Australia), Amy Reynolds (Australia)

9:00am – 9:02am

Introduction

9:02am – 9:22am

Circadian-informed lighting speeds up night shift adjustment in submariners

Alisha Guyett (Australia)

9:22am – 9:42am

Sleep and circadian misalignment on the ice and in the sky: Case studies from Antarctica and long-haul aviation

Tracey Sletten (Australia)

9:42am – 10:02am

Sleep, circadian rhythms, and performance in space: Exploring the challenges and opportunities for astronauts

Erin Flynn-Evans (United States)

10:02am – 10:22am

Strategies to improve the safety and sleep quality among truck drivers

Claudia Moreno (Brazil)

10:22am – 10:30am

Question and answer

S77: Catching up on sleep: Insights into the bidirectional relationship between drug use and sleep impairments

9:00am – 10:30am | Room 34

Chairs: Lais Berro (United States), Monica Andersen (Brazil)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Overview on sleep and substance use disorders

Monica Andersen (Brazil)

9:18am – 9:34am

Progressive sleep alterations following cocaine or oxycodone self-administration in rats

Robert Gould (United States)

9:34am – 9:50am

Pre-Clinical evidence for a bidirectional relationship between alcohol use and sleep impairment

Jaren Reeves-Darby (United States)

9:50am – 10:06am

Methamphetamine-Induced sleep impairment: Insights from nonhuman primate studies

Lais Berro (United States)

10:06am – 10:22am

Identifying risks associated with developing hypnotic dependence

Timothy Roehrs (United States)

10:22am – 10:30am

Question and answer

D03: Consumer sleep trackers Guidelines by the WSS International Sleep Medicine Guidelines Committee Task Force

9:00am – 10:30am | Room 37

Chair: Clete Kushida (United States)

9:00am - 9:05am

Introduction and background

Clete Kushida (United States)

Sleep tracker technology and use

9:05am - 9:10am

Sleep tracker types and sensor technology

Syed Anas Imtiaz (United Kingdom)

9:10am - 9:15am

Sleep tracker use cases

Hannah Scott (Australia)

Open discussion

9:25am - 9:30am

Sleep tracker collection and management

Sleep staging

Michael Chee (Singapore)

9:30am - 9:35am

Sleep-related respiratory events

Thomas Penzel (Germany)

Open discussion

9:45am - 9:50am

Sleep tracker performance evaluation

Bias, performance evaluation vs. validation, and limitations

Cathy Goldstein (United States)

9:50am - 9:55am

Performance testing methods

Nicola Cellini (Italy)

Open discussion

Future directions

10:05am - 10:10am

Open interfaces for third-party integration

Stanley Liu (United States)

10:10am - 10:15am

Application to sleep behavior change and clinical populations

Kelly Baron (United States)

Open discussion

10:25am - 10:30am

Closing remarks

Clete Kushida (United States)

S78: Economic burden of obstructive sleep apnoea and health disparities in different countries

9:00am – 10:30am | Room 38

Chairs: Carlos Rivas Echeverria (United Kingdom), Lizmar Molina (Spain)

9:00am – 9:02am

Introduction

9:02am – 9:18am

Economic burden of obstructive sleep apnea and health disparities in different countries

Carlos Rivas Echeverria (United Kingdom)

9:18am – 9:34am

Differences in the health safety at work acts (their equivalent) in several countries and direct non-health related costs of OSA for business

Leo Ramos (Ecuador)

9:34am – 9:50am

Health inequities and its burden and consequences in OSA

Pedro Serrano Aísa (Brazil)

9:50am – 10:06am

Is it reducing the burden of OSA achivable?

We propose this plan

Carlos Rivas Echeverria (United Kingdom)

SCIENTIFIC PROGRAM

10:06am – 10:22am

A practical approach to legal aspects of the laws regarding OSA (traffic and health and safety at work)

Lizmar Molina (Spain)

10:22am – 10:30am

Question and answer

O21: Insomnia: Epidemiology and risk factors

9:00am - 10:30am | Room A06

Chairs: Jason Ong (United States), Till Roenneberg (Germany)

9:00am - 9:13am

Insomnia during pregnancy and risk of childhood mortality in offspring, Florida, 2006-2019

Anthony Kendle (United States)

9:13am - 9:26am

Wake intrusions in the EEG: A novel application of the odds ratio product in identifying subthreshold arousals within COMISA patients

Matthew K. P. Gratton (United States)

9:26am - 9:39am

Exploring the link between premature ovarian insufficiency, insomnia, and circadian pathways

Anna Kloster (Brazil)

9:39am - 9:52am

Estimation of the global prevalence of chronic insomnia among adults: A literature-based analysis

Adam V. Benjafield (Australia)

9:52am - 10:05am

Predictors of behavioral sleep problems and intervention outcomes in early childhood

Perran Boran (Turkey)

10:05am - 10:18am

Early identification of patients most vulnerable to acute insomnia after trauma

Anthony Reffi (United States)

O22: Aging and development

9:00am - 10:30am | Room A07

Chairs: Xiao Tan (China), Sonia Ancoli-Israel (United States)

9:00am - 9:13am

Interactive association between insomnia symptoms and sleep duration for incident dementia – A prospective study in the Swedish National March Cohort

Xiao Tan (China)

9:13am - 9:26am

Effects of sleep deprivation and recovery sleep on serum biomarkers of Alzheimer’s Disease in retired night shift workers and retired day workers

H. Matthew Lehrer (United States)

9:26am - 9:39am

Daytime sleepiness as a mortality predictor in nursing home residents: The FIRST Study

Ronaldo Piovezan (Australia)

9:39am - 9:52am

Association of 24-h rest-activity rhythms and future risk of Parkinson’s disease in middle-aged to older adults: Results from the UK Biobank Shahab Haghayegh (United States)

9:52am - 10:05am

Pericyte biology, sleep fragmentation, and cognitive decline in community dwelling older adults

Mahnoor Hamid (Canada)

10:05am - 10:18am

Shorter total sleep duration and lower sleep efficiency are associated with higher beta amyloid deposition in precuneus and cortical regions in cognitively normal older adults

Catherine

F. Siengsukon

(United States)

S79: Making sense of sensors and signals in assessing sleep

10:45am – 12:15pm | Room 07

Chair: Carlos Teixeira (Portugal)

10:45am - 10:47am

Introduction

10:47am - 11:07am

Transforming Sleep Diagnostics with Advanced Technologies: Opportunities and Challenge

Pedro Genta (Brazil)

11:07am - 11:27am

The Role of Technologists in the Future of Sleep Medicine

Carlos Teixeira (Portugal)

11:27am - 11:47am

From Clinic to Home: Making Sleep Studies

Accessible to All

Naresh Punjabi (United States)

11:47am - 12:07pm

Data-Driven Insights for Population Health Management of Sleep Disorders

Dennis Hwang

12:07pm - 12:15pm

Question and answer

S80: The fall of the AHI: Obstructive sleep apnea metrics and outcomes

10:45am – 12:15pm | Room 17

Chairs: Ofer Jacobowitz (United States), Edilson Zancanella (Brazil)

10:45am – 10:47am

Introduction

10:47am – 11:03am

The significance and limitations of the AHI

Ofer Jacobowitz (United States)

11:03am – 11:19am

The AHI and OSA metrics in women

Erna Sif Arnardóttir (Iceland)

11:19am – 11:35am

Metrics for OSA beyond the AHI

Edilson Zancanella (Brazil)

11:35am – 11:51am

Clinical outcomes for OSA therapies: PAP and appliances

Mario Milkov (Bulgaria)

11:51am – 12:07pm

Clinical outcomes for OSA: Surgery and neurostimulation

Shintaro Chiba (Japan)

12:07pm – 12:15pm

Question and answer

S81: The multiple levels of real-time auditory stimulation during sleep: From neuromodulation to sleep and brain health

10:45am – 12:15pm | Room 23

Chairs: Daniela Noain (Switzerland), Miguel Navarrete (United States)

10:45am – 10:47am

Introduction

10:47am – 11:07am

The relevance of vigilance states for the therapeutic potential of gamma sensory stimulation in Alzheimer’s disease

Cristina Blanco-Duque (United Kingdom)

11:07am – 11:27am

Closed-loop auditory stimulation of slow waves during sleep: Development of the rodent technique and preclinical applications

Daniela Noain (Switzerland)

11:27am – 11:47am

The sleeping brain as a bioacoustics transducer to modulate cortical electrophysiology and sleep function

Miguel Navarrete (United States)

11:47am – 12:07pm

Auditory modulation of sleep on human aging

Daniela Grimaldi (United States)

12:07pm – 12:15pm

Question and answer

S82: Sleepiness at the wheel: New evidence to select relevant biomarkers and preventive strategies applicable to acceptable International legislative driving regulations

10:45am – 12:15pm | Room 24

Chairs: Pierre Philip (France), Walter McNicholas (Ireland)

10:45am – 10:47am

Introduction

10:47am – 11:03am

Clinical determinants of patients predicting driving risk: The importance of COMISA in the driving risk of apneic patients

Andrew Vakulin (Australia)

11:03am – 11:19am

Results of a novel program to address OSA in commercial drivers

Allan Pack (United States)

11:19am – 11:35am

Impact of treatment on alertness and driving risk, how to measure it and what recommendations to give to the patients

Pierre Philip (France)

11:35am – 11:51am

European regulations on commercial and noncommercial drivers

Walter McNicholas (Ireland)

11:51am – 12:07pm

Global proposal for acceptable international legislative rules

Pierre Philip (France)

12:07pm – 12:15pm

Question and answer

S83: Socio-ecological determinants of sleep health disparities in disadvantaged and marginalized populations of young children

10:45am – 12:15pm | Room 27

Chairs: Candice Alfano (United States), Rebecca Spencer (United States)

10:45am - 10:50am

Introduction

10:50am - 11:10am

Sleep health among children currently versus formerly placed in foster care: A propensity score matching study

Candice Alfano (United States)

11:10am - 11:30am

Socioeconomic effects on sleep and sleepdependent memory consolidation in early childhood

Rebecca Spencer (United States)

11:30am - 11:50am

Ecological stressors of sleep: The unseen societal determinants to a child’s health

Karen Spruyt (France)

11:50am - 12:10pm

Relationships between maternal sleep during pregnancy and offspring sleep in the environmental influences on child health outcomes (ECHO) program

Maristella Lucchini (Italy)

12:10pm - 12:15pm

Question and answer

O23: Recent advances in restless legs syndrome

10:45am – 12:15pm | Room 28

Chairs: Diego Garcia-Borreguero (Spain), Elias Karroum (United States)

10:45am - 10:58am

Determinants of restless legs syndrome during pregnancy: Focus on iron status and hormones

Silvia Riccardi (Switzerland)

10:58am - 11:11am

Timescales of response to tonic motor activation (TOMAC) therapy for refractory restless legs syndrome (RLS)

Jonathan Charlesworth (United States)

11:11am - 11:24am

Effects of acute exposure to altitude on restless legs syndrome

Abubaker Ibrahim (Austria)

11:24am - 11:37am

The iron deficiency conundrum: Limitations of existing clinical practice guidelines and next steps Scout McWilliams (Canada)

11:37am - 11:50am

A transcriptome analysis of mRNAs in patients with restless legs syndrome

Maria Paola Mogavero (Italy)

11:50am - 12:03pm

Previous Dopaminergic Augmentation of RLS symptoms reduces the Therapeutic Response to Non-Dopaminergic Treatments: The case of DORAs

Diego Garcia-Borreguero (Spain)

SCIENTIFIC PROGRAM

O24: RBD: Neurophysiology, machine learning and prodromal synucleinopathy

10:45am – 12:15pm | Room 33

Chairs: Brad Boeve (United States), Matteo Cesari (Austria)

10:45am - 10:58am

A neurophysiologic study of the effect of clonazepam and melatonin on REM sleep without atonia in isolated REM sleep behavior disorder

Maria Paola Mogavero (Italy)

10:58am - 11:11am

Development, assessment and application of home ambulatory sleep polysomnography in sleep-related motor behaviors

Greta Mainieri (Italy)

11:11am - 11:24am

Isolated REM sleep without atonia in early-stage Parkinson’s Disease is not synonymous of REM sleep behavior disorder

Pauline Dodet (France)

11:24am - 11:37am

Preliminary data on the prodromal synucleinopathy rating scale among patients with REM sleep behavior disorder

Brad Boeve (United States)

11:37am - 11:50am

A machine learning algorithm to predict shortterm phenoconversion from polysomnography in isolated REM sleep behavior disorder

Matteo Cesari (Austria)

11:50am - 12:03pm

Towards fully automatic quantification of REM sleep without atonia according to the Sleep Innsbruck Barcelona (SINBAR) scoring method

Irene Rechichi (Italy)

12:03pm - 12:16pm

Beta band functional connectivity increases prior to dream enactment behavior in patients with idiopathic/isolated REM sleep behavior disorder

Shumpei Date (Japan)

S84: Sleep-based therapeutics for acute and chronic brain disease

10:45am – 12:15pm | Room 34

Chair: Christian R. Baumann (Switzerland)

10:45am – 10:47am

Introduction

10:47am – 11:07am

IL-10 as a novel therapeutic to treat fragmented sleep after experimental traumatic brain injury

Rachel K. Rowe (United States)

11:07am – 11:27am

Sleep-wake cycles in traumatic brain injury: From hospitalization to recovery

Nadia Gosselin (Canada)

11:27am – 11:47am

Slow wave enhancement in Parkinson disease: From symptomatic benefit to neuroprotection

Angelina Maric (Switzerland)

11:47am – 12:07pm

The promise of circadian-based interventions in Parkinson disease

Aleksandar Videnovic (United States)

12:07pm – 12:15pm

Question and answer

O25: Basic sciences of sleep and circadian rhythms

10:45am - 12:30pm | Room 37

Chairs: Sarah Wurts Black (United States), Thomas Kilduff (United States)

10:45am - 10:58am

ORX750, an oral selective orexin receptor 2 agonist, promotes wakefulness and reduces cataplexy in the orexin/ataxin-3 mouse

Sarah Wurts Black (United States)

10:58am - 11:11am

Assessing genetic variation for effects of lithium on circadian clock period, sleep behaviour, and mortality in fruit flies

Noah Fryou (United States)

11:11am - 11:24am

The causal associations of altered inflammation proteins with sleep duration, insomnia, and daytime sleepiness

Yuan Zhang (China)

11:24am - 11:37am

Autonomic cardiac modulation in patients with co-morbid insomnia and obstructive sleep apnea using heart rate variability analysis during wakefulness prior to sleep

Hua Qin (Germany)

11:37am - 11:50am

Sleep and sociality: The influence of acute sleep loss on social motivation in female and male rats

Joel Raymond (Australia)

11:50am - 12:03pm

Examining the information flow dynamics (topdown or bottom-up) in the gamma frequency band (≈40 Hz) of the EEG during wakefulness and sleep

Santiago Castro (Uruguay)

12:03pm - 12:16pm

Role of transient receptor potential vanilloid type 2 (TRPV2) channel in sleep and thermoregulation

Dr Rajesh Yadav (India)

S85: Silencing the locus coeruleus noradrenergic system to optimize sleep health: The potential of repurposing dexmedetomidine

10:45am – 12:15pm | Room 38

Chairs: Hans-Peter Landolt (Switzerland), Helene Benveniste (United States)

10:45am – 10:47am

Introduction

10:47am – 11:07am

Key physiological regulators of GlymphaticLymphatic function

Helene Benveniste (United States)

11:07am – 11:27am

Psychiatric consequences of restless sleep: Overnight limbic plasticity deficits by a lacking noradrenalin time-out?

Eus van Someren (Netherlands)

11:27am – 11:47am

Dexmedetomidine and closed-loop acoustic stimulation: Implications of slow wave enhancement for optimizing perioperative care

Ben Palanca (United States)

11:47am – 12:07pm

Buccal dexmedetomidine delivery: Tool to probe the LC-NA system in human sleep and potential to ameliorate impaired sleep health

Hans-Peter Landolt (Switzerland)

12:07pm – 12:15pm

Question and answer

SCIENTIFIC PROGRAM

O26: Sleep role in behavior and cognition: Clinical aspects

10:45am - 12:15pm | Room A06

Chairs: Mary Carskadon (United States), Péter Ujma (Hungary)

10:45am - 10:58am

Obstructive sleep apnea and Alzheimer’s disease stage transition: Using the NIA-AA research framework to characterize cognitive normal older adults with OSA at heightened risk of developing AD

Omonigho Bubu (United States)

10:58am - 11:11am

The relationship between sleep EEG and cognitive performance in a diverse sample of older adults: The DISCO Study

Tamara Taporoski (United States)

11:11am - 11:24am

Moderate pre-sleep alcohol has a negative impact on next-day PVT performance

Mary Carskadon (United States)

11:24am - 11:37am

Sleep Quality, Cognitive Performance, and Glymphatic Function in Fatigued Breast Cancer Patients

Ali Amidi (Denmark)

11:37am - 11:50am

The Budapest Sleep, Experiences, and Traits Study: an accessible resource for understanding associations between daily experiences, individual differences, and objectively measured sleep

Péter Ujma (Hungary)

11:50am - 12:03pm

Exercise as a strategy to mitigate the cognitive effects of partial sleep deprivation

Celine H. Le Roux (South Africa)

O27: Sleep disordered breathing: Disease and treatment associations

10:45am - 12:15pm | Room A07

Chairs: Yu Sun Bin (Australia), Peter Eastwood (Australia)

10:45am - 10:58am

What measure of CPAP treatment is most closely associated with reduced risk of future major cardiovascular events (MACE)?

Nigel McArdle (Australia)

10:58am - 11:11am

Obstructive sleep apnea in non-IPF fibrotic ILD patients: who, how and what should we offer?

Catarina Gouveia Cardoso (Portugal)

11:11am - 11:24am

Simulated obstructive sleep apnea impacts lipid levels differently between men and women: A randomized crossover study

Vincent Bourgon (Canada)

11:24am - 11:37am

Obstructive sleep apnea and cancer risk: Results of a case-control analysis using data from the Cancer Lifestyle and Evaluation of Risk (CLEAR) Study

Yu Sun Bin (Australia)

11:37am - 11:50am

Obstructive sleep apnea severity is associated with longitudinal cholinergic basal forebrain volume changes in late middle-aged and older adults

Marie-Ève Martineau-Dussault (Canada)

11:50am - 12:03pm

Association between sleep-disordered breathing and psychomotor vigilance performance in elementary school children

Qinye Zhu (Japan)

O28: Sleep health and developmental/lifespan issues

12:30pm - 2:00pm | Room A06

Chair: Mauro Manconi (Switzerland), Maria Paola Mogavero (Italy)

12:30pm - 12:43pm

Sleep and sleep disorders during pregnancy and postpartum: The life-ON study

Mauro Manconi (Switzerland)

12:43pm - 12:56pm

The organization of sleep-wake patterns around daily schedules in college students

Sinh Lu (Australia)

12:56pm - 1:09pm

A systematic review investigating the associations between prenatal sleep health and child outcomes

Melissa Nevarez-Brewster (United States)

1:09pm - 1:22pm

Insufficient sleep and late bedtime are associated with greater dietary intake in adolescent females with Polycystic Ovary Syndrome (PCOS) and obesity

Stacey Simon (United States)

1:22pm - 1:35pm

Bidirectional associations between the duration and timing of nocturnal sleep and naps in adolescents differ from weekdays to weekends

Ruth Leong (Singapore)

1:35pm - 1:48pm

Multidimensional sleep health and long-term cognitive decline in community-dwelling older men

Clémence Cavaillès (United States)

O29: Environmental and cognitive aspects of pediatric sleep

12:30pm - 2:00p | Room A07

Chairs: Maristella Lucchini (Italy), Narong Simakajornboon (United States)

12:30pm - 12:43pm

Daytime sleep duration in early life as an indicator for cognitive development at school age: A prospective cohort study

Jianfei Lin (China)

12:43pm - 12:56pm

The longitudinal associations between sleep and registry-based school grades among Norwegian adolescents

Ingvild West Saxvig (Norway)

12:56pm - 1:09pm

Daylight saving time and sleep in children 4-24 months of age

Maristella Lucchini (Italy)

1:09pm - 1:22pm

NREM nap differences in children with and without visual impairment: The role of fast sleep spindles

Helene Vitali (Italy)

1:22pm - 1:35pm

Effect of the home environment on sleep problems in children with developmental disorders and their siblings

Maya Ramagopal (United States)

1:35pm - 1:48pm

Phenotyping Sleep Disturbances in Children and Adolescents with ADHD based on Clinical Assessment and SDSC Scoring

Osman Ipsiroglu (Canada)

SCIENTIFIC PROGRAM

K13: Chandra Jackson: Climate change and sleep health: A call to action to address impending exacerbation of inequities

2:00pm – 2:45pm | Room 17

2:00pm – 2:02pm

Introduction

Phyllis Zee (United States)

2:02pm – 2:45pm

Keynote presentation

Chandra Jackson (United States)

K14: Laura Lewis: Neural, vascular, and cerebrospinal fluid dynamics of the sleeping brain

2:00pm – 2:45pm | Room 34

2:00pm – 2:02pm

Introduction

Dalva Poyares (Brazil)

2:02pm – 2:45pm

Keynote presentation

Laura Lewis (United States)

S86: Non OSA sleep-disordered breathing

3:00pm – 4:30pm | Room 07

Chairs: Luciana Palombini (Brazil), Luciana Godoy (Brazil)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Sleep disordered breathing (SDB) is more than AHI : How can we improve the diagnosis of these patients?

David Rapoport (United States)

3:18pm – 3:34pm

UARS patients: Diagnosis controversies and consequences of not getting the adequate treatment

Luciana Palombini (Brazil)

3:34pm – 3:50pm

RERAs, RDI and inspiratory flow limitation: What is the evidence of clinical significance

Philip Terrill (Australia)

3:50pm – 4:06pm

Arousals during sleep: Limitations of current validated criteria to evaluate the consequences of SDB

Thomas Penzel (Germany)

4:06pm – 4:22pm

Normal PSG according to AASM manual criteria: Is it enough?

Carlotta Mutti (Italy)

4:22pm – 4:30pm

Question and answer

D04: Best of SLEEP MEDICINE – Journal

Highlights 2023

3:00pm – 4:30pm | Room 17

Chairs: Oliviero Bruni (Italy), Winfried Randerath (Germany)

3:00pm - 3:16pm

Introduction

3:16pm - 3:32pm

Translational sleep science

Robert Thomas (United States)

3:32pm - 3:48pm

Insomnia and parasomnia

Dalva Poyares (Brazil)

3:48pm - 4:04pm

Movement disorders

Birgit Högl (Austria)

4:04pm - 4:20pm

Sleep related breathing disorders

Winfried Randerath (Germany)

4:20pm - 4:30pm

Question and answer

S87: New insights into the role of sleep in pain and pain management for highly prevalent health problems: Musculoskeletal conditions, Long COVID and opioid-related disorders

3:00pm – 4:30pm | Room 23

Chair: David Klyne (Australia)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

The role of sleep in musculoskeletal pain: An update from recent animal and human studies

David Klyne (Australia)

3:22pm – 3:42pm

Does sleep differently impact musculoskeletal pain of different etiologies?

Mary Barbe (United States)

3:42pm – 4:02pm

Sleep disturbance as a driver of pain in Long COVID: The role of disruptions in inflammatory resolution and pain processing

Monika Haack (United States)

4:02pm – 4:22pm

Insomnia and sleep loss impact inflammatory pain and opioid analgesia

Michael Smith (United States)

4:22pm – 4:30pm

Question and answer

S88: Entanglement between sleep and brain health

3:00pm – 4:30pm | Room 24

Chairs: Ambra Stefani (Austria), Wolfgang Ganglberger (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Predicting cognitive functioning and brain aging from sleep

Wolfgang Ganglberger (United States)

3:22pm – 3:42pm

Sleep and neurodegeneration: A chicken and egg situation

Ambra Stefani (Austria)

3:42pm – 4:02pm

How health disparities affect sleep and brain health

Priscila Tempaku (Brazil)

SCIENTIFIC PROGRAM

4:02pm – 4:22pm

How explainable AI can help disentangle sleep and brain health

Ankit Parekh (India)

4:22pm – 4:30pm

Question and answer

S89: Validation and performance evaluation of consumer sleep technology: Data from sleep revolution

3:00pm – 4:30pm | Room 27

Chairs: Anna Islind (Iceland), Timo Leppänen (Finland)

3:00pm – 3:02pm

Introduction

3:02pm – 3:18pm

Understanding the rise of consumer sleep technology

Walter McNicholas (Ireland)

3:18pm – 3:34pm

Contextualizing validation and performance evaluation of new sleep technologies

Thomas Penzel (Germany)

3:34pm – 3:50pm

Reliability and accuracy of consumer-grade devices for SDB screening

Henri Korkalainen (Finland)

3:50pm – 4:06pm

Reliability and accuracy of consumer-oriented sleep-tracker devices and apps

Erna Sif Arnardóttir (Iceland)

4:06pm – 4:22pm

Guidelines and recommendations for the validation of consumer sleep technologies

Gabriel Natan Pires (Brazil)

4:22pm – 4:30pm

Question and answer

O30: Excessive daytime sleepiness: Detection, assessment, and consequences

3:00pm – 4:30pm | Room 28

Chairs: Jed Black (United States), Hans Van Dongen (United States)

3:00pm - 3:13pm

Characteristic of novel sleep EEG biomarkers with central disorders of hypersomnolence

Taoran Bi (China)

3:13pm - 3:26pm

Cardiovascular burden of patients diagnosed With idiopathic hypersomnia: Real-World idiopathic hypersomnia total health model (CVRHYTHM)

Jed Black (United States)

3:26pm - 3:39pm

Mapping neuroimaging using artificial intelligence to detect hypersomnia and its neurobiological correlates

Diego Z. Carvalho (Brazil)

3:39pm - 3:52pm

Effects of solriamfetol on cognition in participants with cognitive impairment associated with excessive daytime sleepiness in obstructive sleep apnea: SHARP study results

Hans Van Dongen (United States)

3:52pm - 4:05pm

Validation of day-time electroencephalography (EEG) as a measure of day time alertness in university students – A pilot study

Nasreen Akhtar (India)

4:05pm - 4:18pm

Utilizing commercial off-the-shelf smartwatches in a real-time drowsiness detection system

Luigi Pugliese (Italy)

O31: New Investigator Award

3:00pm – 4:30pm | Room 33

Chair: Clete Kushida (United States)

3:00pm - 3:13pm

Does the Odds Ratio Product Predict Treatment Response in People with Co-Morbid Insomnia and Sleep Apnoea

Josh Fitton (Australia)

3:13pm - 3:26pm

Poor sleep quality and insomnia severity before infection predict long-term symptoms after COVID19

Federico Salfi (Italy)

3:26pm - 3:39pm

Sleep stage classification with a network of wearable and contactless devices

Oriella Gnarra (Switzerland)

3:39pm - 3:52pm

Comprehensive Analysis of Circadian Protein Expression Patterns in Healthy Adults

Adrien Specht (United States)

3:52pm - 4:05pm

Circadian photoreception impacts thoughts of self

Malisa Burge (Australia)

4:05pm - 4:18pm

Poor Sleep Quality During Pregnancy Predicts

Neonatal White Matter Integrity and Subsequent

Negative Emotionality in Infancy

Melissa Nevarez-Brewster (United States)

S90: Translating mathematical models of sleep and circadian rhythms to the real world

3:00pm – 4:30pm | Room 34

Chair: Olivia Walch (United States)

3:00pm - 3:02pm

Introduction

3:02pm - 3:22pm

Detecting sleep with a consumer wearable in healthy and clinical samples

Olivia Walch (United States)

3:22pm - 3:42pm

Tracking circadian phase in shift workers in real world conditions

Anthony Reffi (United States)

3:42pm - 4:02pm

Topological modeling to diagnose sleep apnea: While awake

Aarti Sathyanarayana (United States)

4:02pm - 4:22pm

Personalized sleep-wake patterns based on wearables and mathematical modeling

Jaekyoung Kim (Korea, Republic of)

4:22pm - 4:30pm

Question and answer

SCIENTIFIC PROGRAM

S91: Cardiometabolic implications of sleep and circadian disturbances

3:00pm – 4:30pm | Room 37

Chairs: Marie-Pierre St-Onge (United States), Erin Hanlon (United States)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

Exercise and metabolism during insufficient sleep and circadian misalignment

Kenneth Wright (United States)

3:22pm – 3:42pm

Circadian rhythms of the endocannabinoid system and food intake

Erin Hanlon (United States)

3:42pm – 4:02pm

Impact of insufficient sleep on cardiometabolic health

Marie-Pierre St-Onge (United States)

4:02pm – 4:22pm

Therapeutic applications of circadian rhythms and body weight

Marta Garaulet (Spain)

4:22pm – 4:30pm

Question and answer

S92: Brain changes in isolated REM sleep behavior disorder: A critical review of recent findings and implications

3:00pm – 4:30pm | Room 38

Chair: Shady Rahayel (Canada)

3:00pm – 3:02pm

Introduction

3:02pm – 3:22pm

The use of advanced brain imaging and computational neuroscience to study brain atrophy in iRBD

Shady Rahayel (Canada)

3:22pm – 3:42pm

Locus coeruleus and nigral changes using multimodal MRI in iRBD

Rahul Gaurav (France)

3:42pm – 4:02pm

EEG and sleep structure features as disease progression biomarkers in iRBD

Matteo Cesari (Austria)

4:02pm – 4:22pm

Brain molecular imaging as biomarker of phenoconversion in iRBD

Beatrice Orso (Italy)

4:22pm – 4:30pm

Question and answer

O32: Neurological disorders

3:00pm – 4:30pm | Room A06

Chairs: Gabriel Dias Rodrigues (Italy), Jennifer Zitser (Israel)

3:00pm - 3:13pm

Cardiac sympathetic modulation is predominated during wake and sleep in patients with Rett syndrome: A possible trigger of cardiovascular risk?

Gabriel Dias Rodrigues (Italy)

3:13pm - 3:26pm

Mutational mechanisms related to sleep disturbance in patients with SYNGAP1–associated syndrome

Amanda Cristina Mosini (Brazil)

3:26pm - 3:39pm

Home Sleep EEG biomarkers of neurodegeneration

Flavia Fagundes Bueno (United States)

3:39pm - 3:52pm

Sleep features and long-term incident neurodegenerative diseases: A polysomnographic study

Abubaker Ibrahim (Austria)

3:52pm - 4:05pm

Automatic sleep staging and detection of sleep disorders through wearable EEG monitoring devices

Elisabeth Heremans (Belgium)

4:05pm - 4:18pm

The aggravation of motor symptom in Parkinson’s disease with obstructive sleep apnea is correlated with reduced overnight decline of slow wave activity

Yun Shen (China)

O33: Sleep disordered breathing: Modeling, predictors, and pathogenetic mechanisms

3:00pm – 4:30pm | Room A07

Chair: Diane Lim (United States), Bingqian Zhu (China)

3:00pm - 3:13pm

Exploring backscatter ultrasound imaging in different demographic subgroups for assessing obstructive sleep apnea severity

Pien Bosschieter (United States)

3:13pm - 3:26pm

Identifying longitudinal patterns of CPAP treatment in OSA using growth mixture modeling: Disease characteristics and psychological determinants

Huijie Yi (China)

3:26pm - 3:39pm

Comparison of novel electrophysiological biomarkers and circulating cardiac biomarkers on cardiovascular modality and all-cause mortality in the Akershus Sleep APnea (ASAP) epidemiological cohort

Xin Feng (Norway)

3:39pm - 3:52pm

Early life predictors of obstructive sleep apnoea in young adults: Insights from a longitudinal community cohort (Raine Study)

Mon Ohn (Australia)

3:52pm - 4:05pm

Arousal versus chemoreflex contributions to ventilatory drive in obstructive sleep apnea

Laura K. Gell (United States)

4:05pm - 4:18pm

Obstructive sleep apnea and Alzheimer’s disease and related dementias: A bidirectional Mendelian randomization analysis

Clémence Cavaillès (United States)

S93: Sleep and psychosocial behavioral outcomes across the lifespan

4:45pm – 6:15pm | Room 07

Chairs: Olivia Veatch (United States), Mariana Moysés Oliveira (Brazil)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Sleep and cognition in children with neurodevelopmental disabilities

Rosalia Silvestri (Italy)

5:07pm – 5:27pm

NREM sleep oscillations and their role in memory consolidation, emotional processing and psychiatric symptoms in youth

Bengi Baran (United States)

5:27pm – 5:47pm

The impact of stress and sleep on memory processing: Insights from a large, multinational dataset

Lauren Whitehurst (United States)

5:47pm – 6:07pm

Sleep and cognition in older individuals: Impacts of slow wave sleep and OSA

Andrew Varga (United States)

6:07pm – 6:15pm

Question and answer

S94: Global Sleep Health Taskforce: Sleep data across the globe

4:45pm – 6:15pm | Room 17

Chairs: Diane Lim (United States), Arezu Najafi (Iran)

4:45pm - 4:47pm

Introduction

4:47pm - 5:03pm

Collecting big data across the globe

Leanne Riley (Switzerland)

5:03pm - 5:19pm

European region: Sleep data

Thorarinn Gislason (Iceland)

5:19pm - 5:35pm

Sleep in Singapore: An East Asian example

Ju Lynn Ong (Singapore)

5:35pm - 5:51pm

Region of the Americas: Sleep data

Dalva Poyares (Brazil)

5:51pm - 6:07pm

African region: Sleep data

Morenikeji A. Komolafe (Nigeria)

6:07pm - 6:15pm

Question and answer

D05: Promoting safe sleep in pediatric medical settings

4:45pm – 6:15pm | Room 23

Chairs: Umakanth Katwa (United States), Judith Owens (United States)

4:45pm - 4:55pm

Safety in the pediatric sleep lab: A medical director’s perspective

Umakanth Katwa (United States)

4:55pm - 5:05pm

Ensuring safe sleep for children in resource-poor facilities

Oluwatosin Olorunmoteni (Nigeria)

5:05pm - 5:15pm

Developing local and national guidelines for pediatric sleep labs

Saadoun Bin-Hasan (Kuwait)

5:15pm - 5:25pm

Implementing safe sleep for infants in hospitals: A nursing perspective

Jennifer Gingrasfield (United States)

5:25pm - 6:15pm

Group discussion

S96: Revisiting sleep waves, slow and sharp

4:45pm – 6:15pm | Room 27

Chair: Giulio Tononi (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

A neuropixels view of slow and sharp waves

Chiara Cirelli (United States)

5:07pm – 5:27pm

Sleep/ wake interventions across lifespan

Luis de Lecea (United States)

5:27pm – 5:47pm

The diversity of slow waves explored by phase locked auditory stimulation

Reto Huber (Switzerland)

5:47pm – 6:07pm

The role of sleep slow oscillations in memory consolidation: Neural correlates and functional significance

Niels Niethard (Germany)

6:07pm – 6:15pm

Question and answer

SCIENTIFIC PROGRAM

O34: Technology: Measuring brain activity

4:45pm – 6:15pm | Room 28

Chairs: Mickael Tanter (France), Peter Eastwood (Australia)

4:45pm - 4:58pm

Functional ultrasound imaging as an emerging tool for whole brain imaging of sleep in rodents

Mickael Tanter (France)

4:58pm - 5:11pm

The use of bispectral index (BIS) monitoring during sleep endoscopy (DISE) In adult patients with obstructive sleep apnea

Karuna Dewan (United States)

5:11pm - 5:24pm

REM sleep alpha and theta oscillations can be modulated using phase-locked closed-loop auditory stimulation in humans

Valeria Jaramillo (United Kingdom)

5:24pm - 5:37pm

Tripolar concentric ring electrodes for capturing localized electroencephalography signals during sleep

Nicole Stuart (Australia)

5:37pm - 5:50pm

Modeling EEG data using deep learning for automatic sleep stage classification in mice

Laura Rose (Denmark)

5:50pm - 6:03pm

Estimated Sleep Durations and Sleep Architecture

Obtained from a Large U.S. Sample by HomeBased Under-Mattress Monitoring Devices

Jennifer Zitser (Israel)

S97: The promise and perils of digital health in sleep medicine

4:45pm – 6:15pm | Room 33

Chairs: Eric Zhou (United States), Sooyeon (Aly) Suh (Korea, Republic of)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Use of a consumer wearable to provide individualized reporting of sleep

Sooyeon (Aly) Suh (Korea, Republic of)

5:07pm – 5:27pm

Tailoring an automated internet-delivered insomnia intervention to improve program engagement in an underserved minority population

Eric Zhou (United States)

5:27pm – 5:47pm

Integration of an evidence-based digital CBT-I program into routine clinical care

Christopher Miller (United Kingdom)

5:47pm – 6:07pm

Importance of integrating human interactions with telehealth programs to improve patient adherence with OSA treatment

Jason Ong (United States)

6:07pm – 6:15pm

Question and answer

S98: Research by early-stage investigators in the sleep apnea global interdisciplinary consortium

4:45pm – 6:15pm | Room 34

Chairs: Allan Pack (United States), Thomas Penzel (Germany)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Beyond the AHI: New metrics of disease severity in OSA

Mohammadreza Hajipour (Canada)

5:07pm – 5:27pm

Different dimensions of sleepiness

Elin Thorarinsdottir (Iceland)

5:27pm – 5:47pm

MAD versus CPAP in blood pressure lowering in Asians with hypertension and high cardiovascular risk: A noninferiority trial

Yihui Ou (Singapore)

5:47pm – 6:07pm

Use of EHR to study comorbidities in patients with OSA

Tue Te (United States)

6:07pm – 6:15pm

Question and answer

S99: Periodic leg movements and beyond: Paving the way for improved leg movement detection

4:45pm – 6:15pm | Room 37

Chairs: Ambra Stefani (Austria), Leticia Azevedo Soster (Brazil)

4:45pm – 4:47pm

Introduction

4:47pm – 5:07pm

Evolution of the definition and scoring of sleep related leg movements

Raffaele Ferri (Italy)

5:07pm – 5:27pm

The “human factor” in expert leg movement scoring

Stefan Seidel (Austria)

5:27pm – 5:47pm

Inter-rater reliability of sleep related leg movement scorings: Results from the world’s largest and most varied expert scorer data set Diego Alvarez-Estevez (Spain)

5:47pm – 6:07pm

Does shape matter? A novel approach to leg movement analysis

Stephany Fulda (Switzerland)

6:07pm – 6:15pm

Question and answer

SCIENTIFIC PROGRAM

S100: Central disorders of hypersomnolence across the life span: A patient centered approach to comprehensive shared care management

4:45pm – 6:15pm | Room 38

Chair: Anne Morse (United States)

4:45pm – 4:47pm

Introduction

4:47pm – 5:03pm

Pediatric central disorders of hypersomnolence: Social, academic and developmental concerns and management considerations

Heather Elphick (United Kingdom)

5:03pm – 5:19pm

Looking beyond sleepiness: The impact of gender, ethnicity, comorbidity, socioeconomic status and geographic location on individuals with CDH

Christianne Martins Bahia (Brazil)

5:19pm – 5:51pm

Personalizing care for central disorders of hypersomnia through patient partnership

Anne Morse (United States), Juliana Angelim Neves (Brazil)

5:51pm – 6:07pm

Educational, social and behavioral support for individuals with central disorders of hypersomnolence

Julie Flygare (United States)

6:07pm – 6:15pm

Question and answer

O35: Sleep health, technology, and performance

4:45pm – 6:15pm | Room A07

Chair: Gary Garcia Molina (United States), Henri Korkalainen (Finland)

4:45pm - 4:58pm

Subjective health is associated with neurobehavioral performance: A cross-sectional study on physicians’ work-style reform surveillance

Yoshihito Kameda (Japan)

4:58pm - 5:11pm

Enhancing both sleep stage classification and obstructive sleep apnea event detection tasks with a unified sound-based multi-task model

Daewoo Kim (Korea, Republic of)

5:11pm - 5:24pm

Comparative analysis of 11 consumer sleep trackers with polysomnography

Dongheon Lee (Korea, Republic of)

5:24pm - 5:37pm

Feasibility of unobtrusively estimating blood pressure during sleep using ballistocardiography-based pulse transit times Gary Garcia Molina (United States)

5:37pm - 5:50pm

SnoreFormer: Home snoring detection with deep neural networks

SooFeel Kim (Korea, Republic of)

5:50pm - 6:03pm

Automatic sleep scoring via deep learning: Do it at home!

Luigi Fiorillo (Switzerland)

Closing ceremony

6:15pm – 7:00pm | Room 34

POSTER HALL DIRECTORY

Posters in the poster hall are organized by submission category. Refer to the categories below and their board numbers in the poster hall to help plan your attendance at the poster sessions. Please note that the final board assignments on site may vary slightly from this directory.

Poster Setup and Takedown

Please place your poster at your assigned board by 12pm if you are presenting in Group 1 on Sunday or by 9:30am if you are presenting in Groups 2 and 3 on Monday and Tuesday. Please remove your poster after your presentation session ends to ensure the board is open for the next presenter.

Sponsors & Exhibitors

2023 SPONSORS

Gold Sponsor

Silver Sponsors

Bronze Sponsors

INDUSTRY SYMPOSIA & WORKSHOPS

Monday, October 23

Philips: Personalizing Sleep Apnea Therapy for Optimal Outcomes

12:30pm – 2:00pm | Room 33

Chairs: Teofilo Lee-Chiong (United States), Manuel Sánchez-de-la-Torre (Spain)

Asleep: AI-driven Innovations in Sleep Health: With Sound of Sleep

12:45pm - 2:00pm | Room 07

Chairs: Clete Kushida (United States), Daewoo Kim (Korea, Republic of)

Medscape Education Global: Narcolepsy and Idiopathic Hypersomnia: Unraveling the Connection Between Orexin/Hypocretin and Patient Struggles

12:30pm – 2:00pm | Room 37

Organized by Medscape Education Global Supported by independent funding from Takeda

German Research Foundation: Science Lunch on Funding Opportunities and Collaboration Programs for Research in and with Germany

1:00pm - 1:45pm | Room 28

ResMed: Unravelling the OSA Patient Journey: Awareness, Diagnosis and Treatment

12:30pm – 2:00pm | Room 38

Chairs: Claudia Albertini (Brazil), Adam V. Benjafield (Australia)

INDUSTRY SYMPOSIA & WORKSHOPS

Tuesday, October 24

Nox Medical: The Future of Sleep Diagnostics with Nox SAS and Level II Testing

12:30pm – 2:00pm | Room 23

Chairs: Jason Ong (United States), Snorri Helgason (Iceland)

Philips: Remote Management of Sleep Apnea patients

1:00pm – 1:45pm | Room 27

Chairs: Edilson Zancanella (Brazil), Teofilo Lee-Chiong (United States)

An Expert Panel Presentation by Avadel CNS Pharmaceuticals, LLC: Evolving the Therapeutic Landscape for Narcolepsy

12:30pm – 2:00pm | Room 33

This presentation is intended for US healthcare professionals only. Product not approved outside of the US.

Revery Labs

Pocket Kado: Changing behavior through gaming

1:00pm - 2:00pm | Room 38

Idorsia Pharmaceuticals: Managing chronic insomnia disorder - what have we learned from clinical trials and real-world practice?

12:30pm – 2:00pm | Room 37

Chair: Göran Hajak (Germany)

12:45pm - 2:00pm | Room 07

Search the schedule, build your personal agenda, see the floor plans, and find more info in the official World Sleep 2023 app!

EXHIBIT HALL FLOOR PLANS

FLOOR 0

FLOOR 1

2023 EXHIBITORS

SPONSORS & EXHIBITORS

Thank you to the following supporters of World Sleep 2023 in Rio de Janeiro, Brazil. Listed in alphabetical order.

Booth 194 aladsweb.com

Derived from the Latin American Federation of Sleep Societies (FLASS), the Latin American Sleep Association (ALADS) was born and within the World Sleep Congress 2023 its First Meeting and presentation to the scientific community of Sleep Medicine will be held.

Bronze Sponsor

alkermes.com

Alkermes plc is a fully integrated, global biopharmaceutical company focused on developing innovative medicines for the treatment of serious, chronic central nervous system (CNS) diseases. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information visit www.alkermes.com.

Booth 134 amcad.com.tw

AmCad BioMed Corporation (AmCad) is a pioneering ultrasound AI software company, creates a world’s first ultrasound based obstructive sleep apnea (OSA) detection in 10 minutes for awake patients, AmCAD®-UO. With laser-guided positioning and automated ultrasound scanning device, AmCAD®UO can precisely scan upper airway and analyze the gap between normal breathing and Müller Maneuver. AmCAD®-UO system standardizes ultrasound transducer scanning to make the assessment more consistent and avoid high operator dependent variations.

Booth 067

ambulatory-monitoring.com

AMI has been the industry leader for more than 35 years, pioneering actigraphy and reaction time measurement (PVT) in sleep medicine. Our Motionlogger and Sleep Watch models have been used in hundreds of publications and landmark studies all over the world. Our devices are the most highly validated in sleep medicine. Please visit our booth and see our new models, new features, and cloud solutions.

apnimed.com

Apnimed is a clinical-stage pharmaceutical company working to transform the treatment of sleep apnea based on a simple idea – patients with obstructive sleep apnea could benefit from treatment with a safe and effective oral medication dosed once daily at bedtime. Apnimed’s lead program targets the neurologic control of upper airway muscles to maintain an open airway during sleep. The company is developing novel pharmacologic therapies for sleep apnea and related disorders.

SPONSORS & EXHIBITORS

Booth 008

appscent.com

Appscent Medical Ltd. is a privately-held Israeli company developing an advanced artificial intelligence medical device that offers continuous, non-contact, detection, and relief for sleep apnea. Appscent Medical was founded in 2018 by experienced entrepreneurs with extensive technology and medical background. The company is working in full cooperation with the Weizmann Institute of Science, which developed some early technology and IP. Appscent’s team comprises entrepreneurs, neurobiologists, and data scientists, all perfectly positioned to reap the benefits of the predicted ten bn/year Global sleep apnea device market.

Gold Sponsor

Booth 013

avadel.com

Avadel Pharmaceuticals plc (Nasdaq: AVDL) is a biopharmaceutical company focused on transforming medicines to transform lives. Our approach includes applying innovative solutions to the development of medications that address the challenges patients face with current treatment options. Avadel’s commercial product, LUMRYZTM, was approved by the U.S. Food & Drug Administration (FDA) as the first and only once-at-bedtime oxybate for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. For more information, please visit www.avadel.com.

Bronze Sponsor

Booth 025 asleep.ai

Asleep is a sleep-tech company that specializes in offering the world’s first Sleep SaaS and medical diagnostic devices, powered by accurate soundbased sleep stage and OSA tracking AI. The core AI technology has achieved a 75% level of sleep staging agreement with polysomnography. Our medical diagnostic device is undergoing regulatory approval in South Korea, with plans underway for FDA approval in the United States. Asleep enables seamless integration of sleep tracking features for business partners.

Booth 083

biolabfarma.com.br

Pursuing a future with a better quality of life requires a relentless search for safe and innovative treatments. That’s why Biolab, a Brazilian pharmaceutical company founded in 1997 and with an international footprint, invests in research and partnerships to tackle the ever-increasing health challenges. With more than 3.800 employees, three production units, and a modern factory complex under construction, Biolab is among the largest pharmaceutical companies in Brazil. And it doesn’t stop there: in Canada, it is the 1st Brazilian pharmaceutical company with a Research Center and it has acquired Exzell Pharma to expand its borders. Experience Evolution!

SPONSORS & EXHIBITORS

Booth 064

biomedequipamentos.com.br

Biologix was born with the aim of democratizing sleep health in Brazil, the Biologix Sleep study is a nocturnal simplified polysomnography used for diagnosis and monitoring of snoring and sleep apnea treatment, and allows healthcare professionals to offer their patients a clinical validated solution, using only a cell phone and a compact wireless sensor.

Booth 043

biomedequipamentos.com.br

Founded in 1969, Biomed is proud to collaborate with neurology in Brazil, supporting courses and events and offering high quality products. The company supplies the best products in the market such as transcranial doppler, electroencephalography, electroneuromyography, neurophysiological monitoring, polysomnography and evoked potentials, including consumables, accessories and supplies. In addition, we maintain our own structure for after sales support and technical assistance that is constantly trained and capable of providing the necessary care throughout the country.

BY NEWSOM

Booth 182

bluepro.pro

BluePro is an oral appliance designed to effectively treat sleep apnea and snoring. Worn during sleep, it adjusts the jaw’s position to keep airways open, reducing breathing interruptions and snoring. Exclusively available to healthcare professionals, BluePro offers an innovative and affordable solution for managing sleep disorders.

Booth 088

en.bmc-medical.com

BMC Medical Co., Ltd. (BMC), established in Beijing, China in 2001, was built to partner with families worldwide to overcome the discomfort of chronic respiratory disease with quality products, professional services, and proactive care. Over the past 20 years, BMC helps people in more than 100 countries and regions around the world to sleep better and breathe easier.

Booth 192 absono.com.br

Brazilian Sleep Association (ABS), founded in August 1985 under the name Brazilian Sleep Society, is the interdisciplinary institution for all Brazilians who study sleep and who practice sleep medicine and related care. ABS promotes numerous activities, including courses, meetings with civil society and public policymakers, and the facilitation of sleep research and care.

Booth 177

cmosdrake.com.br

Established by the entrepreneur Marco Aurélio Marques Félix in 1989, CMOS DRAKE started with the goal of developing smart solutions to preserve and save lives. A pioneer in Latin America´s defibrillator market, CMOS DRAKE has become a reference due to the high survival rate the equipment offers. Nowadays, more than 300 thousand people die every year of cardiorespiratory arrest in Brazil, and the quick service is essential to victim survival.

SPONSORS & EXHIBITORS

Booth 156

compumedics.com

Compumedics is a global technology leader in computer-based patient monitoring and diagnostic systems, with over 30 years’ industry experience. We offer innovative computer-based diagnostic technologies in the areas of Sleep, Neurology, Doppler Sonography and Cardiology for clinical and research applications. Compumedics systems are leading edge, strongly appealing to hospitals, medical clinics and home service providers.

CONDOR INSTRUMENTS

Booth 054

condorinst.com/en

Condor Instruments, a Brazilian company founded in 2013, specializes in innovating and industrializing solutions for precision instruments and equipment. Our dedicated team of engineers, developers, and researchers is committed to delivering high-quality and efficient products, primarily focusing on meeting the demands of medical and scientific markets, with a special focus on sleep and circadian rhythm.

Booth 003

elsevier.com

Elsevier, a global leader in information and analytics, helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. Growing from our roots in publishing, we have supported the work of our research and health partners for more than 140 years. Elsevier offers knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Elsevier publishes over 2,650 digitized journals, including The Lancet and Cell.

Booth 068

ems.com.br

For us, EMS, nothing is more inspiring than promoting a full life, full of possibilities and choices. Our mission is to take care of people, taking each of them, our specialty: excellent drug products, unprecedented in large part and, increasingly, innovative by nature. We have been the leader of the Brazilian pharmaceutical market for 17 consecutive years. We’re proud to daily contribute to people’s increase of quality of life and well-being.

Booth 131

cpaps.com.br

CPAPS.com.br is the largest and most complete online store specializing in products for sleep apnea and respiratory therapy. We offer a wide variety of quality products, attractive prices, easy payment, fast delivery and specialized service to help you in your search for a healthy sleep and better quality of life.

Booth 026

eurofarma.com.br

Eurofarma is a Brazilian multinational company with 100% Brazilian capital. Since 1972, it has been recognized by the medical community and society for promoting access to health and improving quality of life through accessible treatments, quality, and innovation.

SPONSORS & EXHIBITORS

Booth 181

firstmedical.com.br

First Medical is a certified company to offer modern and high performance products through representation, import and distribution of medical and hospital equipment, with exclusivity, from internationally recognized brands. In this way, the latest generation equipment is available to its customers, offering first-hand launches and novelties to the Brazilian market.

Booth 066

fphcare.com |

fphcare.com.br

We are a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. Driven by a strong sense of purpose, we are working to improve patient care and outcomes through inspired and world-leading healthcare solutions. The needs of our customers and their patients drive everything we do. We call this commitment Care by Design.

research-in-germany.org/en

“Research in Germany” is an initiative of the Federal Ministry of Education and Research. It presents Germany as a country of research and innovation and creates a forum for international exchange and cooperation. It also provides international researchers with information about funding and career opportunities in Germany.

Bronze Sponsor

Booth 105

gaslive.com.br

We provide products and services for Respiratory Therapy and Sleep Apnea, specializing in home care business and complex rehabilitation. Through a dynamic and flexible operation, we develop global solutions to deliver the best treatment and business to partner resellers. Our mission is to promote lasting business and build solid alliances toward our main objective: taking care of people.

Booth 133

homed.com.br

Homed was founded in 1991 and is now 33 years old. It operates in the sale, rental and distribution of ResMed and Philips/Respironics products for the treatment of Obstructive Sleep Apnea.

Booth 178

hypersomniafoundation.org

The Hypersomnia Foundation is a non-profit organization that engages, informs and champions our global community to improve the lives of people with idiopathic hypersomnia and related sleep disorders. Recognizing the significant impact these disorders can have on quality of life, the foundation works diligently to increase awareness, promote research, and offer educational resources to both patients and medical professionals. Through its various initiatives, including outreach programs, information-sharing events, and collaborative research efforts, the Hypersomnia Foundation aims to bring hope to those affected, while striving for a deeper understanding and more effective treatments for these often-misunderstood conditions.

SPONSORS & EXHIBITORS

Booth 183

icelera.com.br

We are manufacturers of a complete line of equipment for polysomnography and electroencephalography. There are more than 800m² of structure for our factory, technical assistance and showroom, working to simplify diagnoses with stateof-the-art technology, continuous training of our manufacturing, technical support and sales teams, giving special attention to our customers with a complete and efficient after-sales structure. All this effort and investment puts ICELERA at the top of its market! Come meet us!

Booth 014

institutodosono.com

Founded in 1992, The Sleep Institute is a pioneer and reference center in the study and diagnosis of sleep disorders. It has one of the largest and most diverse groups of researchers in the world, a comprehensive range of facilities for carrying out exams and consultations, and has trained more than 5,000 number of professionals in the area of sleep science in the last 25 years.

Silver Sponsor

jazzpharma.com

Booth 141

website

The purpose of Idorsia is to discover, develop, and commercialize innovative medicines to help more patients. We have more ideas, we see more opportunities and we want to transform the horizon of therapeutic options.

Jazz Pharmaceuticals is a fully integrated, global biopharmaceutical company with a diverse portfolio of marketed medicines and novel product candidates for adults and children. We are an industry leader in treating sleep disorders, using our deep knowledge of and commitment to neuroscience to innovate and identify new solutions where none previously existed.

US-SLE-2300210 REV0923

Booth 176

yuwell.com/en

Booth 188

inspiresleep.com

Inspire Medical Systems, Inc. is the leading developer of implantable neurostimulation systems to treat moderate-to-severe Obstructive Sleep Apnea (OSA). Utilizing well-established technologies from cardiac pacing and neurostimulation, Inspire developed a proprietary Upper Airway Stimulation (UAS) therapy designed to improve sleep and enrich the lives of people suffering from this challenging condition.

Yuwell Medical, a Chinese A-share listed company been focusing on medical and health care for 25 years. It covers 10 medical and health solutions including respiratory therapy, diabetes management, in vitro diagnosis, infection control, ultrasound diagnosis, and others. It has set up 12 R&D centers and 9 production bases around the world, serving more than 300,000 medical institutions and more than 90% of grade A class 3 hospitals in China, covering 131 countries and regions overseas and benefiting 300 million families worldwide.

Bronze Sponsor

SPONSORS & EXHIBITORS

Booth 187

livanova.com/en-us

At LivaNova, we unite to provide hope for patients and their families through innovative medical technologies, delivering life-changing improvements for both the Head and Heart. Our shared purpose is to improve the lives of patients, and to this end, we develop novel products and therapies to address multiple disease states.

Our aura6000 THN Sleep Therapy for Obstructive Sleep Apnea, a fully implanted neurostimulation device, is one of the therapies from our portfolio. It aims at restoring quality of life to the patients that do not or cannot comply with the traditional therapies.

medscape.com/neurology

Medscape is the leading online global destination for physicians and healthcare professionals worldwide, offering the latest medical news and expert perspectives; essential point-of-care drug and disease information; and relevant professional education and CME.

Booth 047 en.micomme.com

Booth 053

locmed.com.br

Locmed is specialized in providing products and services for respiratory therapy, oxygen therapy, invasive and non-invasive ventilation, diagnosis and treatment of obstructive sleep apnea, high flow therapy, monitoring, oximetry, hospital and home care furniture, pneumatic mattresses and the entire chain of accessories and supplies that orbit these devices. Locmed serves customers throughout Brazil, either directly at operating units or in physical stores or online, as well as providing equipment for public and private health institutions and reseller companies throughout the country, including the entire operational structure for home care companies, health operators and pharmacy chains.

Micomme Medical, established in 2013, focuses on equipment innovation and chronic respiratory disease management services in the field of respiratory diagnosis and treatment, and is committed to becoming the leading company in the field of non-invasive ventilation therapy in China. The company currently owns more than 40 independently developed, proprietary products covering four series, including Hospital Non-invasive Ventilators, Heated and Humidified High Flow Nasal Cannula oxygen therapy devices, Home-care Non-invasive Ventilators, and respiratory consumables.

Booth 161 iner.org.br | proespuma.org.br

National Institute of Rest Studies was the pioneer in the creation of the Pro-Espuma Certificate, our certification for mattresses and pillows, which operates under the most rigorous quality tests on the brazilian market. Since 1984 we have acted as partners of the companies and brands of the sleep ecosystem, promoting consumer awareness, the exposure of our associates, the training of channels and support to service teams.

SPONSORS & EXHIBITORS

Booth 018

nesa.world

Technological group specialized in the manufacture, distribution and training of patented medical devices focused in the NON-INVASIVE NEUROMODULATION. Our essence and purpose translates into the mission of improving the life quality of millions of people through the care of their nervous system with our technology and work methodology through all healthcare professionals around the world.

Booth 063

openairway.ca | o2vent.com

OADS is a world leader in sleep disorder treatment that commercializes a suite of revolutionary oral devices and inspires a new paradigm of care – taking the treatment of OSA to the next level by providing a real alternative for the broader population within a unique treatment platform. The Optima O2Vent is far more than just another oral appliance – it represents a breakthrough in sleep apnea treatment. Its innovative design and advanced features address the specific challenges faced by sleep apnea patients, offering unmatched comfort and effectiveness. The O2Vent Optima has a proven effectiveness in transforming the lives of sleep apnea patients.

Booth 138

neurovirtual.com/

At Neurovirtual, we take pride in manufacturing PSG products within the United States. With our headquarters located in Fort Lauderdale, Florida, we offer round-theclock technical support to our esteemed customers. We provide complimentary software upgrades, unique software customization, and unlimited report templates. Our business model is designed to keep your sleep lab ahead of the curve while remaining within your budget.

Bronze Sponsor

Booth 086

noxmedical.com

Nox Medical is a global leader in the sleep diagnostic technology space. The company provides sleep specialists with patient-friendly diagnostic devices and robust, reliable data collection. With easy-to-use medical device technology, Nox Medical eliminates common diagnostic pain points by prioritizing patient comfort and reliability of results, allowing providers to better assess, diagnose and treat the entire range of sleep health issues. Products include the Nox T3s HST, the Nox A1 PSG, the Nox SAS solution, and Noxturnal Software.

Booth 046 oxigenar.com.br

Oxigenar is a company that sells medical equipment for respiratory therapy, which will be sixteen years old in 2023. Its foundation took place in Volta Redonda, south of Rio de Janeiro by the physiotherapist Ivan Machado and today it is present in the three main states of Brazil, Rio de Janeiro, São Paulo and Minas Gerais. With the mission of taking care of the health of its patients, Oxigenar will continue to work with ethics, professionalism and empathy.

Bronze Sponsor

Booth 016

At Philips, we offer connected care solutions that connect data, technology and people across the care continuum to provide safe and effective therapy in sleep and respiratory care. We have centered our business around our commitment to quality patient care, with solutions that are aimed at improving the lives of people with respiratory and sleep challenges.

SPONSORS & EXHIBITORS

Booth 184

prosomnus.com

ProSomnus is the first manufacturer of precision, masscustomized Precision Oral Appliance Therapy devices to treat OSA, which affects over 74 million Americans and is associated with serious comorbidities, including heart failure, stroke, hypertension, morbid obesity and type 2 diabetes. ProSomnus’s patented devices are a more comfortable and less invasive alternative to Continuous Positive Airway Pressure (CPAP) therapy, and lead to more effective and patient-preferred outcomes. With more than 150,000 patients treated, ProSomnus’s devices are the most prescribed Precision Oral Appliance Therapy in the U.S.

Booth 028

re-timer.com

Re-Time Pty Ltd is an Adelaide based company which was incubated from an industry collaboration between Flinders University and Samvardhana Motherson Group. The company was formed around a decade back to deliver science-based sleep health solutions to consumers around the globe, foremost among them the Re-Timer light therapy glasses.

Bronze Sponsor

Booth 084

resmed.com.br

At ResMed, we pioneer innovative solutions that treat and keep people out of the hospital, empowering them to live healthier, higher-quality lives. Our digital health technologies and cloud-connected medical devices transform care for people with Sleep Apnea, COPD, and other chronic diseases.

Our comprehensive out-of hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

Revery Labs

Bronze Sponsor

Booth 155

reverylab.com

Revery Labs is a mental health gaming company on a mission to make wellness accessible to everyone.

Bronze Sponsor

Booth 085

SPONSORS & EXHIBITORS

Bronze Sponsor

Booth 196

exciteosa.com

Signifier Medical is a pioneer in addressing the root causes of sleep-disordered breathing by focusing on the development and commercialization of innovative solutions that help people breathe normally and naturally all night – without needing to use a wearable medical device or surgical implant. The first of its kind, eXciteOSA is an FDA-authorized, non-invasive daytime treatment for snoring and mild OSA.

Booth 166

sleepmultimedia.com

SleepMultiMedia 2023 is a comprehensive computerized textbook of sleep medicine: text, audio, graphics, animation, and video; suitable for sleep specialists, trainees and researchers. SleepMultiMedia contains Medline references and abstracts. Updated annually with 140 CME credits, the program covers adult and pediatric clinical sleep medicine, dental sleep medicine, sleep physiology, polysomnography, sleep research and sleep practice management.

Booth 168

sleepimage.com

SleepImage is an FDA cleared software to diagnose and manage sleep disorders including obstructive and central sleep apnea. SleepImage features multinight testing, simplicity and the clinical accuracy of a polysomnography. SleepImage is featured in over 100 peer-reviewed articles and is FDA cleared for both children and adults.

Booth 044

somnomedics.com

SOMNOmedics designs, manufactures, markets, distributes and services products dedicated to sleep diagnostics. Our products are utilized for a variety of sleep related tests and comply with the AASM standards. SOMNOmedics devices are small, lightweight and worn by the patient. We are compatible with in lab diagnostics as well as home sleep testing. SOMNOmedics wireless solution allows patients video, audio and data to be observed from any environment.

Booth 167

sleepup.com

SleepUp® is the first DTx approved by ANVISA (Brazilian FDA) for sleep disorders in Brazil. SleepUp offers personalized and clinically validated digital therapeutics for chronic insomnia and homecare sleep monitoring, using proprietary algorithms of CBTi, electroencephalogram, oximeter, CPAP, and medication management. SleepUp® was born with the purpose to democratize sleep health, making it accessible to all.

SPONSORS & EXHIBITORS

Silver Sponsor

Booth 087

Takeda Neuroscience is driven by the unmet needs of patients with rare neurological diseases. Our mission is to bring innovative and potentially diseasemodifying medicines to these patients by leveraging advances in molecularly and genetically defined targets, biomarkers, and targeted modalities. Our commitment to patients is focused on developing new treatments for those who need them most.

Booth 158

withingshealthsolutions.com

Withings Health Solutions is a leader in connected health. With more than a decade of expertise and millions of users of our solutions, we excel at taking the complication out of running a digital health program. Our portfolio of solutions, from connected devices such as blood pressure monitors and a smart temporal thermometer to remote patient monitoring platforms, are beautifully designed and easy to use while providing medical-grade insights from home. We help both care teams and patients to achieve higher quality care.

Booth 152 vivisol.com

VIVISOL was established by the SOL Group in 1986. Today, with over 35 years of experience in the field, VIVISOL has become one of Europe’s largest home care groups, allowing people to receive treatment at home. VIVISOL offers home care services for Oxygen Therapy, Ventilatory Support, Sleep-related respiratory disturbances, Aerosol Therapy, Artificial Nutrition, Infusion Therapy, At-Home Medical Care and Telemedicine.

The CG Fund

In his memory, World Sleep Foundation, a nonprofit 501c(3) organization, created an endowment in honor of Dr. Guilleminault. The CG Fund awards travel grants to young investigators in sleep medicine and research to encourage and enable their participation in the scientific sleep community.

CG Award Applications

Applications for the CG Award are accepted year-round. Applications are reviewed three times per year and awards disbursed. The deadlines are: April 30 | August 31 | December 31

For more information visit worldsleep.info/yi

Christian Guilleminault “CG” | 1938 – 2019

Dr. Christian Guilleminault (known as “CG” among colleagues) devoted his career to the development and advancement of sleep medicine and research. His groundbreaking research in the areas of sleep apnea, pediatric sleep disorders, and narcolepsy made him a leader in the field of sleep medicine and research. Throughout his career, Dr. Guilleminault mentored hundreds of physicians and scientists.

Get Involved!

• Contribute to the CG Fund

• Share the CG Award application with colleagues

Your Trusted Source for Improving Sleep

Healthier Sleep is a public awareness magazine that acts as a trusted source for information regarding sleep health, disorders, and research. The magazine is published up to six times per year and is available for free online

Issue Topics

• Sleep Apnea

• Healthy Sleep

• Sleep Disorders

• Insomnia

• Daytime Sleepiness

• Restless Legs Syndrome (RLS)

For more information visit Healthiersleepmag.com

Get Involved!

• Contribute to the magazine as an author

• Serve on the review and advisory committee

NOTES

Join

All individual memberships include the following benefits:

• Discounted registration at the World Sleep congress

• Access to Sleep Medicine

• Eligibility to serve on World Sleep Society committees and task forces

Become a Member worldsleepsociety.org